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ABSTRACT
Nitric Oxide, Salivary Hypofunction and Sjogren’s Syndrome 
Vicky Louise Caulfield
Sjogren's syndrome is a systemic autoimmune disorder which specifically targets the 
exocrine glands, primarily the salivary and lacrimal glands and leads to an 
impairment of secretory function and is characterised by lymphocytic infiltration of the 
salivary and lacrimal glands. Until relatively recently it was believed that the glandular 
hypofunction was a direct consequence of immune mediated destruction of the 
acinar tissue but most recent data suggests that the glandular hypofunction is more 
likely to be the result of immune mediated inhibition of acinar function, which if 
prolonged could lead to acinar atrophy.
Many factors may induce this observed glandular hypofunction in Sjogren's 
syndrome but, based on the presence of elevated levels of nitric oxide (NO) in the 
saliva and expired air of Sjogren's syndrome patients, NO was suggested as a 
possible cause of this induced hypofunction. The findings presented here 
demonstrate that NO has the ability to both amplify and inhibit the acinar cells 
response to ACh, which suggested that NO may have a role in acinar cell 
desensitisation. This response pattern was observed in both submandibular and 
lacrimal cells from both humans and mice. The use of four NO donors (SNAP, NOC- 
12, SNP and NOC-5) makes it unlikely that the responses were an artefact of the NO 
donor and the use of multiple cell types suggests the process might be a universal 
mechanism. The initial amplification induced by NO was significant with all four NO 
donors in the mouse submandibular acinar cells (SNAP P<0.01, NOC-12 POD.001, 
SNP P< 0.05 and NOC-5 P<0.05). The induced inhibition following prolonged NO 
exposure was also significant with SNAP (P<0.001) and SNP (P<0.01) and total 
inhibition of response to ACh following prolonged exposure to SNAP occurred within 
36 minutes.
Following the use of four NO donors, the downstream activity of NO was determined. 
The amplification was shown to act through the cGMP pathway through use of two 
inhibitors of this pathway, ODQ and Ryanodine. However, the chronic NO effect 
resulting in desensitisation to ACh appeared to be independent of cGMP pathway as 
desensitisation to ACh still occurred in the presence of both inhibitors. These data 
may suggest a role for NO in the development of glandular hypofunction in Sjogren's 
syndrome.
Following the determination that NO was able to induce desensitisation of the acinar 
response in individual acinar cells the possible effect at the acinus level was 
investigated. It initially had to be determined if cell to cell communication did occur in 
salivary acinar cells. The data indicate that there was some degree of cell to cell 
communication occurring between salivary acinar cells and that this may result in the 
production of a synchronous oscillatory response pattern which was clearly observed 
in some instances. However, NO was shown to have no effect on the oscillatory 
response pattern which suggested that NO did not appear to desensitise at the 
acinus level and in fact NO may function under normal conditions to sensitise the 
cells to ACh by enhancing the level of cell to cell coupling.
Overall the work has demonstrated, for the first time that NO induced desensitisation
may have an important role in the development of glandular hypofunction in
Sjogren's syndrome.
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Chapter One
Introduction
U N 1 V JJR  S_ I 0 F
LIVERPOOL
1.1 Salivary Secretion
Nervous Control of Fluid Secretion
Salivary secretion as a result of nervous stimulation was demonstrated over a 
hundred years ago, using electrical stimulation of the lingual nerve and the 
submandibular glands from a dog (Ludwig, 1850). More recent studies have shown 
that salivary secretion is dependent on nerve-mediated mechanisms (Smith, 1996). 
The neural control of salivation is outlined in figure 1.1.1. Taste is the primary 
stimulation for salivation (Hector MP, et al, 1999) and the afferent pathway for input 
from taste is carried to the solitary nucleus within the medulla via the facial (VII) and 
the glossopharyngeal (IX) nerves. The solitary nucleus may also integrate input from 
mastication and responses in higher centres to senses such as smell or sight or even 
thought but mastication and taste are by far the most important stimulators of salivary 
secretion. The parasympathetic efferent pathways for the submandibular and 
sublingual glands are produced from the facial nerve via the submandibular ganglion.
The efferent (secreto-motor nerves) are controlled by both the sympathetic and 
parasympathetic divisions of the autonomic nervous system. Experimental animal 
models have demonstrated that stimulation of each nerve type independently leads 
to a variation in release and subsequently a variation in response. The 
parasympathetic nerves, which release acetylcholine (ACh), stimulate fluid secretion 
whilst the sympathetic nerves, which release noradrenalin (NA), stimulate protein 
secretion (Starling, 1927).
Many factors have the ability to affect salivary secretion. The classic examples for 
demonstration of this point are the ‘conditioned-reflex’ experiments performed by 
Pavlov, who induced salivation in dogs in response to the sound of a bell (Pavlov, 
1927). For the parotid glands the parasympathetic efferent supply is from the
2
glossopharyngeal nerve via the otic ganglion. The sympathetic postganglionic 
pathways are from the cervical ganglion of the sympathetic chain (Smith, 1996). In 
addition there are several additional reflexes that are responsible for salivation; these 
include vomiting and stimulation of mechanoreceptors in the periodontal ligaments of 
the teeth (Hector and Linden, 1987; Scott et al., 1999) and oral mucosa (Scott et al.,
1998). The stomach or upper intestines may also stimulate salivation in order to 
dilute or neutralize irritating substances such as when an individual feels nauseated 
(Dawes, 2004). In addition resting salivary flow is also subject to the natural circadian 
rhythms, which peak late afternoon and fall to almost zero during sleep (Dawes, 
2004).
As a result of all these at findings it was determined that fluid secretion by salivary 
acinar cells is ultimately controlled by the afferent and efferent nerve pathways. 
Figure 1.1.1. Outlines the neural control of secretion.
AFFERENT EFFERENT
Figure 1.1.1: Diagram of the Afferent and Efferent pathways in
the control of salivary secretion. Reproduced by the kind 
permission of Dr. P.M.Smith
So in summary the afferent pathways allow the response induced by taste to travel 
along the facial and glossopharyngeal nerves to the solitary nucleus in the medulla, 
which also integrates signals from other response centres such as smell or sight. The 
efferent pathways include both the parasympathetic and sympathetic nervous 
systems. Parasympathetic stimulation, by the facial nerve via the submandibular 
ganglion, results in secretion by the sublingual and submandibular glands.
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Parasympathetic stimulation of the parotid gland is by the glossopharyngeal nerve 
via the otic ganglion. The sympathetic pathway is primarily responsible for protein 
secretion and involves the post ganglionic fibres from the cervical ganglion of the 
sympathetic chain.
The two nerve types, sympathetic and parasympathetic, travel by separate routes 
outside of the salivary glands but once within the glands they intermingle to form 
Schwann axon bundles (Garrett and Kidd 1993). The general distribution and number 
of cholinesterase positive parasympathetic nerves is similar in both the 
submandibular and parotid gland in man. The main nerve trunks run in the 
connective tissue adjacent to the main ducts and blood vessels. Nerve fibres are 
seen distributed to the blood vessels, acini and ducts. Adrenergic sympathetic nerves 
follow a similar pattern of distribution to the cholinergic nerves but are fewer in 
number (Garrett 1967).
Work conducted by Garrett and Kidd in 1993 focused on the neuro-effector 
relationships with the acinar cells at the terminal branches of the axons. Their data 
demonstrated that there were two possible relationships between the acinar cells and 
the nerves innervating the glands. These relationships were termed Epilemmal and 
Hypolemmal (Garrett and Kidd 1993). The key difference was how open the 
arrangement was between the axon and the acinar cell. The Epilemmal arrangement 
consisted of an axon which maintained its association with its Schwann cell and was 
positioned approximately 100nm beneath the basement membrane of the acinar cells 
but had a free surface exposed to the acinar cells. This particular arrangement is also 
observed between the axons and the smooth muscle of blood vessels occurring 
within the salivary glands.
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The alternative, hypolemmal, situation occurs much less frequently. In this 
arrangement the axon is bare and dissociated from its Schwann cell laying between 
two acinar cells. Therefore, in this situation the axon is contained within the 
basement membrane and is in almost direct contact with the acinar cells as there is 
only a gap of 25nm or less (Garrett and Kidd 1993) (Figure 1.1.2).
Epilemmal Hypolemmal
Figure 1.1.2: (A) Epilemmal and (B) 
Hypolemmal relationship of neurones 
to acinar cells. Used with the 
permission of Dr.L.J. Dawson
Within the submandibular and minor glands of humans both neuro-effector 
relationships have been demonstrated to occur (Garrett and Kidd 1993) but the 
situation in mice is as yet unknown. The hypolemmal arrangement is far more suited 
to situations which require more rapid responses to stimulation as the diffusion 
distance is greatly reduced allowing more rapid transit of the transmitter molecule to 
its designated receptor.
The more common, epilemmal arrangement, is consistent with the 1959 autonomic 
nervous system ground plexus concept described by Hilarp. This particular 
arrangement involves the neurons from both the sympathetic and parasympathetic 
nervous systems running side by side with maintained association with a Schwann 
cell. The axon then innervates a group of cells and the transmitter molecule moves 
by simple transmitter diffusion (Hilarp 1959). In situations when tissue is more 
sparsely innervated fewer cells will be directly contactable by axons. In such 
situations it is plausible that only one cell within a group is maintained in an effector
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relationship with an axon. So as a direct result of this the whole group of cells are 
reliant on the transmission of signal from the axon contacted cell to the rest of the 
group and this would require some form of intercellular communication.
Intercellular communications have been demonstrated in many cell types and often 
involve the diffusion of second messengers and calcium through gap junctions 
(Rottingen and Iversen 2000) however with relation to acinar cells no such processes 
have, to date been, identified. This particular area of research will be considered 
further in the cell-cell introduction section.
Dual innervation is also observed in blood vessels as parasympathetic stimulation 
induces vasodilation and sympathetic stimulation induces vasoconstriction. However, 
vasoconstriction is independent of the salivary reflex (Garrett, Kerret al. 1999).
Salivary glands also contain other types of transmitters as well as the main 
neurotransmitters acetylcholine (ACh) and adrenaline, and so do not rely solely on 
cholinergic and adrenergic stimulation (Ekstrom 1999). These alternative non- 
adrenergic, non-cholinergic (NANC) transmitters consist of neuropeptides and have 
also been described in the major and minor salivary glands. Gland fibres isolated 
from human submandibular tissue have been shown to be positive for neuropeptide 
Y (NPY), Vasoactive intestinal polypeptide (VIP), galanin (GAL), substance P (SP) 
and calcitonin gene-related peptide (CGRP) (Kusakabe, Matsuda et al. 1997). 
Further data suggest that the NPY, VIP, SP, CGRP and GAL fibres are densely 
distributed around the acini, ducts and blood vessels. In addition, when mucous and 
serous acini are compared (Kusakabe, Matsuda et al. 1997) fibres containing VIP, 
NPY and GAL are at a higher density around mucous acini and nerves containing 
VIP are more numerous in human submandibular glands (Kusakabe, Matsuda et al. 
1998). However expression of particular nerves and transmitter may vary over time
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with changes in salivary glands during development (Virta, Tornwall et al. 1992) and 
in the case of some conditions such as Sjogren’s syndrome where there is focal 
infiltration of inflammatory mediators the nerve expression of neuropeptides may be 
downregulated (Pedersen, Dissing et al. 2000).
Signal transduction in salivary acinar cells
The neurotransmitter of the parasympathetic pathways is ACh which regulates fluid 
secretion.
ACh was the first neurotransmitter to be recognised. It was initially identified by 
Henry Hallett Dale in 1914 (Dale 1914) for its actions on heart tissue and 
subsequently confirmed as a neurotransmitter by Otto Loewi (Loewi 1921). ACh is a 
chemical transmitter involved in both the peripheral nervous system (PNS) and the 
central nervous system (CNS) of many organisms and is the neurotransmitter in all 
autonomic ganglia. ACh may be viewed as the classical neurotransmitter of the 
parasympathetic nervous system. In the salivary gland, once ACh is released from 
the nerve terminus it must diffuse a short distance before binding and stimulating cell 
surface muscarinic receptors (mAChR).
Muscarinic Receptors
The mAChR belong to a 7-membrane spanning domain receptor family but also 
belong to a class of metabotropic receptors which use heterotrimeric guanine 
nucleotide-binding proteins (G-proteins) as their signalling mechanism (Wess, Blin et 
al. 1995) and are separated into five subtypes. The five subtypes of mAChR are 
designated M1-M5 based on data from cDNA cloning, their intracellular coupling 
through different G-proteins and observable interactions with agonists and
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antagonists of these receptors (Caulfield and Birdsall 1998). The use of the 
competitive mAChR antagonist atropine demonstrated that the release of ACh from 
parasympathetic nerves acts as the main inducer of fluid secretion.
Based on data from rat parotid gland (Baum and Wellner 1999), until relatively 
recently, there was widespread acceptance that an increase in salivary secretion in 
response to muscarinic agonists was mediated entirely through the mAChR type 3 
receptor (M3R) (Caulfield 1993). M3R is known to predominate in rat, mice and 
human salivary glands (Perez Leiros, Sterin-Borda et al. 1999), but more recent data 
from rat and rabbit submandibular and rat sublingual glands have suggested that M1 
receptors and other non-M3 receptors may also partially mediate fluid secretion 
(Culp, Luo et al. 1996); (Tobin 1995); (Tobin, Giglio et al. 2002). Tobin and co­
workers also noted that cholinergic effects via M1 receptors involving nitric oxide may 
occur in the submandibular gland (Tobin 2002). More recent studies using knockout 
mice have enabled a much greater insight into the various mAChR subtypes 
involvement in salivary secretion (Gautam, Heard et al. 2004); (Nakamura, Matsui et 
al. 2004).These more recent data suggest that both M1 and M3 receptors may make 
contributions towards salivary secretion, but also that compared with M3 receptors, 
M1 receptors are not ubiquitously expressed on submandibular acinar cells 
(Nakamura, Matsui et al. 2004).
With respect to M3R there do not seem to be significant differences between species 
with regard to receptor homologs based on their pharmacological profiles (Caulfield 
and Birdsall 1998). Their amino acid sequences (aa) are highly conserved between 
species and they vary very little with regard to molecular mass as shown (table
1.1.1.). Mouse and rat aa M3R sequences only differ by 16h aa and the rat 
subsequently only varies from humans by 49 aa. So if you allow for conservative aa
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changes this equates to a 94.4% homology between the M3R seen in the rat and that 
in the human.
Species GenPet accession Amino acid Molecular m
Code Number
Rat P08483 589 64.79kd
Mouse AAG14344 589 64.79kd
Human P20309 590 64.90kd
Table 1.1.1: Basic data for M3R for rat, mouse and human.
M1-M5, share a very similar three-dimensional arrangement. This structure 
comprises seven membrane-spanning domains which are referred to as 
transmembrane domains (TM) I -VII and these spanning domains are inter-linked by 
three extracellular and three intracellular loops referred to as i1-i3 (Wess, Blin et al. 
1995) as demonstrated in figure 1.1.3.
Figure 1.1.3: Diagrammatic 
representation of the orientation 
of the components of
muscarinic receptors in the cell 
membrane. I-VII represent 
transmembrane domains. i1-i4 
intracellular loops. Used with 
the permission of Dr.L.J. 
Dawson
Intracellular
9
Data suggest that ACh binds within a narrow cleft which is enclosed by a ring like 
arrangement of the seven TM domains and is believed to be about 1 to 1.5 nm away 
from the surface of the membrane. Site directed mutagenesis studies conducted 
using rat M3 receptors suggested that the ACh binding domain is formed from a 
series of hydrophilic aa that are located within the upper half of the TM domains 
between regions III, V, VI and VII and most likely consisted of Aspartate (Asp) and 
Tyrosine (Tyr). The most likely site of the interaction is the negatively charged TM III 
Aspartate residue, which is highly conserved between all biogenic amine receptors, 
as ACh is positively charged (Wess, Blin et al. 1995).
Signal Cascade
When the whole process of fluid secretion is broken down into individual parts of the 
signal cascade the point of initiation occurs when ACh binds to M3R and termination 
occurs with the secretion of electrolytes and fluid (Berridge 1993). The key point of 
this signal transduction process is that it has in-built amplification because the target 
enzyme is stimulated to generate multiple molecules of 2nd messenger for as long as 
the a-subunit of the G-protein is bound by guanosine 5’-triphosphate (GTP). 
Amplification is extremely significant to 2nd messenger signalling because it allows a 
very small extra-cellular stimulus to produce a very large intracellular event (Rodbell 
1995).
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G-Proteins
Once ACh binds to the M3R it activates the associated G-protein (figure 1.1.4: Part 
1) which stimulates a cascade of responses involving subsequent 2nd messengers.
ACh acts as a ligand and binds with high specificity to M3R. How the M3R then 
interact with their G-protein is 
not completely understood 
(Wess, Blin et al. 1995;
Kostenis, Zeng et al. 1999).
The most likely scenario is that 
binding of ACh within the 
proposed cleft induces a 
conformational change which 
in turn allows a distinct 
intracellular domain to then 
interact with specific G- 
proteins. The most likely points 
of interaction are areas within 
the i2 and i3 loops as well as a 
long portion of the ¡4 tail as 
these are all thought the have 
the ability to form a three 
dimensional surface which would allow G-proteins to interact but only upon binding of 
ACh to the receptor (Wess, Blin et al. 1995).
Figure 1.1.4: 1 = the binding of ACh to M3R activates Gaq 
which binds GTP. 2 = the a subunit activates PPLC. 3 = PLC 
splits PIP2 into DAG which activates protein kinase C and 
lns(1,4,5)P3 which diffuse into the cytoplasm. This picture was 
reproduced by the kind permission of Dr. P.M. Smith.
The G-proteins themselves have a unique heterotrimeric structure, which is 
comprised of a, p and y subunits and may be divided into four families based on their
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a-subunits, termed s, i, q and 12/13 (Morris and Malbon 1999). With regard to fluid 
secretion the G-protein of interest are the Gaq (Wess, Blin et al. 1995) as these are 
linked to the M3R within the salivary glands. Upon activation of the G-protein the a- 
subunit dissociates leaving a Py-dimer and subsequently activates its target enzyme 
(Hancock 1997) (Figure 1.1.4: Part 2).
Dissociation of the heterotrimer into the a-subunit and (3 y-dimer occurs because the 
normally bound GDP is released from its guanine nucleotide-binding site and is 
rapidly replaced by GTP. The a-subunit also has an intrinsic GTP-ase which 
determines the duration of activation time. The heterotrimer is rapidly re-formed 
following hydrolysis of the GTP to GDP which allows for subsequent activations 
(Morris and Malbon 1999). The dissociation of the G-protein into its subunits provides 
the next link in the signal cascade.
The target of the newly dissociated a-subunits is PPLC with which they interact and 
regulate the activity of (Morris and Malbon 1999). Data also demonstrated that the 
Py-dimer is also active within this process (Boyer, Waldo et al. 1992) and that the 
pPLC enzyme is also able to function as a GTP activating protein (Berstein, Blank et 
al. 1992). PPLC is known to have 4 isoforms produced from soluble multidomain 
proteins (Rebecchi and Pentyala 2000). The larger region is responsible for the 
interaction with G-proteins and the different isoforms have been shown to have 
different sensitivities to the a-subunit and p y-dimer which may also bind at different 
regions and have the ability to act additively (Rhee and Bae 1997); (Katan 1998).
When activated by the a-subunit of the G-protein PPLC function by cleaving the polar 
head group from inositol phospholipids and hydrolyse the membrane bound 
phospholipid phosphatidylinositol 4, 5-bisphosphate (PIP2). Within the salivary 
glands hydrolysis of PIP2 generates two intracellular 2nd messengers: Inositol 1,4,5,
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trisphosphate (IP3) and diacylglycérol (DAG) (Berridge 1993) (Figure 1.1.4: Part 3). 
The purpose of IP3 generation is to activate the release of intracellular Ca2+ and DAG 
is produced to activate protein kinase C (Rebecchi and Pentyala 2000). For the 
purpose of this discussion IP3 will only be considered in relation to fluid secretion in 
salivary acinar cells.
Inositol 1,4,5, trisphosphate (IP3)
IP3 is the intracellular 
2nd messenger that is 
responsible for fluid 
secretion in salivary 
acinar cells (Ambudkar
2000). Upon its 
formation IP3 diffuses 
rapidly into the cytosol 
where it binds to the IP3 
receptors (IP3R). The 
IP3R are predominately 
located at the apical
FIGURE 1.1.5. 4 = lns(1,4,5)P3 binds to a tetrameric IP3R on the
intracellular Ca2+ stores and causes Ca2+ release into the
cytoplasm. There are at least 3 isoforms of IP3R (I,II & III), the 
complete receptor may be a homo- or heterotetramer. 5 = Ca2+ 
released from the stores feeds back onto the IP3R to stimulate Ca2+ 
-induced Ca2+ release. This picture was reproduced by the kind 
permission of Dr. P.M. Smith.
pole of acinar cells (Lee, Xu et al. 1997; Zhang, Wen et al. 1999).
The IP3R are located on the endoplasmic reticulum (ER) which is generally accepted 
as the intracellular Ca2+- store. IP3R function as a receptor with an integral calcium 
channel. Their purpose is to facilitate Ca2+ release from intracellular stores (Berridge 
1997; Gallacher and Smith 1999; Ambudkar 2000) as demonstrated by Figure 1.1.5: 
Part 4.
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IP3R is a homo- or heterotetrameric intracellular Ca2+-release channel that has a 
monomeric molecular mass of approximately 313kDa. The IP3R’s are tetramers and 
have three distinct domains, the ligand-binding domain, a regulatory domain and the 
Ca2+ - channel domain (Gallacher and Smith 1999). Three isoforms of IP3R 
designated IP3R1-3 have been identified in mammalian tissue and all three isoforms 
are structurally and functionally related (Gallacher and Smith 1999; Ambudkar 2000). 
All three isoforms have also been identified in salivary acinar cells and more 
importantly identified at the apical pole (Lee, Xu et al. 1997). It has also been 
determined that the different isoforms have different sensitivities to Ca2+ and IP3 
(Gallacher and Smith 1999). Of the three isoforms IP3R1 is the most widely 
expressed and is found in all tissue types at all stages of development. Along with 
the 3 receptor isoforms four IP3R genes have also been identified (Berridge 1997).
Based on the location of the binding site for IP3the major part of the protein resides 
in the cytosol (reviewed in (Bezprozvanny 2005)). Ca2+acts as a complex regulator of 
IP3Rs as high concentrations of intracellular Calcium (Ca2+) ion concentrations 
([Ca2+]i) inhibit IP3R while inversely low [Ca2+]i stimulate IP3R activity (Finch, Turner et 
al. 1991); (Bezprozvanny, Watras et al. 1991). The regulation of IP3R by Ca2+, IP3 
itself, sites of phosphorylation and calmodulin (Berridge 1997; Gallacher and Smith 
1999; Ambudkar 2000) offers considerable scope for the dynamic regulation of IP3R 
sensitivity. Its most likely that this positive regulation of the IP3R by calcium is largely 
due to a direct binding of Ca2+to the receptor ((Miyakawa, Mizushima et al. 2001); 
(Mak, McBride et al. 2003)) (figure 1.1.6. Part 5) but the mechanism by which 
calcium deactivates the receptor is much less clear but Calmodulin (CaM) has been 
suggested as being important to this process (Nadif Kasri, Bultynck et al. 2002).
The response of IP3R to cytosolic Ca2+ levels is biphasic and upon activation IP3R 
remain open longer when local [Ca2+]i is low but rapidly close when a threshold level
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of cytosolic Ca2+ is exceeded. This ability of IP3R to regulate Ca2+ provides a dramatic 
enhancement of the Ca2+ mobilising properties of IP3 and this phenomena is known 
as Ca2+-induced Ca2+ release (CICR) (Berridge 1997). This process is believed to be 
a fundamental feature and determines the spatial extent and also the magnitude to 
which IP3 induces [Ca2+]j signals (Berridge 1997); (Marchant and Parker 2000).
Ryanodine Receptors (RyR)
In addition to IP3R (Berridge 2005) there are also a second set of receptors, the 
Ryanodine receptors (RyR), which also facilitate Ca2+ release from the ER. Some 
cells contain both receptor types and may have more than one isoform of each 
(Morton-Jones et al., 2006; Yang et al., 2005). Like the IP3R, RyR also undergo 
CICR. However, the sensitivity of RyR to Ca2+ is controlled by the cytosolic 
concentration of an alternative 2nd messenger to IP3, known as cyclic adenosine 
diphosphate-ribose (cADPr). cADPr is a product of PNAD which is in turn a product 
of ribosyl cyclase which is regulated by cyclic GMP and Nitric Oxide (NO) levels (see 
Introduction section 1.2 Nitric Oxide).
RyR are named after the plant alkaloid ryanodine to which they have a high affinity. 
RyR are also known to exist in 3 isoforms in mammals and each is encoded by a 
different gene (Conti, Gorza et al. 1996; Marziali, Rossi et al. 1996). Although found 
in small amounts in many types of tissues the RyR are also named after sources 
where they are found at high concentrations. RyR1 is expressed in skeletal muscle 
and was first isolated in rabbit fast twitch skeletal muscle and so may also be termed 
skeletal. RyR2 is expressed in the myocardium (muscle of the heart) and was first 
isolated in tissue from a canine heart and so is also termed cardiac. RyR3 is 
expressed widely, but at highest concentrations in the brain and so is also termed
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brain but was first isolated in bovine diaphragm muscle (Vites and Pappano 1994); 
(Jeyakumar, Copelloetal. 1998); (reviewed (Fleischer 2008)).
The functional RyR was initially thought to be a homotetramer which has a quarter 
foil shape and a size of approximately 22-27nM on each side and forms a cation- 
selective channel for the release of Ca2+ from the ER (Zucchi and Ronca-Testoni 
1997). RyR were determined to be the largest channel structures with dimensions of 
approximately 29nm x 29nm x 12nm and a smaller trans-membrane assembly which 
protrudes 7nm. The isoforms are very similar but the variations between them are 
very important. Natural mutations in the human receptors are associated with a 
number of muscle diseases. The receptor has a mass of 2.3 ± 0.3 megadaltons 
(Saito, Tnui et al. 1989), the size of the polypeptide was subsequently estimated 
using northern blot analysis and was found to be about 550kDa (Marks, Tempst et al. 
1989). The full aa sequence of RyR1 was found to be approximately 565 kDa. From 
all this data it was determined that the RyR must be comprised of 4 identical subunits 
or receptor protomers and is therefore a homotetramer (reviewed (Fleischer 2008)).
Within excitable tissues RyR’s are considered to be the principal mediator of Ca2+- 
induced- Ca2+ release in (CICR) (Gallacher and Smith 1999), the primary reason for 
this is that other ligands are unable to activate the channel when Ca2+ is absent 
(Zucchi and Ronca-Testoni 1997). The two receptor types are found at opposing 
poles in acinar cells because as previously stated the IP3R are predominantly located 
at the apical pole where as the RyR’s are primarily located in the basolateral pole In 
the rat parotid gland (Lee, Xu et al. 1997; Zhang, Wen et al. 1999). Therefore, the 
Ca2+ signal is triggered by the activity of IP3 but then actively propagated across the 
acinar cell by CICR following the activity of both IP3R and RyR.
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Calcium Signals
In salivary acinar cells the brief burst of Ca2+ needed for the initiation of cellular 
signalling events is usually derived from the stores of Ca2+ present within the ER, as 
a result of the coordinated opening of the IP3R and/or the RyR (Berridge 1997). Both 
the IP3R and the RyR are sensitive to Ca2+ i.e. they display the phenomenon of 
CICR. As is found in the IP3R Ca2+ also has a biphasic effect upon RyR, as the [Ca2+]i 
increases there is a positive feedback resulting in more Ca2+ release, but as soon as 
the [Ca2+]i reaches a certain level the feedback switches from positive to negative 
inhibiting further channel activity (Berridge 1997). Due to the regenerative nature of 
the Ca2+ signal the activity of the IP3R and RyR can be coordinated directly via the 
level of Ca2+ (Figure 1.1.6 .).
Figure 1.1.6: Diagrammatic
representation of the ER 
arrangement to allow for Ca2+ - 
tunnelling. The diagram also 
introduces the concept of Ca2+ - 
induced Ca2+ release and the 
coordination of receptors by the 
level of Ca2+. 1 = Ca2+ blip/quark. 2 
= Ca2+ puff/spark. 3 = propagation 
of intracellular Ca2+ wave. Yellow 
lines = endoplasmic reticulum, 
Blue circles = Ca2+ and Red ‘Y’ 
shapes IP3R and RyR. The level 
of Ca2+ released determines the 
over all outcome and extent of the 
cellular response hence the 
smaller Ca2+ releases stated here. 
Used with the permission of 
Dr.L.J. Dawson
The main function of ACh-evoked Ca2+ -signalling in salivary acinar cells is to drive 
movement of water from the basolateral pole of the acinar cell to the apical pole 
situated along the glandular lumen. This whole process is made possible by the 
activation of Ca2+-dependent Cl' and K+ channels which are situated in the apical and 
basolateral parts of the acinar cell plasma membrane respectively (Smith 1996)
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which in turn leads to mobilisation of electrolytes and fluid secretion (Melvin, Yule et 
al. 2005).
The secretory process also utilises extra-cellular Ca2+ as well as mobilising stored 
Ca2+. Movement of Ca2+ from the extra-cellular environment to the intracellular Ca2+ 
stores across the plasma membrane is stimulated by depletion of intra cellular Ca2+ 
and is known as capacitance Ca2+entry (CCE) ((Putney 1990); (Berridge 1995) but is 
still poorly understood but most likely depends on the conformational coupling 
between IP3 receptors and the plasma membrane Ca2+ influx channels, this whole 
process is termed calcium influx.
Calcium signals are highly expensive in metabolic terms because the cell has to 
actively pump Ca2+ out of the cytoplasm as sustained elevated Ca2+ levels are 
cytotoxic. The ability of acinar cells to spatially restrict Ca2+ signals offers a solution 
to the problem. The polarisation of the acinar cell and arrangement of all the 
secretory processes in the apical pole of the cell also makes discrete Ca2+ signals 
possible.
The images in figure 1.1.7 are of a mouse submandibular acinar cell, loaded with a 
Ca2+ sensitive fluorescent dye and stimulated with a low concentration of ACh. They 
demonstrate the ability of salivary acinar cells to generate local Ca2+ signals. The 
fluorescence intensity is colour coded to produce a clear visualisation of variations in 
Ca2+ concentration. The apical pole is at the bottom right of the images which were 
captured at 500ms intervals (see sections 2.8 measurement of [Ca2+]i and 2.9 
microfluorimetry).
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Figure 1.1.7: Series of cell images clearly showing that the [Ca2+]i increases and decreases very 
rapidly at only the apical pole. Data suggest that it is possible to stimulate fluid secretion with a 
signal as small as the one demonstrated here (Harmer, Smith et al. 2005). The most simplistic 
explanation as to why these small local Ca2+ signals do not develop into global Ca2+ signals is that 
they are so brief that they do not have time to do generate sufficient Ca2+ levels around the IP3R or 
RyR to induce CICR. Images used with kind permission of Dr P.M.Smith.
Salivary acinar cells have a wide repertoire of Ca2+ signals they are capable of that 
include very brief localised signals through to cell-wide sustained elevations in [Ca2+]i 
that may persist for minutes at a time. It is unclear which of these responses is the 
most "physiological". However, spatially restricted, low level, signals in many ways 
make the most biological sense because they will be least cytotoxic and the most 
energy efficient.
As stated earlier, in salivary acinar cells Ca2+ signals initiate at the apical pole of the 
cell. This observation has caused some controversy as the main Ca2+ store is the ER 
that is primarily situated at the basolateral pole of the cell. Available data support the 
model of Calcium tunnelling (Mogami, Nakano et al. 1997). In this model there are 
tiny strands of ER at the apical pole of the cell from which Ca2+ is released. Localised 
on these strands of ER are high concentrations of IP3R (Nathanson, Fallon et al. 
1994) and would therefore be more sensitive to IP3 (Thorn, Lawrie et al. 1993). 
Furthermore, the ER is a continuous element throughout the cell so Ca2+ stored in 
the ER at the basolateral pole of the cell could in theory "tunnel" through the cell to 
be released at the apical pole as shown in figure 1.1.8.
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blood
Figure 1.1.8: Shows a highly simplified diagram of an acinar cell including movement of Ca2+ from the 
basolateral to the apical pole of the cell via calcium tunnelling for calcium release at the apical pole of 
the cell. Diagram by kind permission Of Dr P.M.Smith.
Cyclic adenosine diphosphate-ribose (cADPr)
Cyclic adenosine diphosphate-ribose (cADPr) is a relatively recently described 
second messenger. It was originally identified in 1989 by Lee and colleagues (Lee et 
al., 1989), whilst studying calcium release by microsomes derived from the 
endoplasmic reticulum of sea urchin eggs, and was subsequently demonstrated to 
have a role in Ca2+ mobilisation in both sea urchin eggs (Galione, McDougall et al. 
1993; Galione, White et al. 1993) and pancreatic acinar cells (Thorn, Gerasimenko et 
al. 1994). cADPr was found to be a low molecular weight metabolite of the pyridine 
nucleotide; nicotinamide adenine dinucleotide (NAD+). Lee and co-workers also 
provided direct evidence that both cADPr and IP3 were involved in mediating the 
increase in during fertilisation in sea urchin eggs (Lee, Aarhus et al. 1993).
These data suggested that cADPr, was likely to be an important addition to the family 
of cyclic nucleotides acting as second messengers.
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Following the experimental determination that cADPr was as functionally active as 
IP3 in terms of its ability to mobilise intracellular calcium in sea urchin eggs, the 
production of the enzyme responsible for cADPr had to be determined. The enzyme 
was originally purified in Aplysia californica as an aqueous soluble enzyme from the 
ovotestis (Hellmich and Strumwasser 1991) and was immediately suggested to be 
some type of NADase. Work done by Lee and Aarhus (1991) (Lee and Aarhus 1991) 
demonstrated that the Aplysia enzyme catalysed the conversion of NAD+ to cADPr 
and nicotinamide. In order to distinguish this enzyme from other conventional 
NADases that also produce ADP-ribose, the name ADP-ribosyl cyclase was 
suggested.
Data indicated that either cADPr was functioning along a totally alternative receptor 
system pathway or it had a much higher affinity for IP3 receptors than IP3 itself 
(Worley, Baraban et al. 1987). The idea of a higher affinity for IP3 receptors was 
rapidly dismissed because high concentrations of cADPr had little effect on IP3 
response and functioned only to desensitise the microsomes to it. The receptor 
responsible for binding cADPr was determined to be different to IP3 receptor as the 
use of heparin, a competitive inhibitor of IP3 binding, still allowed cADPr to function 
(Worley, Baraban et al. 1987); (Dargie, Agre et al. 1990).
It was also determined that IP3 and cADPr had an inverse relationship with one 
another in terms of the amount of calcium available for release. When the release of 
calcium by one activator (IP3 or cADPr) was small the response induced by the other 
activator, at maximal dose, would be great although there was no change in total 
amount of releasable calcium (Dargie, Agre et al. 1990). These data strongly 
suggested that IP3 and cADPr released calcium from overlapping stores. There was 
also no obvious evidence of synergy between the activators as the use of both only
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increased the amount of calcium released by 20-30% compared to each individually. 
Experimental results for cADPr suggested: (a) that the effectiveness of cADPr in vivo 
was comparable to IP3; and (b) the mechanism for calcium release was independent 
to IP3(Dargie, Agre et al. 1990).
Although there was obviously a specific binding site for cADPr on sea urchin egg 
microsomes, its exact nature was at this point undetermined (Lee 1991). Upon 
identification of the second class of intracellular calcium release channels, the RyR, 
in sea urchin eggs (Galione, Lee et al. 1991), the idea that cADPr was an 
endogenous regulator of the RyR formed.
Recent data suggest cADPr may have a role in Ca2+ mobilisation in salivary gland 
cells isolated from the rat (Yamaki, Morita et al. 1998), dog (Masuda and Noguchi 
2000) and mouse (Harmer, Smith et al. 2001). Data demonstrate that when mouse 
submandibular acinar cells were exposed to a RyR agonists such as caffeine it 
evoked localised Ca2+ 'spikes’ (Smith and Gallacher 1992). These data provide 
support for c-ADP-ribose/RyR interactions having an important role in Ca2+-signalling 
in salivary tissue.
The original research conducted in sea urchin eggs suggested that the RyR/cADPr 
pathway was ‘redundant’ (Galione, McDougall et al. 1993) as the traditional IP3 
mediated Ca2+-release pathway seemed to fulfil all the requirements for a signal 
transduction pathway. However, it has more recently been demonstrated that the 
level of cADPr within the acinar cell has the ability to determine the magnitude of the 
response to stimulation with ACh (Harmer, Smith et al. 2001). These subsequent 
findings suggest that acinar cells may have an alternative mechanism to adjust their 
sensitivity to agonist stimulation.
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Fluid Secretion
The main function of ACh-evoked Ca2+ -signalling in salivary acinar cells is to drive 
the movement of water from the basolateral pole of the acinar cell to the apical pole 
situated along the glandular lumen. This whole process is made possible by the 
activation of Ca2+-dependent Cl' and K+ channels which are situated in the luminal 
and basolateral parts of the acinar cell plasma membrane respectively (Smith, 1996). 
This step is pivotal for fluid secretion and is regulated by [Ca2+]i. and determines 
whether or not the cell secretes. It would be impossible to study fluid secretion in 
individual acinar cells so the study of Ca2+ is the most appropriate research method 
for fluid secretion as it is a direct representation but only became possible with the 
development of calcium sensitive dyes such as Fura-2AM (Tsien 1980). The vital 
point to note is that mobilisation of Ca2+ drives fluid secretion as demonstrated by the 
simple flow diagram below (Figure 1.1.9).
Figure 1.1.9: simple flow diagram representing simple steps of secretion
Once Ca2+ mobilisation has been stimulated by ACh receptor activation and 
production of IP3, as explained in full in previous sections, the subsequent processes 
involved in fluid secretion may be broken down into three steps as shown in figure 
1.1. 10:
(1). Although not shown in the diagram there is a Na+/K+ ATPase present in 
the basolateral membrane of the cell which uses energy produced from the 
break down of ATP to pump Na+ out of the acinar cell. So the acinar cells use 
active transport to increase cytoplasmic Cl' concentrations. This creates an 
inwardly directed Na+ gradient which energises a Na+/K+/2CI' co-transporter
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which is also situated at the basolateral membrane of the cell. The 
Na+/K+/2CI‘ co-transporter ensures a continuous flow of Cl'.
(2) . As the concentration of Cl' increases above its electrochemical potential it 
moves along its gradient and once Ca2+ has induced opening of the Ca2+ - 
dependent K+ and Cl' channels Cl' will cross the apical membrane into the 
lumen of the acinus. So activation of the luminal Cl' channel allows Cl" to 
enter the glandular lumen along its electrochemical gradient. The purpose of 
the Ca2+ -dependent K+ channel is to balance the loss of Cl' as if left 
unchecked the movement of Cl' would result in a change in membrane 
potential.
(3) . As Cl' accumulates in the glandular lumen Na+ crosses the acinar cell to 
maintain Electro-neutrality. As the levels of NaCI increase the resultant 
osmotic gradient moves water (Smith, 1996). So ultimately the movement of 
Na+ and Cl' drives the movement of water resulting in fluid secretion.
FIGURE 1.1.10: Diagrammatic overview of the formation of primary saliva 
by salivary acinar cells in response to stimulation by ACh. This picture was 
reproduced by kind permission of Dr. P.M. Smith.
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1.2 Nitric Oxide (NO)
Background
In recent years NO has been viewed as a double edged sword capable of inducing 
both positive and negative effects on biological systems. NO has been found to be 
produced in virtually every type of cell in the body and to play important roles in 
controlling the normal functions of the cells. NO may also be involved in the 
regulation of much larger scale processes such as the immune and nervous systems.
NO was first identified in 1772 by Joseph Priestly as a simple gaseous molecule 
which consisted of just one atom of nitrogen and one atom of oxygen and was simply 
viewed as an atmospheric pollutant. However, in the 1980 Robert Furchgott, and co­
workers, (Furchgott and Zawadzki 1980) were investigating the mechanism of 
vasodilatation and noted that ACh could only induce blood vessel relaxation if 
endothelial cells were present. They demonstrated that endothelial cells release a 
vasodilator when stimulated with agonists. These data suggested that the endothelial 
cells released something required by the smooth muscle cells for relaxation of the 
blood vessels. As a result of this finding this potent vasodilator was termed 
Endothelial Derived Relaxing Factor (EDRF) and was initially assumed to be a 
protein like most other signalling molecules and so stimulated intense research to 
identify what EDRF actually was. During a similar period of time Ferid Murad was 
independently investigating how nitroglycerin functioned. His data demonstrated that 
nitrogylcerin released NO which is able to cause relaxation of the smooth muscle 
cells (Murad 1978). However, in 1986 Louis Ignarro (Ignarro, Buga et al. 1987) finally 
put these two pieces of the puzzle together, and identified that EDRF was in fact NO. 
The discovery that EDRF was actually NO, a highly reactive gas, led to an explosion 
of interest in this field and has resulted in the publication of over 60,000 papers. In
25
Biological diversity of NO
NO is a major signalling molecule and has important roles as a bio-regulator within 
the nervous, immune and cardiovascular systems (Moncada, Radomski et al. 1988); 
(Moncada, Palmer et al. 1991); (Stefano, Liu et al. 1996); (Cooke and Dzau 1997); 
(Cooke and Dzau 1997); (Kinoshita, Tsutsui et al. 1997); (Farad, Sigmund et al. 
1998); (Blaise, Gauvin et al. 2005). NO participates in normal cellular function but 
may also initiate cytotoxic events either directly by the formation of free radicals, or 
indirectly by inducing apoptosis. Data suggest that NO acts primarily along the cyclic 
guanosine 3’,5’-monophosphate (cGMP) pathway (Blaise, Gauvin et al. 2005), which 
is hypothesised to be the main physiological pathway of NO (Chung, Pae et al. 2001) 
as shown in figure 1.2.1.
However, NO is also able to act 
independently of this pathway 
(Chung, Pae et al. 2001). NO is 
unique, by being: (i) a gas 
neurotransmitter; (ii) a small 
hydrophobic molecule able to 
diffuse up to several hundred 
microns removing the need for a 
specialised transport system; and 
(iii) being able to affect sites 
distant from its point of origin.
Though it is only able to persist
1998, in recognition of the impact of this discovery Furchgott, Murad and Ignarro
were awarded the Nobel Prize in medicine or physiology.
Figure 1.2.1: The likely NO pathway in salivary acinar cells. 
Abbreviations: NO, diatomic radical nitric oxide; iNOS, inducible 
nitric oxide synthase; ecNOS endothelial nitric oxide synthase; 
nNOS nerve nitric oxide synthase; sGC, soluble guanylate 
cyclase; cADPr, cyclic adenosine diphosphate-ribose; RyR, 
ryanodine receptor.
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and diffuse a limited distance, only several cell diameters, from its point of synthesis 
(Taha, Kiechle et al. 1992); (Malinski, Taha et al. 1993); (Lancaster, Werner- 
Felmayer et al. 1994); (Huang, von Rad et al. 2002) because it is readily oxidised to 
N02' and N03' under normal physiological conditions and therefore needs no 
separate mechanism for its removal.
The biological effects of NO are mediated through its reaction with a number of 
targets such as heme groups, cysteine residues and iron and zinc clusters, as it has 
a high affinity for metal ions.
In the absence of metals and proteins which contribute to NO destruction, and at low 
concentrations of NO, the decomposition of NO is much slower (Denninger and 
Marietta 1999), in these circumstances NO could have the ability to accumulate and 
reach higher concentration levels. When NO is at higher concentration levels it is 
known to react with 0 2 producing N20 3 which is recognised as a powerful nitrosilating 
agent and is capable of reacting with any sulphur or cysteine aa residues (Denninger 
and Marietta 1999).
In the immune system, NO plays a vital role and is produced at high concentrations 
by specialised immune cells such as macrophages and lymphocytes (Forstermann, 
Gath et al. 1995); (Lomniczi, Suburo et al. 1998). The production of NO by immune 
cells helps to protect the body against infection including bacterial, viral and parasitic 
infections. However, just as too much NO is toxic to invading cells, the host cells may 
also be damaged by high NO levels and as a result NO has been implicated in 
conditions involving auto-immunity such as rheumatoid arthritis and Sjogren’s 
syndrome (Konttinen, Platts et al. 1997); (Wanchu, Khullar et al. 2000). NO has also 
been shown to be involved with both the central and peripheral nervous system and
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appears to play a role in promoting the transfer of nerve signals from one neuron to 
another, as a result of this NO has been implicated in nervous system diseases such 
as Parkinson’s, Huntingdon’s and Alzheimer’s disease (Tabuchi, Oh et al. 1996); 
(Fitzsimonds and Poo 1998); (Hawkins, Son et al. 1998); (Tao and Poo 2001). NO 
has also been implicated in numerous physiological and pathophysiological 
neurodegenerative diseases due to its role as a key modulator in physiological 
processes such as memory, long term potentiation and also long term depression 
(Blaise, Gauvin et al. 2005).
Production of NO
NO is a short-lived, highly reactive molecule with a half life of only a few seconds. It 
is produced by a group of enzymes known as nitric oxide synthases or NOS 
(Moneada, Rees et al. 1991); (Moneada and Higgs 1993). These enzymes cause 
conversion of L-arginine into citrulline, NADP and NO through their enzymatic 
oxidation activity on the aa guanidine group of L-arginine (Marietta, Hurshman et al. 
1998). The process occurs in two sequential monooxygenase reactions and requires 
NADPH and molecular Oxygen (Blaise, Gauvin et al. 2005). There are three known 
isoforms of NOS and they were named according to their mode of activity or the type 
of tissue they were originally described in. The three forms are referred to as: Type 1 
neuronal NOS or n-NOS; Type 2 inducible NOS or i-NOS; and Type 3 endothelial 
NOS or e-NOS (Forstermann, Gath et al. 1995). Mitochondria also contain a unique 
NO-producing enzyme known at mt-NOS (Haynes, Elfering et al. 2004).
Data from experimental immunohistochemistry has subsequently demonstrated that 
nNOS is expressed in sympathetic ganglia, adrenal glands, peripheral nerves and in 
the endothelial cells of the lung, uterus and stomach (Forstermann, Gath et al. 1995). 
In addition nNOS has also been identified in the neurones which stimulate the
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salivary acini. NO has also been found, but to a much lesser extent, within the ductal 
cells of rat submandibular and sublingual glands (Takai, Uchihashi et al. 1999); and 
human labial glands (Feher, Zelles et al. 1999; Pedersen, Dissing et al. 2000). 
However, the distribution of iNOS was much more variable particularly dependent on 
the origin of the detection antibody (Konttinen, Platts et al. 1997) so the definitive 
location of iNOS within acinar cells remains open to conjecture.
As the name implies eNOS was first identified in blood vessel endothelial cells 
(Forstermann, Gath et al. 1995). eNOS has been demonstrated in the cytosolic 
fractions of mouse and rat parotid and submandibular glands (Mitsui, Yasuda et al. 
1997). However, in human salivary glands it has only been observed at very low 
levels (Konttinen, Platts et al. 1997; Brennan, Umar et al. 2000). Unlike nNOS and 
iNOS, eNOS is over 90% particulate, but in common with nNOS its activity is 
modulated by physiological levels of Ca2+/calmodulin (Forstermann, Gath et al. 
1995). nNOS and eNOS are constitutively expressed and Ca2+ dependent whereas 
iNOS is inducible and Ca2+ independent. The genes encoding for the three forms of 
NOS are distinct and located on three separate chromosomes, 7, 12 and 17 
respectively (Cooke and Dzau 1997); (Kinoshita, Tsutsui et al. 1997); (Moncada 
1997); (Farad, Sigmund et al. 1998). The existence and presence of both constitutive 
and inducible forms of NOS suggests that they may have distinct functions (Cotton, 
Herrick et al. 1999).
The three types of NOS differ in their: (a) amino acid sequence; (b) post-translational 
modifications; (c) function; and (d) cellular location. There is also a variation in their 
capacity to be regulated by levels of Ca2+V Calmodulin (Forstermann, Gath et al. 
1995). The three main NOS types share a 49-56% homology, which makes 
identifying them via western blot difficult due to the limited antibodies commercially 
available of which most of these antibodies are directed against the C-terminal half of
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the enzyme (the reductase domain) where most of the homology among the NOSs is 
present and this region also shows pronounced sequence similarities to cytochrome 
P450 reductase (Bredt, Hwang et al. 1991); (Haynes, Elfering et al. 2004). nNOS and 
eNOS are constitutively expressed and are involved in signal cascades whereas 
levels of ¡NOS increase in response to cytokines. The constitutive forms, nNOS and 
eNOS, are thought to account for the rapid, transient, calcium-dependent production 
of NO (Bredt and Snyder, 1990; Mayer et al., 1989, 1990) as they produce NO at low 
levels for short periods of time. ¡NOS is only expressed once activated by a signal 
transduction cascade in response to immunological or pathophysiological conditions 
(MacMicking, Xie et al. 1997).
¡NOS produces high levels of NO and is independent of Ca2+7 Calmodulin levels but 
may be induced by many cell types (including lymphocytes, macrophages and 
endothelial cells) in response to contact with both cytokines and bacterial 
lipopolysaccharides (Forstermann, Gath et al. 1995). No other control mechanisms 
have so far been identified for ¡NOS. Therefore ¡NOS functions as both a regulator 
and an effector of the immune response. Within the salivary glands ¡NOS has been 
suggested to be present within macrophages and ducts (Lomniczi, Suburo et al. 
1998) as well as with the acinar cells themselves (Konttinen, Platts et al. 1997).
The functional NOS protein is a dimer formed from two identical sub-units. Within 
each sub-unit there are three distinct domains: (1). a reductase domain; (2). a 
calmodulin-binding domain; and (3). an oxygenase domain. The Reductase domain 
contains Flavin Adenine Dinucleotide (FAD) and Flavin Mononucleotide (FMN) 
moieties which functions to transfer electrons from NADPH to the oxygenase domain 
of the opposite sub-unit of the dimer. The calmodulin binding domain is extremely 
important as calmodulin is necessary for the activity of the constituative NOS 
isoforms eNOS and nNOS and is able to detect changes in [Ca2+]| although exact
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function does vary between these NOS isoforms. The oxygenase domain contains 
the binding site for tetrahydrobiopterin, heme and arginine and acts to catalyse the 
conversion of L-arginine into citrulline and NO (Marietta 1994).
The direct effect that NO exerts for most of its physiological actions is through 
binding to a specialised heme moiety on the enzyme soluble guanylyl cyclase (sGC). 
This interaction results in a conformational change, which in turn activates sGC. The 
activation of sGC induces the production of cGMP from GTP and this molecule is 
able to engage numerous targets downstream. In salivary acinar cells the activation 
sGC by NO results in the accumulation of cGMP which is produced from GTP 
(Michikawa, Mitsui et at. 1998; Denninger and Marietta 1999; Tritsaris, Looms et al. 
2000; Looms, Tritsaris et al. 2001). The RyR are known to be the primary target of 
the cGMP mediated NO signal cascade and interaction with RyR induces release of 
Ca2+ from intracellular stores (Chapter 1 Introduction 1.1 salivary secretion section).
Increasing [cGMP]i is believed to lead to formation of cADPr through the action of 
PGK and sGC (Galione, White et al. 1993; Looms, Tritsaris et al. 2001) on |3NAD+. 
Subsequent data demonstrated that once formed, cADPr has the capacity to activate 
RyR’s which leads to a rise in [Ca2+]j (Smith and Gallacher 1992; Yamaki, Morita et 
al. 1998; Harmer, Gallacher et al. 2001; Looms, Tritsaris et al. 2001).
Overall, these findings may have important implications in Sjogren’s syndrome, as 
the data strongly suggest that NO may have the ability to modulate the magnitude of 
the [Ca2+]i subsequent to salivary acinar cell stimulation by agonist. In Sjogren’s 
syndrome sources of NO include not only that produced by invading immune cells 
but also NO may be produced by the salivary and lacrimal acinar cells themselves as 
NOS activity and cGMP production were significantly increased following activation of 
muscarinic receptors by antimuscarinic antibodies or carbachol (Bacman, Berra et al.
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1998; Perez Leiros, Sterin-Borda et al. 1999; Bacman, Berra et al. 2001) in a Ca2+- 
dependent manner.
Control of NO production
One of the main factors which control NO production is the actual location of the NO 
production or, more precisely, where the NOS are found. Data indicate that: (a) NOS 
isoforms can be targeted to different regions of the cell, so NO will be produced in 
close proximity to its target proteins (Harris, McCormick et al. 2008) as it is rapidly 
broken down; and (b) that there is very little region cross-over between NOS 
isoforms, so the variations in regions may determine that the NO produced has 
different functions and interacts with different targets. The NOS isoforms may also be 
regulated by the phosphorylation and de-phosphorylation of specific residues. eNOS 
shows increased activity following phosphorylation of specific residues (Looms, 
Tritsaris et al. 2002) but data suggests that phosphorylation of nNOS may only 
induce inhibition (Looms, Tritsaris et al. 2002).
NO synthesis may be inhibited by methylated analogues or arginine, asymmetric 
dimethylarginine (ADMA) and mono methylarginine (L-NMMA). These are 
competitive inhibitors of NOS which are produced endogenously by post-translational 
méthylation of arginine residues in proteins but may be liberated by hydrolysis 
(MacAllister, Parry et al. 1996); (Fickling, Holden et al. 1999); (Dayoub, Achan et al. 
2003); (Ayling, Whitley et al. 2006).
1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) may be used as a 
pharmacological control of NO. It is cell permeable and a potent and selective 
inhibitor of NO-sensitive guanylyl cyclise. ODQ doesn’t chemically inactivate NO itself 
but does however inhibit cGMP generation in response to donors of NO. ODQ does
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not inhibit NO-mediated macrophage toxicity, which is unrelated to cGMP and it also 
doesn’t affect the activity of particulate guanylyl cyclase or adenylyl cyclise (Wang, 
Rechenmacher et al. 1998); (Southam, Charles et al. 1996); (Brunner, Stessel et al. 
1995).
Figure 1.2.2: Diagram depicting the pathway of NO activity and control. White arrows signify points of 
inhibition and blue arrows refer to downstream reactions. NO -  Nitric Oxide, sGC -  soluble guanylate 
cyclase, GTP -  Guanasine 5’-triphosphate, cGMP -  cyclic guanasine3’,5’-monophosphate, PNAD -  
beta nicotinamide adenine dinucleotide, cADPr -  cyclic adenosine diphosphate ribose, RyR - 
Ryanodine receptor and ODQ - 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one
ODQ has been shown to specifically inhibit the NO-sensitive sGC (Garthwaite, 
Southam et al. 1995); (Olesen, Drejer et al. 1998) as indicated in figure 1.2.2. This 
inhibitory effect has been demonstrated in a number of tissue types (Garthwaite, 
Southam et al. 1995); (Brunner, Stessel et al. 1995); (Moro, Russel et al. 1996); (Abi- 
Gerges, Hove-Madsen et al. 1997). The binding of ODQ is in a non NO-competitive 
manner but inhibits NO-stimulated activity but leaves basal enzymatic activity
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unchanged. Subsequent research identified oxidation of the heme iron as the 
underlying mechanism (Schrammel, Behrends et al. 1996); (Zhao, Brandish et al. 
2000).
In vivo, the cellular levels of ADMA and L-NMMA are regulated by the enzyme 
dimethylarginine dimethylaminohydrolase (DDAH). When cells were observed in 
culture, if the level of DDAH was inhibited then the level of ADMA increased. The 
subsequent increase in ADMA then inhibited endothelium-dependent relaxation 
(Ayling, Whitley et al. 2006). These data demonstrate that DDAH is active at the 
basal level and if DDAH is inhibited for long enough, the level ADMA increases and 
accumulates within the cell until it reaches a concentration where it can actively 
inhibit NOS. NO has also been described to inhibit sGC expression and sGC activity 
in a cGMP-dependent manner (Filippov, Bloch et al. 1997). It is believed that this 
inhibition of sGC expression acts as a negative feed-back loop which may be a way 
of controlling the efficacy of the NO-cGMP pathway (Francois and Kojda 2004).
Biological activity of NO
There are several ways in which NO is thought to be able to mediate its biological 
effect(s) (reviewed (Blaise, Gauvin et al. 2005)):
1. Directly through the NO/cGMP/cADPr pathway
2. Indirectly by reactive nitrogen species (RNS) due to NO reacting with 0 2 to 
form nitrates, nitrites and peroxynitrite which are highly destructive and 
unstable.
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3. React with cysteine residues in proteins, a process known more commonly as 
s-nitrosylation and this mechanism is emerging as the most important 
mechanism of NO mediated effect and as an important signalling mechanism 
in cells (Marshall and Stamler 2001; Stamler, Lamas et al. 2001; Sun, Xin et 
al. 2001).
S-nitrosylation is an important post-translational protein modification which affects a 
large number of proteins that are involved in a number of cellular processes. S- 
nitrosylation is the modification of cysteine groups of proteins by NO. The role and 
importance of nitrosylation has only recently been recognised, mainly because the 
simple structure of NO was thought to lack the specificity and control observed in 
other post-translational modification systems such as phosphorylation. However, 
current data suggests that nitrosylation does share many properties with 
phosphorylation (Hess, Matsumoto et al. 2005); (Greco, Hodara et al. 2006) and may 
be equally important for post-translational modification of proteins (Mannick and 
Schonhoff 2004). Both nitrosylation and phosphorylation exhibit: (i) substrate 
specificity; (ii) strict spatial and temporal regulation; and (iii) are reversible. With 
nitrosylation the consequences to function are highly dependent on the particular 
protein which is affected and may result in inhibition, in the case of caspases, or 
enhancement, in the case of cGMP-dependent protein kinases (Dash, Cartwright et 
al. 2003). Protein s-nitrosylation exhibits strict spatial and temporal regulations and is 
reversible (Mannick, Hausladen et al. 1999). Proteins identified as being nitrosylated 
are over a hundred in number (Stamler, Lamas et al. 2001). Despite its potential 
importance to biological systems a detailed understanding of s-nitrosylation is 
currently lacking.
There is a general agreement that NO exerts many of its physiological effects 
through cGMP. NO binds to a specific region of the enzyme sGC within a specialised
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heme moiety forming a nitrosyl-heme adduct of sGC and this is also considered to be 
the most important way to activate this enzyme (Wolin, Wood et al. 1982); (Ignarro, 
Wood et al. 1982). As a consequence of this interaction a conformational change 
results in the heme iron being shifted out of the plane of the porphyrine ring which 
initiates the production of cGMP from GTP as it binds at the now available site 
(Ignarro, Cirino et al. 1999). Once formed cGMP is able to engage numerous targets 
downstream.
In salivary acinar cells the accumulation of cGMP produced from GTP follows the 
activation of sGC by NO (Michikawa, Mitsui et al. 1998; Denninger and Marietta 
1999; Tritsaris, Looms et al. 2000; Looms, Tritsaris et al. 2001). cGMP activates 
ribosyl cyclase causing the formation of cADPr from (3NAD. Once formed, cADPr 
has been shown to be capable of activating RyR’s leading to a rise in [Ca2+]i following 
release of Ca2+from intracellular stores (Smith and Gallacher 1992; Yamaki, Morita et 
al. 1998; Harmer, Smith et al. 2001; Looms, Tritsaris et al. 2001). The Use of ODQ 
as an inhibitor of NO demonstrates that NO acts through the cGMP pathway as in the 
presence of ODQ NO has no obvious effect upon intracellular calcium levels (Looms, 
Tritsaris et al. 2002).
NO used in experiments is derived from NO donors due to the inconvenience of 
using NO in its natural gas form. NO donors are compounds that are capable of 
releasing NO in situ and can be divided into different groups (Soff, Cornwell et al. 
1997). A commonly used NO donor is sodium nitroprusside or SNP which is an 
example of an inorganic nitroso-compound. S-nitroso-N-acetyl-penicillamine or SNAP 
is an example of an S-nitrosothiols and these compounds vary in their modes of 
action for the release of NO (Al-Sa'doni and Ferro 2000); (Al-Sa'doni, Khan et al. 
2000). More recently the NOC’s and NONATES have been developed. These are 
zwitterions formed from polyamines. These more recent NO donors release fewer
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biologically reactive bi-products than SNP and SNAP and so reduce the possibility 
that any bi-products are having an effect upon experimental results. They release 
more predictable amounts of NO and their structures have a striking resemblance to 
amino acids which may render them more amenable to participation in biological 
processes (Hrabie 1993; Maragos, Wang et al. 1993). NO acts as a first messenger 
but it differs significantly from all other first messengers in that it is also capable of 
acting as an intracellular messenger. sGC has been proven to be a receptor of NO 
(Denninger and Marietta 1999).
As NO has potent vasodilator ability it would also be reasonable to suggest NO could 
influence salivary secretion by modulation of blood flow within the salivary glands. 
Initial in vivo whole animal experiments demonstrated that there appeared to be no 
direct connection between total glandular blood flow and salivary fluid secretion 
(Larsson and Olgart 1989; Damas 1994). However, A. V. Edwards and colleagues 
conducted experiments in 1999 using cats which demonstrated that when blood 
pressure was reduced (approximately 50%) there was a significant reduction in 
submandibular blood flow and subsequently a reduction in the salivary secretion 
(Edwards et al. 1999). This work demonstrated that submandibular secretion may be 
reduced under conditions which effect blood flow to the gland. Subsequent work 
conducted by Edwards and colleagues in 2002 and 2003 but utilising sheep as the 
model animal again demonstrated that reduction of blood flow reduces salivary 
output and also demonstrated that these findings were not species specific (Edwards 
et al. 2002; Edwards et al. 2003).
37
Summary of NO and Salivary Acinar Cells
In salivary glands (Looms, Tritsaris et al. 2001) and other cell types (Galione, 
McDougall et al. 1993; Galione, White et al. 1993) the formation of cADPr has been 
directly linked to the formation of cGMP, which is itself formed in response to cell 
stimulation with NO (Denninger and Marietta 1999). The ability of cGMP to increase 
the [Ca2+]i in response to ACh stimulation is also consistent with findings using 
cADPr (Harmer, Smith et al. 2001) and therefore suggests further evidence of a link 
between cGMP and cADPr in mouse submandibular acinar cells (Looms, Tritsaris et 
al. 2001). Previous data has also demonstrated that NO donors can stimulate Ca2+ 
mobilisation in salivary acinar cells (Looms, Tritsaris et al. 2001). Furthermore, the 
Use of ODQ, which is an inhibitor of sGC, demonstrates that NO acts through the 
cGMP pathway as in the presence of ODQ NO has no obvious effect upon [Ca2+]i 
(Looms, Tritsaris et al. 2002). The use of the RyR inhibitor Ryanodine also 
strengthened this argument over the effect of NO on the cGMP pathway, as the use 
of Ryanodine also removed the effect of NO on [Ca2+]i. (Data in this thesis also 
confirms these observations).
Increased levels of NO have been demonstrated in both the saliva (Konttinen, Platts 
et al. 1997) and expired air from patients with SjS (Ludviksdottir, Janson et al. 1999). 
In addition data have demonstrated increased levels of NOS are present in the labial 
glands of SjS patients (Konttinen, Platts et al. 1997). Taken together these findings 
may indicate that NO could have a possible role in the glandular hypofunction 
observed in SjS. Additional evidence for a role for NO in SjS is that SjS IgG has the 
ability to increase the levels of both NOS and cGMP in both salivary and lacrimal 
acinar cells (Bacman, Berra et al. 1998; Perez Leiros, Sterin-Borda et al. 1999; 
Bacman, Berra et al. 2001).
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1.3 Adenosine Tri-Phosphate (ATP)
ATP is stored and co-secreted with many neurotransmitters and may have the ability 
to act as a neurotransmitter or a neuromodulator like its metabolite adenosine 
(Fredholm and Hedqvist 1980); (Burnstock 1981); (Stone 1981); (White 1984); 
(Gordon 1986); (Richardson and Brown 1987). Studies using a variety of cells have 
demonstrated that extracellular ATP can cause various changes which include: 
alteration of ion fluxes; cell growth; contraction and relaxation of smooth muscle; 
modulation of vascular tone, platelet aggregation and trans-epithelial chloride 
secretion (Stone 1981); (Chahwala and Cantley 1984); (Gordon 1986); (Reilly, 
Saville et al. 1987); (Harden, Lazarowski et al. 1997); (Boarder and Hourani 1998); 
(King, Townsend-Nicholson etal. 1998); (Kunapuli and Daniel 1998).
Purinergic receptor types
ATP receptors are now known to be widely expressed in mammalian tissues. Data 
from pharmacological studies utilising analogues of ATP have demonstrated the 
existence of two main types of purinergic (P2) receptor. These P2 receptors have 
been classified into two distinct families designated P2X and P2Y. The P2X receptors 
are associated with ligand-gated non-selective cation activity, whereas the P2Y 
receptors are associated with G-protein activation (Abbracchio and Burnstock 1994). 
The ATP-gated P2 purinergic receptors which are designated P2X-[ - P2X6 (cation 
only channels) and P2X7 (a dual function cation channel/pore) all display extensive 
sequence identity (North 1996) but data show considerable variation with relation to 
tissue distribution, bio-physical properties, agonist profiles and pharmacology (P2X!, 
(Valera, Hussy et al. 1994); P2X2 - P2X6, (Collo, North et al. 1996); P2X7, 
(Surprenant, Rassendren et al. 1996). The P2X receptors functionally resemble ACh- 
gated channels with respect to gating and ionic permeability but are structurally 
unique (Ross, Ehring et al. 1997). Four P2 receptor sub-types: P2X4, P2X7, P2Y, and
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P2Y2 have been identified in mammalian salivary glands and were expressed by 
acini and ducts in both parotid and submandibular glands (Turner, Landon et al.
1999). P2Y2 have been identified in a variety of permanent submandibular and 
parotid gland cell lines of salivary gland origin (Quissell, Barzen et al. 1997; Quissell, 
Barzen et al. 1998); (Yu and Turner 1991). Salivary glands are now known to 
express mostly P2X7 (Pochet, Gomez-Munoz et al. 2003) which are some what 
unique among the P2X.
The P2Y have seven transmembrane domains which are coupled to a regulatory 
GTP-binding protein. The P2X on the other hand have only two transmembrane 
domains which are separated by approximately 300 amino acids which form a large 
extracellular loop (North 2002). It is highly likely that both the -NH2 and the -COOH 
termini are cytoplasmic and the extracellular loop was determined to contain several 
conserved N-glycosylation sites and ten cysteine residues which in turn form five 
disulfide bridges (Ennion and Evans 2002). Unlike the P2Y, P2X are not coupled and 
do not have a regulatory protein, so upon activation by an agonist they form a 
cationic channel and it has been speculated that at least three subunits must 
assemble to form the channel, regardless of whether the units are identical or not 
(North 2002).
There is some variation between P2Xi - P2X6 and P2X7. P2X7 has 595 aa whereas 
the other six P2X have only 450 aa (Surprenant, Rassendren et al. 1996). This 
variation in aa number is accounted for by a variation in C-terminus which is 120 aa 
longer in P2X7 (North 2002). P2X7 requires this much longer C-terminus (240 aa) to 
allow it to form pores, however, if this extended C-terminus is removed the receptors 
ability to form pores is abolished but this does not affect its ability to form a channel, 
this data also confirmed the role of the extended C-terminus in pore formation 
(Smart, Gu et al. 2003). The formation of this pore can lead to cell death (Virginio,
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MacKenzie et al. 1999) and as a result this receptor also has the capacity to trigger 
apoptosis (Chow, Kass et al. 1997) in two ways: 1) as a consequence of massive 
uptake of chloride (Tsukimoto, Harada et al. 2005); and 2) leakage of intracellular 
potassium (Kahlenberg and Dubyak 2004).
Purinergic receptors and Calcium
Data suggest that ATP shares similarities with other Ca2+ mobilising agents such as 
vasopressin and phenylephrine insomuch as it was able to activate 
Phosphoinositide-specific-phospholipase C enzymes (PLC) and stimulate the 
breakdown of phosphatidylinositol 4,5-bisphosphate (PIP2) and produce IP3 (Charest, 
Blackmore et al. 1985); (Okajima, Tokumitsu et al. 1987); (Dubyak, Cowen et al. 
1988). Other evidence also suggested that hepatic P2 type receptors were coupled 
through guanine-nucleotide-binding proteins to other 2nd messenger pathways, but 
the contributions to the effect of ATP were as yet unclear (Irving and Exton 1987); 
(Okajima, Tokumitsu et al. 1987). The elevation of [Ca2+]i appears to be a common 
effect induced by ATP in many tissue types and rat parotid acinar cells are a useful 
system for studying the effects of extracellular ATP since the mechanisms of other 
Ca2+ mobilising agonists, such as the muscarinic agonist carbachol (CCh), are well 
characterised in this tissue (McMillian, Soltoff et al. 1988).
It was originally reported by Gallacher that the electrophysiological response of 
parotid glands to ATP was indistinguishable from that induced by other Ca2+ 
mobilising agonists. However, this work was conducted in mice parotid acinar cells 
(Gallacher 1982) and not rat. Alternative experiments were then conducted in rat 
parotid acinar cells. The effect of extracellular ATP on [Ca2+]j were characterised in 
quin2-loaded rat parotid acinar cells and ATP was shown to specifically increase the 
[Ca2+]i six-fold above a basal level of 180nM (McMillian, Soltoff et al. 1987). McMillian
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found that ATP elevates [Ca2+]i in these cells in a highly specific) but reversible 
manner which was considered consistent with the activation of a P2 type purinergic 
receptor (McMillian, Soltoff et al. 1987). These experiments also illustrated that the 
increased [Ca2+]i induced by ATP was similar to that induced by CCh through its 
activation of muscarinic receptors, because like CCh the extracellular ATP stimulated 
the release of K+ and the [Ca2+]j response could be induced by both agonists in the 
absence of extracellular Ca2+ (McMillian, Soltoff et al. 1987). These data suggests 
that ATP may be an important neurotransmitter for the parotid gland.
Subsequent work done by McMillian and co-workers determined that there were 
marked contrasts between ATP and the receptor agonists linked to PLC (McMillian, 
Soltoff et al. 1988). Their theories were based on data which illustrated four distinct 
variations: (i). A combination of maximum concentrations of CCh, substance P and 
phenylephrine had no greater effect on [Ca2+]i than did CCh alone but there was 
some observable synergism between CCh and a maximum concentration of ATP; (ii). 
The use of guanosine 5’-[(3-thio]disphosphate (GDP[S]) by intracellular dialysis 
blocked the muscarinic receptors activated by CCh but did not block activation of ion 
channels by ATP; (iii). In spite of the effects on [Ca2+]i observed, ATP had little effect 
on cellular turnover of phosphatidylinositol which was in complete contrast to CCh 
and other Ca2+ mobilising agents; and (iv). ATP was able to stimulate the release of 
amylase from parotid acinar cells but only at a reduced level (33 ± 9%) when 
compared to PLC-linked receptor agonists (McMillian, Soltoff et al. 1988). The sum of 
these findings suggested that ATP increased [Ca2+]i through activation of a pathway 
which is distinct from that which is shared by PLC-linked receptor agonists such as 
CCh (McMillian, Soltoff et al. 1988).
P2X4 and P2X7 function as non-selective cation channels activated by ATP with high 
and low affinity, respectively. Once activated these receptors stimulate an increase in
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the [Ca2+]j level as a result of calcium influx (McMillian, Soltoff et al. 1987); (Soltoff, 
McMillian et al. 1990).
Purinergic receptors and salivary secretion
The ability to secrete in response to stimulation by exogenous ATP has been 
demonstrated in both the rat submandibular (Dehaye, Moran et al. 1999) and mouse 
parotid gland (Gallacher 1982) and data suggests that this may be mediated by the 
activation of both P2X and P2Y. P2X and P2Y have also been demonstrated in 
human submandibular salivary gland cell lines (Liu, Singh et al. 1999) and more 
recent data have demonstrated the ability of isolated human labial glands to respond 
to ATP (Pedersen, Dissing et al. 2000). Data obtained in other studies also 
demonstrated that when rat submandibular gland acinar cells are placed in culture 
the expression and activity of the P2Y2 increased as a function of time in culture, 
from marginally detectable, when freshly isolated, to a dramatic increase post short 
term culture (Turner, Weisman et al. 1997). As a result of this P2Y2 are up-regulated 
in response to stress or injury and are activated by extracellular ATP and have been 
identified in a variety of tissues including submandibular glands (Koshiba, Apasov et 
al. 1997); (Kishore, Wang et al. 1997); (McMillian, Soltoff et al. 1987); (Turner, 
Landon et al. 1999); (Ahn, Camden et al. 2000); (Seye, Gadeau et al. 1997; Seye, 
Kong et al. 2002). These results suggest a role for P2Y2 in the response to damage 
and disruption of normal salivary gland structure and function. In addition P2Yt are 
known to be expressed in rat submandibular glands and have subsequently been 
suggested to have a role in salivary gland development (Park, Garrad et al. 1997). 
More recent research has determined that P2Yi are most active in submandibular 
glands from immature animals (Schrader, Camden et al. 2005), but as the animal 
develops the Ca2+ response to agonists of P2Yt diminished (Park, Garrad et al. 
1997). P2Y2 receptor expression was barely detectable in salivary glands under
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normal conditions but was up-regulated when tissue homeostasis was disrupted 
using various methods (Turner, Weisman et al. 1997);(Ahn, Camden et al. 2000).
Purinergic receptors and disease
Under pathological conditions nucleotides are released from the cytoplasm of cells in 
a number of ways following activation of cellular responses which include cell 
adhesion, neurotransmission, apoptosis and cell growth (Wilden, Agazie et al. 1998); 
(Bodin and Burnstock 2001); (Chaulet, Desgranges et al. 2001); (Ciccarelli, Ballerini 
et al. 2001); (Coutinho-Silva, Parsons et al. 2003); (Weisman, Wang et al. 2005). 
These responses occur when cells become injured or stressed during periods of 
oxidative stress, ischemia, hypoxia or mechanical stretch (Bergfeld and Forrester 
1992); (Ciccarelli, Di lorio et al. 1999); (Pedersen, Pedersen et al. 1999); (Bodin and 
Burnstock 2001); (Ostrom, Gregorian et al. 2001). In salivary glands it is believed that 
P2 nucleotide receptors are actually activated by ATP that has been co-packaged 
with various neurotransmitters and released from neurons (Brown, Bruce et al. 2004).
P2Y2 up-regulation occurs in the submandibular glands of NOD.B10 mice and also 
demonstrated disease progression as P2Y2 activity in the submandibular gland 
acinar cells increased with age (Schrader, Camden et al. 2005). The NOD.B10 
mouse, which develops an auto-immune exocrinopathy (AEC) similar to Sjogren’s 
syndrome at approximately 8 weeks of age, is an acceptable animal model for 
primary Sjogren’s syndrome (Hu, Nakagawa et al. 1992); (Humphreys-Beher, Hu et 
al. 1994); (Robinson, Brayer et al. 1998; Robinson, Cornelius et al. 1998); 
(Humphreys-Beher and Peck 1999). This up-regulation could suggest an important 
role for P2Y2 in Sjogren’s syndrome as P2Y2 and their signalling pathways could 
contribute to the autoimmune exocrinopathy observed in Sjogren’s syndrome
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(Schrader, Camden et al. 2005). However, the P2Y2 may also be up-regulated to act 
in a more positive role, as alternatively P2Y2 up-regulation may play an important role 
in tissue repair by stimulating mitogenesis (Turner, Landon et al. 1999) or may 
provide an alternative pathway for fluid secretion in the NOD.B10 mouse (Schrader, 
Camden et al. 2005). However, the physiological consequences of P2Y2 up- 
regulation in salivary glands are as yet unknown (Baker, Camden et al. 2008).
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1.4 Cell - Cell Coupling in Salivary Acinar Cells
No cell lives in isolation, and the survival of all multi-cellular organisms requires an 
elaborate network of communication at the intra and intercellular level. Organisms 
need to co-ordinate and regulate their growth and metabolism with strict control over 
the multitude of cells which make up the many diverse tissue types and organs. 
Intercellular communication is mediated through soluble factors including hormones, 
contact with extracellular matrix and even through direct cell to cell interaction. Direct 
cell to cell interactions occur either by cell membrane proteins or through channels 
between the cells which are termed gap junctions.
The use of gap junctions in intercellular signalling may function to co-ordinate and 
synchronise cells that are connected in this manner. Gap junctions allow the 
movement of molecules smaller than 1.5kDa which would allow the involvement of 
the most common second messengers such as cADPr and IP3. Furthermore, a Ca2+ 
signal can also propagate from cell to cell and may induce co-ordinated behaviour in 
adjacent cells (Rottingen and Iversen 2000). It has long been known that myocytes in 
the heart function as a unit through cell to cell Ca2+ signals. Such cell to cell 
communication has also been observed in other excitable cells including glial and 
nerve cells (Giaume and Venance 1998). Importantly, cell to cell communication has 
now been observed in non-excitable cells such as hepatocytes which also seem to 
co-ordinate their function through gap junctions utilising Ca2+ (Eugenin, Gonzalez et 
al. 1998).
Ca2+ oscillations are frequently observed in single cells but are normally 
asynchronous with one another and have variable frequencies and would generally 
be observed as a constant elevated Ca2+ level when the sum responses of many
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cells are summarised. This fact also explains why only biphasic responses are 
observed in populations of cells which are grown in suspension or upon coverslips 
(Rottingen and Iversen 2000). It was not until 1988 that sinusoidal synchronous Ca2+ 
oscilliatory signals were observed and reported in both endothelial monolayers 
(Sage, Adams et al. 1989) and pancreatic acini (Pralong, Wollheim et al. 1988).
Using endothelial cell monolayers to demonstrate synchronised Ca2+ oscillations, it 
was observed that synchrony only occurred in cells which were seeded at low density 
and grown to confluence as this favoured the formation of gap junctions (Sage, 
Adams et al. 1989). Work conducted in 1991 by two separate groups, Pedersen and 
Pickles and co-workers, demonstrated similar sinusoidal Ca2+ oscillations in 
monolayers of sweat gland/ duct cells (Pedersen 1991); (Pickles, Brayden et al. 
1991). Synchronised Ca2+ oscillations have also been observed in recordings from a 
whole pancreatic acinus (approximately 10 cells) (Pralong, Wollheim et al. 1988).
Data derived from electrophysiological recordings demonstrated that a Ca2+ 
dependent current is increased when cells are coupled in pairs or triplets (Petersen 
and Petersen 1991). When pairs of pancreatic acinar cells were stimulated with 
cholecystokinin they oscillated in synchrony and by clamping the two cells membrane 
potentials to a common value, electrical coupling was ruled out as a possible 
synchroniser (Ngezahayo and Kolb 1993). However, it was also noted that different 
agonists differed in their modulating roles upon gap junctions as cholecystokinin 
seemed to inhibit gap junctional transport following a brief period of exposure 
(Ngezahayo and Kolb 1993); (Stauffer, Zhao et al. 1993); (Yule, Stuenkel et al. 1996) 
and similar results were observed with ATP (Ritter and Lang 1991); (Rottingen, 
Camerer et al. 1997).
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The best studied cells are hepatocytes which are coupled by gap junctions allowing 
the transport of both Ca2+ and IP3 (Saez, Connor et al. 1989). This was observed for 
up to four coupled cells which responded by oscillations which were synchronised 
though sequential activation of the cells. The most interesting point of such data was 
the fact that the sequence of activation was the same for each transient which 
suggested that the first cell to respond was the most sensitive to that particular 
agonist and controlled the other cells within the multiplet but when other agonists 
were used to stimulate the cells the controlling cell was different which suggested 
heterogeneous agonist sensitivity (Rottingen and Iversen 2000).
Based on work conducted on individual hepatocytes, Ca2+ signals have also been 
studied in the whole perfused liver (Robb-Gaspers and Thomas 1995). Perfusion of 
the whole liver demonstrated that when agonist was infused all hepatocytes within a 
lobule oscillated in synchrony and this synchronisation was produced by a wave of 
Ca2+ moving from cells at the periphery to more central cells upon each transient. 
The signal always originated at the same point and within the same cell which 
suggested a pace-maker role for this leading cell. The wave of Ca2+was determined 
to travel intracellularly at a constant velocity and appeared independent of agonist 
concentration (Tordjmann, Berthon et al. 1997).
Experiments conducted with relation to synchronisation in situ are highly relevant as 
the structure and architecture of the cell are preserved and any physiologically 
important variations in sensitivity to agonist which may be organised in a gradient 
fashion would be maintained which would be highly advantageous to the researcher 
(Rottingen and Iversen 2000). It was observed that in the salivary glands of blow 
flies, agonist-induced Ca2+ oscillations were synchronised through regenerative 
intercellular Ca2+ waves (Zimmermann and Walz 1997). It was noted that these 
oscillations were independent of Ca2+ influx but relied on the release and refilling of
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internal Ca2+ stores. There were no observable delays between cells but blocking of 
gap junctions by administration of octanol resulted in asynchronous oscillations 
suggesting the importance of gap junctions in this system (Zimmermann and Walz 
1997).
The main mechanism proposed for intercellular Ca2+ waves which are dependent on 
gap junctions is diffusion of IP3 through these intercellular connections (Sanderson 
1995). This suggestion was based on the initial observation of the effect induced by 
heparin on oocytes and airway epithelia, as heparin blocked the intercellular Ca2+ 
wave from follicular cells to the oocytes (Sandberg, Ji et al. 1992) and Ca2+waves in 
airway epithelia (Boitano, Dirksen et al. 1992). Toyofuku and co-workers produced a 
mouse model system through transfection (Toyofuku, Yabuki et al. 1998). The model 
was developed to present cells expressing both RyR and connexin 43 to be 
surrounded by cells only expressing connexion and upon administration of caffeine 
an intercellular Ca2+ wave was induced. Based on the absence of RyR in adjacent 
cells, the wave must be mediated through the IP3R and Ca2+ release from IP3 
sensitive stores. It is highly likely that the initial Ca2+ increase which was mediated by 
caffeine led to the activation of PLC which resulted in production of IP3 and this 
theory was substantiated by the fact that the use of U73122 was able to abolish the 
caffeine-induced Ca2+wave (Toyofuku, Yabuki et al. 1998).
Following focal application of agonist or mechanical stress, PLC is activated and 
produces IP3 which diffuses to neighbouring cells. IP3 acts to sensitise the cells for 
the subsequent Ca2+ wave that propagates much more slowly though CICR 
(Rottingen and Iversen 2000). The Ca2+wave also induces to production of more IP3 
as it activates PLC in the adjacent cells and this allows for further and more distant 
cells to be sensitised for the Ca2+ wave. This model comprises of two regenerative 
waves, the more rapid IP3wave and the much slower Ca2+ wave but the two waves
49
are inter-dependent for their regenerative properties (Rottingen and Iversen 2000). 
This theory was further substantiated by work done by Hirose and co-workers who 
demonstrated that a wave of IP3from the stimulated cell ran in parallel with a Ca2+ 
wave (Hirose, Kadowaki et al. 1999).
The use of a global agonist will stimulate PLC activation and production of IP3 in all 
cells, but at the single cell level the amount of IP3 produced is entirely dependent on 
the individual cells sensitivity to a particular agonist. When Ca2+waves are generated 
the so called ‘pacemaker’ cell is the cell with the highest sensitivity to the agonist. 
The wave spreads from this cell to other adjacent cells where the primary IP3 wave 
acts to sensitise the cells IP3Rs to Ca2+ allowing the intercellular Ca2+ wave 
originating from the ‘pacemaker’ cell to co-ordinate a synchronised oscillatory Ca2+ 
signal. However at low concentrations the wave would not perpetuate and several 
local waves would be initiated as opposed to a global wave induced by the 
pacemaker cell which would result in asynchronous temporal oscillations being 
observed. In contrast to this, high agonist concentration would stimulate IP3 
production above threshold level simultaneously in most cells and the pacemaker 
would be unable to control the phase of others in such a situation which would result 
in asynchronous oscillations or a sustained Ca2+ response. This model was proposed 
by Rottingen and Iversen in 2000 and may be viewed as analogous to the models of 
fundamental and global Ca2+ signals in single cells but at a much higher organisation 
level (Rottingen and Iversen 2000).
Although much is known about the intracellular signalling cascades of salivary acinar 
cells, very little is actually known about the intercellular signalling which has been 
suggested to occur. The mechanisms which drive fluid secretion in acinar cells are 
extremely important. Cytosolic Ca2+ is known to be involved in an extensive number 
of cellular functions and its physiological and pathophysiological roles have been
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extensively studied (Berridge 1993; Berridge 1994); (Berridge 1998); (Mooren and 
Kinne 1998). The whole process must occur at the correct time, in the correct order, 
at the correct place, as spatial and temporal factors are extremely important and play 
a vital role in fluid secretion (Harmer, Smith et al. 2005). The process by which acinar 
cells allow fluid secretion to occur is well known, as discussed previously (chapter 1 
Introduction 1.1 salivary secretion). Ca2+ is the most versatile intracellular messenger 
which has been discovered to date since it is known to be involved in the regulation 
of virtually all known cellular functions and reactions (Petersen, Michalak et al. 2005). 
However, it is also known to play a role in intercellular signalling in some cell types 
such as human neuroepithelioma cells (Palmer, Yule et al. 1996). Could Ca2+ 
function as an intercellular signalling molecule in salivary acinar cells to allow 
communication between acinar cells or is it some other molecule which is 
responsible for this function and what implications could such findings represent in 
relation to Sjogren’s syndrome? Such questions about cell coupling in salivary acinar 
cells must be addressed.
Through use of a high-speed confocal microscope Ca2+ signalling patterns were 
observed in rat salivary ducts (Yamamoto-Hino, Miyawaki et al. 1998) and acini 
(Takemura, Yamashina et al. 1999). The data produced from millisecond analyses 
demonstrated that [Ca2+]i responses in the ducts originated in some ‘pioneer’ cells 
and then moved to neighbouring cells which demonstrated asynchrony and 
heterogeneity (Yamamoto-Hino et al., 1998), but the [Ca2+]i responses observed in 
the acini demonstrated synchronicity (Takemura, Yamashina et al. 1999). These data 
suggested that the Ca2+ signalling system in salivary glands may be constructed 
according to the architecture of the tissue (Segawa, Takemura et al. 2002).
The function of exocrine glands is primarily achieved by the compartmentalisation of 
epithelial domains, acini and ducts which are also known to demonstrate
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characteristic morphological specialisation (Young and van Lennep 1978); (Pinkstaff 
1979). Segawa and co-workers subsequently demonstrated in 2002 that the pattern 
of Ca2+ signalling is also distinct between acini and ducts in the rat parotid gland in 
response to ATP and CCh stimulation (Segawa, Takemura et al. 2002). Their data 
also demonstrated that acinar cells within an acinus respond synchronously and 
behave as a functional syncitium but the ductal cells respond heterogeneously which 
demonstrates diverse signalling kinetics. In addition their data also demonstrated that 
the molecular distribution of connexion 32 and IP3R2 varied between the two 
domains and produced domain distinct patterns. Stimulation with CCh was also 
observed to induce a rise in [Ca2+]i in the acini before the ducts. However, no 
observations were made regarding Ca2+ waves from acini to ducts and the 
propagation of such a signal was considered unlikely. The sum of this data suggests 
that the Ca2+ signalling system in the rat parotid gland is organised in parallel with the 
architecture of the tissue (Segawa, Takemura et al. 2002).
Segawa and co-workers also observed considerable variations in the pattern of Ca2+ 
response to CCh and ATP between the two domains in the presence or absence of 
extracellular Ca2+. The acinar domains responded well to CCh but not to ATP. 
However, the responsiveness to CCh did not require extracellular Ca2+ which 
indicates that the acinar domain induces increased [Ca2+]i through release of Ca2+ 
from intracellular stores following muscarinic receptor stimulation. Conversely, based 
on the lack of response to ATP, purinergic receptor stimulation appears to have little 
effect on both the intra- and extra-cellular Ca2+ signalling mechanisms on cells within 
the acinar domain. In contrast to this the ductal cells responded to both CCh and 
ATP and removal of extra-cellular Ca2+ abolished responsiveness to CCh (Segawa, 
Takemura et al. 2002). The variation in response of the cells from the ductal regions 
combined with their lack of synchronicity may be a direct result of the heterogeneous
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The [Ca2+]j response synchronicity observed in the acini may be a direct result of 
gap junctional communication as has previously been implicated in synchronised 
Ca2+ signalling (Stauffer, Zhao et al. 1993); (Guerineau, Bonnefont et al. 1998). The 
presence of gap junctions in mammalian salivary gland tissue has been 
demonstrated previously using electron microscopy (Dewey and Barr 1964); (Hand 
1972); (Nagato and Tandler 1986) and connexin immunhistochemistry (Hirono et al., 
1995; Lee et al., 1998; Shimono et al., 2000). Gap junctions appear to be primarily 
present in the acinar domains of salivary glands (Segawa, Takemura et al. 2002). 
Other data demonstrated abolishment of synchronisation of Ca2+ response in the 
acini by use of octanol which strongly suggested that the acinar domain acts as a 
functional syncitium through gap junctions (Segawa, Takemura et al. 2002). Similar 
to the data from the gap junction localisation experiments immunohistochemical 
distribution data for IP3R2 also demonstrated that the IP3R2 distribution was also 
primarily within the acini as they were homogeneous here and only heterogeneous 
with relation to ductal regions (Segawa, Takemura et al. 2002).
The epilemmal arrangement of the nerves and the limited innervation within the 
salivary glands (Garrett and Kidd 1993) would suggest that salivary acinar cells are 
reliant on cell coupling for the whole gland to function. Furthermore, this innervation 
arrangement would lend itself to the need for “pacemaker” cells responsible for 
coordination of the cellular activity in the salivary acinus.
The key diagnostic features of SjS are focal perivascular lymphocytic infiltrations 
within the salivary glands (Fox and Maruyama 1997) and severe glandular 
hypofunction. This key feature which is as yet unexplained in SjS may be explained
cell populations present within the ductal regions of salivary glands (Sato and
Miyoshi 1988; Sato and Miyoshi 1998).
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by the pacemaker hypothesis as it would explain why a limited number of infiltrating 
lymphocytes which appear at specific loci within the salivary glands could affect the 
whole gland. A demonstration of pacemaker cell activity within the salivary acinus 
and their subsequent inhibition through immune modulators would provide an 
attractive explanation to this problem.
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1.5 Sjogren's syndrome
History o f S jogren's syndrom e
The original description of Sjogren’s syndrome was made by Johannes von Mikulicz 
in 1892. He described a 42 year old man exhibiting bilateral enlargement of the 
parotid and lacrimal glands which was associated with infiltration of a small round cell 
type (Mikulicz 1892). It was subsequently documented that this individual continued 
to suffer with recurrent episodes throughout his lifetime and following his death, a 
post-mortem examination revealed that his glands were found to contain “extensive 
lymphocytic infiltrations, but with no evidence of malignancy or infection”. Prior to his 
identification of this particular condition the term Mikulicz’s syndrome had been used 
to describe a wide variety of conditions including lymphoma, sarcoidosis, tuberculosis 
and other infections and so the term fell into disuse based on its inefficiency to 
provide adequate prognostic or therapeutic information (Daniels and Fox 1992). 
However the term may occasionally be used as a histological reference when focal 
lymphocytic infiltrates are observed on salivary-gland biopsy samples (Morgan and 
Castleman 1953).
The disorder was subsequently named after Danish opthamologist Henrik Sjogren 
(1899-1986), who first encountered it in 1930 when he was presented with a female 
patient suffering from dry and painful eyes. The case fascinated him and from this 
point he proceeded to identify similar cases and by 1933 he had described clinical 
and histological findings in a total of 19 patients all suffering from dry mouth and eyes 
and 13 of whom had probable rheumatoid arthritis. Through collection and 
observations made on conjunctival biopsies from each patient he was also able to 
characterise the histological nature of the disorder (Bell, Askari et al. 1999; Wollheim
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1999). He presented the sum of this data as a doctoral thesis written in German in 
1933 (Sjögren 1933) and so Sjogren’s syndrome was born.
Sjögren also introduced the term keratoconjunctivitis sicca for use with this syndrome 
so that it was clearly distinguishable from dry eyes induced by a lack of vitamin A 
which is termed xeropthalmia. The data collected by Sjögren went largely unnoticed 
for two decades until American investigators William Morgan and John Castleman 
presented a case study in 1953 at a clinical pathological conference involving a 
patient with Sjogren's syndrome and re-ignited interest in the disorder originally 
known as Mikulicz’s disease but re-named Sjogren’s syndrome (Morgan and 
Castleman 1953). It was Morgan and Castleman who suggested that Sjogren's 
syndrome and the earlier reported Mikulicz disease were actually the same disorder. 
In 1956 Bloch and colleagues outlined the clinical features of the syndrome and are 
still relevant today (Bloch, Buchanan et al. 1956). Over five decades later the 
condition which still bears Sjogren’s name remains as intriguing a subject and an 
area of intensive research for systemic auto-immune disorders.
Clin ical aspects o f S jogren's Syndrom e
glands, primarily the salivary and
Sjogren's syndrome (SjS) is an
is characterised by lymphocytic
autoimmune disorder which
specifically targets the exocrine
lacrimal glands. SjS leads to an
impairment of secretory function and
infiltration of the salivary (Figure Figure 1.5.1: H&E stained histological section of a 
labial gland from a patient with Sjogren's syndrome. 
There is a distinct loss of glandular architecture with 
areas of fibrosis. A dense lymphocytic infiltration is also 
seen which is characteristic of the disease.
1.5.1.) and lacrimal glands.
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SjS is one of the three most common autoimmune disorders (Pillemer, Matteson et 
al. 2001) with population prevalence believed to be similar to that of rheumatoid 
arthritis (Hazes and Silman 1990) having an estimated overall incidence of 3% 
(Thomas, Hay et al. 1998; Jonsson, Haga et al. 2000). In keeping with the majority of 
autoimmune diseases there is a bias in the prevalence of the illness, with females 
being affected nine times more commonly than men (Scully 1986). There also 
appears to be two age peaks of sufferers: the first after menarche (approximately 20- 
30 years of age); the second after menopause (approximately 50-60 years of age) 
(Bowman, Ibrahim et al. 2004); (Fox 2005). Sjogren's syndrome is rare in children 
and when it does occur it is reported to be milder than in adults insofar as the most 
frequent primary symptoms are benign parotid swelling, whereas the sicca symptoms 
occur later and much less frequently (Cimaz, Casadei et al. 2003).
The term syndrome is used in connection with SjS because a “Syndrome” is defined 
as “a combination of signs and/or symptoms that form a distinct clinical picture 
indicative of a particular d is o rd e r In SjS these symptoms typically range from 
difficulty in speaking and eating, oral candidiasis and rampant caries to chronic 
sialadenitis, blindness and B-cell lymphoma (Scully 1986). The typical clinical picture 
is keratoconjunctivitis sicca (drying and inflammation of the conjunctiva as a result of 
insufficient lacrimal secretion (dry eyes)) and xerostomia (a dryness of the mouth 
from salivary gland hypofunction (dry mouth)) (Fox, Stern et al. 2000).
Patients suffering with SjS also produce a wide variety of serum auto-antibodies such 
as anti-Ro and anti-La which provides compelling evidence to support an auto­
immune origin for the disease (St Clair 1992); (Jonsson, Moen et al. 2002). However, 
to date definitive anti-secretory antibodies have remained elusive but most recent
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data further promotes the idea by demonstrating IgG antibodies from patients with 
SjS having the ability to inhibit secretion in salivary acinar cells (reviewed by, 
(Dawson, Fox et al. 2006)).
In spite of extensive molecular, histological and clinical studies, the underlying cause 
of Sjogren's syndrome and its pathogenesis remains unknown (Garcia-Carrasco, 
Fuentes-Alexandro et al. 2006).
C riteria  fo r D iagnosis o f S jogren's syndrom e
In Sjogren's syndrome there are prominent and consistent oral and dental findings 
which were directly related to the loss of salivary function (Daniels and Fox 1992). 
However, establishing the diagnosis of Sjogren's syndrome has proved difficult in 
light of the non-specific primary symptoms of dry mouth and eyes and the total lack 
of both sensitive and specific laboratory markers (Fox 2007). Another factor which 
makes diagnosis problematic is the lack of intermediary subjects as all studies to 
date have been done on subjects in whom the disease is already established so it 
remains debatable whether the changes identified are actually a cause or an effect of 
the disease (Fox 2007).
For a patient to be diagnosed with Sjogren's syndrome it must be established that 
they have subjective and objective symptoms of both lacrimal and salivary gland 
hypofunction in combination with evidence of immunological abnormalities, which 
may be indicated by the presence of autoantibodies and/or lymphocytic infiltration of 
the labial salivary glands (Fox, Robinson et al. 1986; Vitali, Bombardieri et al. 1993; 
Fox and Saito 1994; Vitali, Bombardieri et al. 1996). The current universally accepted 
diagnostic criteria are summarised in the two SjS tables (Tables 1.5.1 .and 1.5.2.).
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Primary Sjogren's syndrome is classified as an autoimmune disease but to date no 
truly specific auto-antigens or auto-antibodies have ever been identified (Fox and 
Speight 1996). Many auto-antibodies have been suggested and described including 
anti-salivary and anti-nuclear antibodies. Of these anti-nuclear antibodies the most 
well known are the anti-Ro/SSA and anti-La/SSB auto-antibodies which although not 
specific to Sjogren's syndrome are highly characteristic and occur in 60% and 40% of 
primary Sjogren's syndrome respectively (Scully 1986; Jonsson, Haga et al. 2000). 
Although extremely useful for establishing a diagnosis such auto-antibodies are not 
specific enough to Sjogren's syndrome to be used in isolation.
Sjogren's syndrome does however share many features in common with auto­
immune diseases: (i) evidence suggests that it is mediated and antigen driven; (ii) 
patients share HLA types with other auto-immune disease; (iii) it shares systemic 
features with other auto-immune diseases such as production of rheumatoid factors; 
and (iv) the histopathology of the salivary gland implicates an auto-immune 
component (Fox and Speight 1996).
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American-European Consensus Group classification criteria for Sioaren’s syndrome (Vitali. Bombardieri et
al. 2002»
Table 1.5.1: Sjogren’s syndrome classification criteria part 1
1. Ocular symptoms: A positive response to at least 1 of the following 3 questions:
a) Have you had daily, persistent, troublesome dry eyes for more than 3 months?
b) Do you have a recurrent sensation of sand or gravel in the eyes?
c) Do you use tear substitutes more than 3 times day?
2. Oral symptoms: A positive response to at least 1 of the following 3 questions:
a) Have you had a daily feeling of dry mouth for more than 3 months?
b) Have you had recurrent or persistently swollen salivary glands as an adult?
c) Do you frequently drink liquids to aid swallowing dry foods?
3. Ocular signs
Objective evidence of ocular involvement determined on the basis of a positive result on at least
1 of the following 2 tests:
a) Schirmer-I test (< 5 mm in 5 minutes)*
b) Rose bengal score (> 4, according to the van Bijsterveld’s scoring system)
4. Histopathology:
In minor salivary glands (obtained through normal-appearing mucosa) focal lymphocytic 
sialoadenitis evaluated by an expert histopathologist, with a focus score >1, as defined as 
lymphocytic foci (which are adjacent to normal-appearing mucous acini and contain more than 50 
lymphocytes) per 4 mm2 of glandular tissue.
5. Salivary gland involvement
Objective evidence of salivary gland involvement, determined on the basis of a positive result on 
at least 1 of the following 3 tests:
a) Salivary scintigraphy showing delayed uptake, reduced concentration and/or delayed excretion 
of tracer
b) Parotid sialography showing the presence of diffuse sialectasias (punctuate, cavitary or
destructive pattern), without evidence of obstruction in the major ducts.
c) Unstimulated salivary flow (<1.5 ml in 15 minutes)"
6. Autoantibodies: Presence of at least 1 of the following serum autoantibodies:
a) Antibodies to Ro/SS-A or LA SS-B antigens, or both.
Therefore to summarise the pathogenesis of the disease is multi-factorial and 
requires several steps to establish the disease. It has been suggested that 
environmental factors initiate inflammation in individuals who have a genetic pre­
disposition but the processes which drive autoimmunity and lead to the differentiation 
of auto-reactive lymphocytes into autoantibody-producing plasma cells remains 
largely unknown. To date several epitope mapping studies have suggested 
autoimmunity in primary Sjogren's syndrome to be driven by autoantigens (Dorner 
and Lipsky 2002). Fox and co-workers have also proposed an excellent model for 
Sjogren's syndrome that incorporates all the current histopathological, genetic, 
serological and gene-profiling data available (Fox, Michelson et al. 2000); (Fox 
2005).
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This area of research considered the importance of studying the outcome measures 
in SjS patients which was also the focus of recent conferences (Bowman 2002). 
Assessment of the disease must be broken down into subdivisions: exocrine 
(inclusive of sicca symptoms and signs) and non-exocrine disease activity and 
systemic symptoms (objective evidence of extra-glandular activity and damage 
(present for over six months)); health-related and generic quality of life (inclusive of 
fatigue); standard approaches to adverse events and toxic effects; and health- 
economic elements (Fox 2005). There was also suggestion that the use of bio­
markers similar to those in systemic lupus erythematosus (lllei, Tackey et al. 2004), 
inclusive of auto-antibodies, chemokines and cytokines would supplement clinical 
measurements.
Prim ary versus secondary
Clinically, Sjogren's syndrome is described as primary if dry mouth and dry eye’s 
occur in isolation but secondary if it occurs in conjunction with another connective 
tissue disease (Scully 1986), such as rheumatoid arthritis, systemic lupus 
erythematosus and primary biliary cirrhosis (Jonsson, Haga et al. 2000).
Primary Sjogren's syndrome represents an idiopathic inflammatory exocrinopathy 
clearly characterised in two ways: (i) Organ-specific autoimmunity involving the 
salivary and/or lacrimal glands being preferentially chronically attacked by immune 
cells (Dorner and Lipsky 2002); (Li, Dai et al. 2004); (ii) numerous extra-glandular 
systemic features including fatigue, arthritis, pulmonary complications, interstitial 
nephritis, peripheral neuropathy and vasculitis (Garcia-Carrasco, Fuentes-Alexandro 
et al. 2006). Sjogren's syndrome may also be characterised by other severe 
complications such as lymphoma, congenital heart blocks, neonatal lupus and 
secondary infections as well as problems with caries (Fox, Howell et al. 1984);(Fox, 
Michelson et al. 2000);(Ramos-Casals, Anaya et al. 2004).
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Table 1.5.2: Sjogren’s syndrome classification criteria part 2.
American-European rules for classification and exclusion criteria of Sjogren’s syndrome (Vitali. Bombardieri
et al. 2002)
For Primary Sjogren’s syndrome
In patients without any potentially associated diseases, primary Sjogren's syndrome may be defined as follows:
1. The presence of any 4 of the 6 items as indicative of primary Sjogren’s syndrome, as long as 
either item 4 (Histopathology) and 6 (Serology) is positive.
2. The presence of any 3 of the 4 objective criteria items (that is items 3, 4, 5 and 6 from previous 
table).
3. The classification tree procedure represents a valid alternative method for classification, although 
it should be more properly used in clinical-epidemiological surveys.
For Primary Sjogren’s syndrome
In patients with a potentially associated disease (for instance, another well defined connective tissue disease), the 
presence of item 1 or item 2 plus any 2 among items 3, 4 and 5 (from the previous table) may be considered as 
indicative of secondary Sjogren’s syndrome.
Exclusion criteria:
Past head and neck radiation treatment 
Hepatitis C infection
Acquired immunodeficiency disease (AIDS)
Pre-existing lymphoma 
Sacoidosis
Graft versus host disease
Use of anticolinergic drugs (since a time shorter than 4 -  fold the half life of the drug)
When groups of patients with primary Sjogren's syndrome were compared to those 
with secondary Sjogren's syndrome there were some striking differences in terms of 
HLA types (Moutsopoulos, Mann et al. 1979; Moutsopoulos, Chused et al. 1980) 
(HLA DR and DQ) and lymphocyte antigen expression (Kroneld, Halse et al. 1997). 
However, when comparing the degree of glandular hypofunction experienced by 
patients with primary Sjogren's syndrome to those with secondary Sjogren's 
syndrome, no obvious differences were found (Dawson, Holt et al. 2001). The 
available evidence suggests that primary and secondary Sjogren's syndrome 
probably do represent conditions with different aetiologies but the conditions do 
share similar features and common mechanisms related to the glandular 
hypofunction.
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Causes o f g landular hypofunction: Traditional v iew  versus Current view  
of S jogren 's syndrom e
Traditionally, the lack of glandular fluid secretion associated with Sjogren's syndrome 
was attributed to the immune mediated destruction of acinar cells within the salivary 
and lacrimal glands (Fox and Saito 1994). However, recently it has become clear that 
this traditional view is unable to explain more recent findings which included: (i) data 
which determined that in many patients experiencing glandular hypofunction there 
were large areas of apparently healthy tissue remaining (Fox and Maruyama 1997; 
Fox, Tornwall et al. 1999; Humphreys-Beher, Brayer et al. 1999); (ii) data from 
Immunohistochemical experiments demonstrated that Sjogren's syndrome glandular 
tissue, of both human and animal origin, presented overall neuronal innervation 
which remained intact subsequent to acinar cell loss (Konttinen, Platts et al. 1997; 
Zoukhri, Hodges et al. 1998); (iii) previous reports demonstrated that glandular 
hypofunction may be reduced in some SjS patients by the administration of immune- 
modulating drugs such as hydroxychloroquine (Tishler, Yaron et al. 1999) or 
interferon-a (Shiozawa, Tanaka et al. 1998; Ship, Fox et al. 1999) which would 
suggest that glandular hypofunction required components of the inflammatory 
process.
The sum of this data suggested that in many patients with Sjogren's syndrome the 
glandular hypofunction was not a direct result of loss of acinar tissue as was 
previously suggested (Kong, Ogawa et al. 1997; Nakamura, Koji et al. 1998) and 
subsequently led to the suggestion that glandular hypofunction was actually related 
to functional quiescence of the acinar cells (Humphreys-Beher and Peck 1999). The 
situation observed in SjS was very surprising as hypofunction was still occurring 
when physiologically normal tissue remained and the situation was complicated 
further by other data which demonstrated that acinar atrophy occurs in non-Sjogren's
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elderly individuals but there is no accompanying reduction in salivary flow rate (Heft 
and Baum 1984; Ship and Baum 1990; Sreebny 1996) which would suggest that 
salivary glands have a functional reserve.
Although the late stages of the disease are characterised by the significant degree of 
fibrous-atrophy within the salivary glands and it would be sensible to assume that 
there would be a correlation between loss of acinar tissue and reduction in fluid 
secretion this is not the case when many patients are diagnosed with SjS. Data from 
numerous studies have also demonstrated a direct correlation between the degree of 
minor salivary gland infiltration and the resulting reduction in stimulated parotid 
salivary flow rates (Daniels 1984; Tsianos, Tzioufas et al. 1985; Hernandez and 
Daniels 1989; Saito, Fukuda et al. 1997). Glandular hypofunction has also been 
observed in other inflammatory conditions involving the salivary glands which include 
sialadenitis (Scully 1986) and SOX (Kassimos, Shirlaw et al. 1997).
The traditional model to explain glandular hypofunction in Sjogren's syndrome is loss 
of tissue as a direct result of immune attack mediated by a combination of apoptosis 
and cytotoxic cell death (Reviewed (Ramos-Casals and Font 2005)). This ‘classical’ 
model stipulates that the process of glandular destruction is self-sustained by 
continued production of novel auto-antigens following formation of an apoptotic bleb 
or cell-death (Nagaraju, Cox et al. 2001) and organ failure was perceived to directly 
follow tissue loss. This was the research direction for Sjogren's syndrome for six 
decades with experiments conducted to determine the underlying mechanisms which 
resulted in destruction of the salivary and lacrimal acinar tissue. Such research 
considered the salivary glands to be only a 'reactor' for the infiltrating lymphocytes 
and not having a direct role in the pathological process of the disease (Dawson, Fox 
et al. 2006).
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Most recent data suggests that the lack of secretory function in Sjogren's syndrome 
is due to hypofunction of the salivary acinar cells not actual destruction of the gland 
tissue, the destruction of the tissue is most likely subsequent to hypofunction and a 
direct result of this hypofunction as proposed in Dawson and co-workers non- 
apoptotic model of glandular hypofunction (Dawson, Fox et al. 2006). The remaining 
residual acinar tissue found present in many individuals should have the ability to 
maintain fluid secretion which would suggest a functional disruption of the any 
remaining acinar/neural tissue. Dawson and co-workers made a surprising discovery 
when they found that it was possible to stimulate Ca2+ mobilization in human labial 
cells, taken from labial gland biopsies of SjS patients, with ACh (Dawson, Field et al.
2001). This proved the cells were able to function in vitro but a clear right shift in ACh 
concentration was observable demonstrating a dose-dependence activity (Dawson, 
Field et al. 2001).
This relatively new idea of a ‘non-apoptotic’ model for glandular hypofunction 
observed in Sjogren's syndrome has been proposed and accommodates these 
previously stated findings (Fox and Maruyama 1997); (Humphreys-Beher, Brayer et 
al. 1999); (Dawson, Smith et al. 2000); (Gordon, Bolstad et al. 2001). This new model 
puts an alternative spin on the ‘classical’ model and suggests that glandular atrophy 
actually follows chronic immune-mediated inhibition of acinar secretory function but 
the many mechanisms of glandular hypofunction implicated in the ‘classical’ model 
apply equally well to this new ‘non-apoptotic’ model (Dawson, Fox et al. 2006). The 
key difference is that the atrophy is a consequence of salivary gland hypofunction 
and not the direct cause of it and this new theory therefore has significant 
implications from a clinical perspective as glandular destruction is irreversible 
whereas this immune-mediated glandular hypofunction may not be (Dawson, Fox et 
al. 2006). This new model offers hope to Sjogren's syndrome patients because 
identification of the underlying mechanisms may lead to the development of more
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So to summarise the numerous recent observations made challenge the ‘classical’ 
model and cast serious doubt upon the principles upon which it was based: (i) 
apoptosis of epithelial cells within the salivary glands has been determined to be a 
rare event (Ohlsson, Skarstein et al. 2001); (ii) as stated previously many patients 
with Sjogren's syndrome who have significantly reduced or totally absent glandular 
function (demonstrated by fluid secretion output) have large residual amounts of 
histologically normal acinar tissue within their salivary glands (Fox and Maruyama 
1997); (iii) this residual tissue is able to function in-vitro (Pedersen, Dissing et al.
2000); (Dawson, Field et al. 2001), however, the acinar cells do demonstrate a 
reduced sensitivity to muscarinic stimulation (Dawson, Field et al. 2001). This final 
point is the most remarkable and a crucial observation as this outcome may also be 
observed in-vivo by the administration of systemic sialogogues to Sjogren's 
syndrome patients to stimulate secretion (Rhodus 1997). This observation is in total 
contrast to the ‘classical’ model as Sjogren's syndrome patients with no salivary flow 
should have no functional salivary tissue present but this is obviously not the case 
(Dawson, Fox et al. 2006).
direct and sensitive diagnostic tools and hopefully to the development of disease
modifying treatments.
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1.6 Aims of the Study
The main aim of this project was to investigate the effect of NO on salivary acinar 
cells and determine if it had a role in fluid secretion. Previous work demonstrated that 
NO has the ability to mobilise calcium independently of ACh and also enhance the 
ability of ACh to mobilise calcium which could suggest a role for NO in secretion.
Sjögrens syndrome (SjS) is an auto-immune condition characterised by salivary and 
lacrimal gland hypofunction resulting from failure of acinar cells to secrete. NO is 
known to be elevated in SjS patients and the project focussed on determining if NO 
could have a role in glandular hypofunction. Previous work suggested NO could 
induce hyper-function but the work presented in this thesis may suggest that NO 
could have a role in hypo-function.
There were also two smaller sub-projects based on two separate hypotheses:
(1) . That a signal induced by a marker of stress such as ATP may induce a signal 
pattern other to that induced by mediators of salivary secretion such as ACh but our 
experimental techniques were unable to visualise any obvious variations but did 
observe an additive effect when ACh and ATP were used in combination.
(2) . That cells designated as so called ‘pacemaker’ cells, such as those found in the 
heart, may be present in the salivary glands and may account for the specific focal 
lymphocytic infiltration observed in SjS and the likelihood and importance of cell to 
cell signalling within the salivary glands.
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Chapter Two
Materials and Methods
U N _l V_E_R SJ _T Y 0
LIVERPOOL
Materials and Methods
2.1 - Solutions
Standard Extra-cellular Bathing Solution
The extracellular bathing solution “Na HEPES” used for all experiments comprised 
the following (mM): NaCI (BDH 10241AP) 140, KCI (BDH 101985M) 4.7, MgCI2 (BDH 
101494V) 1.13, Glucose (Sigma G-7021)10 and HEPES (Sigma H-3375) 10 ± CaCI2 
(Sigma C-4901) 1.
Na HEPES was constituted in deionised water, titrated to pH 7.4 using 1M NaOH 
(Sigma S-5881) and stored at 4°C. When required, Ca2+was added immediately prior 
to the experiment.
Test Solutions
Stock solutions were generally 1000x working solution and stored at 4°C or -20°C.
When DMSO (Sigma D-5879) was used as a vehicle, final concentrations of DMSO 
were <0.1% to avoid effect on cells.
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Table 2.1.1: Table of all chemical details.
^  Chem ical,^iastciis.. , SupplierW ^ :Brimaryi;Vehicle -eStecond'a#!;;fa^iVehipleMl > Stock r Cone. > Working Cone.
Acetylcholine Sigma A- 
2661
Water Na HEPES 10mM 5 - 5000nM
ATP Sigma A- 
2383
Water Na HEPES 100mM 50
1000mM
Atropine Sigma A- 
0132
Water Na HEPES 2mM 2pM
Carbachol Sigma C- 
4382
Water Na HEPES 10mM
50pM
5 -  5000nM
EGTA BDH E-4378 Water Na HEPES 100mM 1 - 10pM
FURA-2 Sigma F- 
0888
DMSO Na HEPES 1mM 2pM
lonomycin Sigma I-0634 DMSO Na HEPES 10mM 1 - 10pM
NOC-5 Calbiochem
487950
NaOH Na HEPES 100mM 100pM
NOC-12 Calbiochem
487955
NaOH Na HEPES 100mM 100
1000mM
ODQ Sigma O- 
3636
DMSO Na HEPES 10mM 10mM
Ryanodine Sigma R- 
6017
Water Na HEPES 10mM 10mM
SNAP Sigma N- 
3398
DMSO Na HEPES 200mM 50 - 200pM
SNP Sigma
228710
Water Na HEPES 100mM 50 - 200mM
Thapsigargin Sigma T- 
9033
DMSO Na HEPES 10mM 1 - 10mM
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Tissue Culture Medium
Primary Tissue Culture
When cells were in primary culture, Gibco D-MEM: F-12 (1:1) + L-Glutamine + 15mM 
HEPES (Ref: 31330-038) was used in conjunction with 1% antibiotics/ antimycotics 
(Sigma A-5955). Media was serum free, to limit proliferation, reducing the risk of any 
phenotypic changes.
Cell Line Culture
When cells were in continuous cell culture, such as the standard CHO cell line, then 
Gibco D-MEM: F-12 (1:1) + L-Glutamine + 15mM HEPES (Ref: 31330-038) was 
supplemented with 5% foetal calf serum (Sigma F-7524).
Cell Isolation Solution
Acinar cells were harvested from the isolated salivary glands using collagenase 
(200U/ml) in calcium containing “Na HEPES” (Worthington Biochemical Corporation, 
USA Ref: 5273). Following reconstitution the collagenase solution was stored at 
-20°C in 1ml aliquots. This type of collagenase based solution was used for both 
human and mouse tissue digestion.
71
2.2 - Nitric Oxide Donors
SNAP -  S-nitroso-N-acetylpenicillamine
SNAP (Table 2.1.1) was stored at -20°C. Each day SNAP was dissolved in DMSO, 
forming a 100mM stock solution. The stock solution was then diluted in “Na HEPES” 
forming the 100 to 200|jM working solution.
SNP -  Sodium nitroprusside
SNP (Table 2.1.1) was stored at room temperature. Each day SNP was dissolved in 
water forming a 100mM stock solution. The stock solution was then diluted in “Na 
HEPES” forming the 100 to 200pM working solution.
NOC-5 - 3-[2-hydroxy-1 -(1 -methylethyl)-2-nitrosohydrazino]-1 -propanamine 
NOC-12 - N-ethyl-2-(1-ethyl-2-hydroxy-2-nitrosohydrazino)ethanamine
NOC-5 and NOC-12 (Table 2.1.1) were stored at -20°C. The solutions were initially 
dissolved in DMSO to form 100mM stock solutions. These stock solutions were then 
dispensed into 10pl and 20pl aliquots and maintained at -20°C for 3 months. At the 
start of an experiment the stock solution aliquots were diluted in “Na HEPES” to form 
the working solution of 200pM.
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2.3 - Nitric Oxide Inhibitors
ODQ - 1H [1,2,4]oxadiazolo[4,3,alpha] quinoxaline-1-one
ODQ (Table 2.1.1) was stored at 4°C. The solution was initially dissolved in DMSO to 
form a 10mM stock solution. This stock solution was then dispensed into 100pl 
aliquots and maintained at -20°C for 3-4 weeks or 4 °C for 3-4 days. Prior to an 
experiment the stock solution aliquots were diluted in “Na HEPES” to form the 
working solution of 10pM.
RYANODINE
Ryanodine (Table 2.1.1) was stored at room temperature. The solution was initially 
dissolved in water to form a 10mM stock solution. This stock solution was then 
dispensed into 10pl aliquots and maintained at -20°C for 6 months. The stock 
solution aliquots were diluted in “Na HEPES” to form the working solution of 10pM.
Precautions
All working solutions were used on the day they were made up and any remaining 
solution discarded at the end of the day due to the instability of all working solutions 
once made up in calcium containing “Na HEPES”. All solutions were also light 
sensitive so were maintained in the dark and used under red light conditions only. All 
NO donors and inhibitors are more fully described and explained in detail within the 
introduction and result sections.
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2.4 - Preparation of Mouse Acinar Cells
Submandibular salivary acinar cells were obtained from Male CD-1 mice (5-8 weeks 
of age). The CD-1 mice strain is a standard out-bred strain and was obtained from 
Charles River Laboratories (Charles River UK Ltd, Margate, UK) but maintained 
within the University animal house for up to 3 weeks.
Following sacrifice, by cervical dislocation, the submandibular and/or lacrimal glands 
were removed. Acinar cells were obtained from the glands following digestion with 
the cell isolation solution. Digestion was facilitated by injection of cell isolation 
solution directly into the gland lobules followed by microdissection and removal of the 
glandular capsule. To facilitate the disassociation of the acinar cells from the 
glandular connective tissue, the injected gland sample was then incubated in an 
additional 1ml of cell isolation solution at 34°C for 15 minutes in a shaking water bath 
with additional vigorous manual agitations at 5 minute intervals. After the 15 minute 
incubation period large undigested glandular fragments were removed and the 
smaller fragments were further dissociated using a pastette to agitate the solution. 
The free acinar cells were then concentrated via centrifugation at 370 RCF for 2 
minutes at room temperature. The supernatant was decanted and the cell pellet was 
re-suspended in experimental medium (“Na HEPES” or Primary Tissue Culture 
medium), to extinguish any residual collagenase activity by dilution. This procedure 
for cell isolation yielded either individual acinar cells or small clumps of 2 to 10 acinar 
cells.
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2.5 - Preparation of Human Acinar Cells
Following local ethical committee approval (Ref EC.75.98) and informed consent, 
small samples of submandibular gland were obtained from patients that were 
undergoing routine head and neck surgery. The samples obtained were so small that 
they had no impact on the subsequent diagnosis or treatment of the patients. Tissue 
was not obtained from patient’-s who had undergone radiation to the head and neck, 
had salivary gland malignancy or were taking known xerogenic medications.
Upon removal from the patient, the tissue samples were immediately placed into ice 
cold primary tissue culture medium and transported on ice to the laboratory within 1 
hour. On arrival in the laboratory the human tissue samples required micro-dissection 
to facilitate dispersal of the acinar cells. To aid digestion all the connective tissue was 
removed and the tissue sample was opened up manually to allow better digestion 
and dispersal of cells from the connective tissues. Following dissection of the sample 
acinar cells were obtained using cell isolation media and the methods stated 
previously for mouse acinar cells.
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2.6 - P rim ary Cell Culture
Matrigel coated coverslips:
The experimental protocols required the acinar cells to be immobilised on coverslips. 
To facilitate this we pre-coated coverslips with matrigel (Cat No. 354234) which acts 
as a synthetic basement membrane, allowing the cells to anchor to the glass 
coverslip.
The matrigel was allowed to set on the coverslips for 30 minutes at 37°C within a 
humidified 95%02/5%C02 incubator. The individual cover-slips were maintained 
within separate wells of a 6 well plate (Greiner Bio-one Cell star No. 657160). Once 
the cells were dispensed onto the cover-slips they were allowed to settle for 
approximately 30 minutes to allow for attachment. The coverslips were then covered 
with approximately 3ml of primary tissue culture medium. Identical procedures were 
used for both mouse and human cell types for primary cell culture. The cover-slips 
were used for their size and shape (22mm circular cover-slips thickness No.1 VWR 
International Cat-No. 631-0158) as these were able to act as the base of the 
perfusion chamber once incorporated into the custom built chamber.
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2.7 -  Suitability of Cells Selected
The acinar cell preparation procedure ensures the removal of the majority of non- 
acinar cells such ductal cells. The ductal cells would remain primarily within the 
connective tissue fraction following collagenase digestion and mechanical agitation. 
So due to the discarding of any undigested tissue prior to dispersal of cells onto 
coverslips the majority of the ductal cells would be discarded. It is however 
impossible to ensure that all ductal cells are removed from the test sample but ductal 
cells will not respond as acinar cells do so would not be selected for experimentation.
Each coverslip is only used for a single experiment which ensures continuity of 
results so cells are not pre-exposed to any agonists prior to experimental runs.
The number of experiments conducted was totally dependent on the experimental 
outcome i.e. if it was a clearly observable, large response then fewer experiments 
were conducted, however, in all cases enough experiments were conducted to give 
an acceptable number of runs with relation to statistical analyses.
There was no observable variation between time points, if cells were viable they were 
viable regardless of time spent in culture so viability was independent of time with 
relation to these experiments.
Cells were considered healthy if they had an irregular shape and a low resting 
calcium level.
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2.8 - Experimental Procedures and Nitric Oxide Protocol
Ca2+ concentration is used as an indicator of secretion so by studying the effect of 
NO on Ca2+ secretion the effect which NO may or may not elicit on salivary secretion 
can be demonstrated.
The response of mouse submandibular acinar cells to ACh follows a typical pattern, 
which may be divided into three phases (figure 2.8.1: trace A). Phase one was 
initiated immediately upon exposure to stimulus and is characterised by a rapid rise 
in [Ca2+]i, observed as an upward "spike" in the trace from resting [Ca2+]i level. The 
presence, absence, or size of the spike is largely independent of the agonist 
concentration. In phase two the [Ca2+]i level stabilises and is characterised by a 
sustained plateau in the [Ca2+]i, at a level below that of the "spike". The magnitude of 
the plateau phase of the response increased in proportion with agonist concentration. 
In phase three, once the stimulus was removed there was a return to the resting 
[Ca2+]i level. A rapid rate of recovery was used as a further indicator of cell viability.
The data in figure 2.8.1: trace B show the time-course of the change in the [Ca2+]i 
response following application of ACh in mouse submandibular acinar cells. Three 
concentrations of ACh of were used; 50, 500 and 5000nM. Low resting [Ca2+]i was 
used as an indicator of cell viability and cells with elevated resting [Ca2+]i levels were 
discarded. Application of ACh induced a rapid rise in the [Ca2+]jthat persisted for the 
duration of the stimulus. Once ACh was removed the [Ca2+]j rapidly returned to pre­
stimulus resting levels.
On average, 50nM ACh caused an increase in [Ca2+]j of 62.40 ± 10.96nm (n=25), 
500nM ACh caused an increase in [Ca2+]i of 156.60 ± 19.80nm (n=25) and 5000nM
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Figure 2.8.1
Change in [Ca2!  in response to 50nM ACh and the [Ca2+l  
variation in response to 50, 500 and 5000nM ACh.
50 nM
30 seconds
ACh (50, 500 and 5000nM) stimulated increased [Ca2^  measured in mouse 
submandibular acinar cells maintained in primary tissue culture fluid for 
24hours.
Trace A shows single response to 50nM ACh and illustrates the phases of 
the response.
Trace B shows repeated responses to ACh at three concentrations, which 
increase in magnitude, the second response to 5000nM ACh illustrates how 
repeated exposure to higher concentrations of ACh cause a decrease in the 
level of response. The red circles highlight the rectangles, numbers and 
agonist, the rectangles demonstrate duration of exposure to agonist, the 
number defines the specific concentration of agonist and agonist stated.
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ACh caused an increase in [Ca2+]i of 202.40 ± 26.27nm (n=22). Based on these data, 
a 50nM concentration of ACh was selected as being suitable for this particular set of 
experiments on the basis that this concentration of ACh would stimulate consistent 
responses in [Ca2+]i.
The experimental protocol used in this thesis was designed to allow direct evaluation 
of the effect of Ca2+ signal modulators, such as Nitric Oxide (NO), on the acinar cell 
[Ca2+]i response (figure 2.8.2). The protocol allowed the experiments to be clearly 
divided into two group’s, control and NO exposed, and then further sub-divided into 
pre and post NO exposure responses, with the response to ACh being determined 
prior to application of NO donor and then throughout the duration of exposure to the 
NO donor. Control experiments demonstrated that any changes, amplifications or 
reductions in the [Ca2+]i response were attributable only to the effects of the NO 
donor.
The acinar cells were initially stimulated two or three times with 50nM ACh until a 
consistent response was achieved. Then, dependent on experiment protocol, the 
cells were either maintained under control conditions (NO free) or continuously 
subjected to the NO donor. Three minutes post exposure to the NO donor the cells 
were again exposed to 50nM ACh. Control cells were given an equivalent time gap. 
For the remainder of the experiment acinar cells were subjected to 50nM ACh 
approximately every four minutes.
80
Figure 2.8.2 
Experimental Protocol
SNAP 100 nM
□
2
CU ACh 50 nM CU C d  
4 7 8 9 ,  10
□
Vy*..
11
Time Point Experimental Procedure Description
Average
Duration
(Seconds)
1
Experiment initiates and cells bathed in hepes 
only which sets base line 60
2 Cells exposed to ACh to determine response 30
3 Cells returned to hepes and recover to baseline 60
4
Cells exposed to ACh to ensure consistency of 
response , this step repeated if 2 and 4 vary 30
5 Cells returned to hepes and recover to baseline 60
6
Dependent on experimental type (i.e. If control 
or NO affected) cells are either maintained in 
hepes (control) or are continuously exposed to 
NO donor, NO inhibitor or combined NO donor/ 
inhibitor solution (NO effect)
180
7
Cells exposed to ACh to demonstrate response 
(If NO effect experiment expect variation) 30
8
Cells returned to control hepes or experimental 
hepes dependent on experiment type 150
9
Cells exposed to ACh to demonstrate response 
(If NO effect experiment expect variation) 30
10
Cells returned to control hepes or experimental 
hepes dependent on experiment type 150
11
Steps 9 and 10 repeated as many times as 
necessary either until cells no-longer responsive 
or a comparable time point for controls achieved
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2.9 - Measurement of [Ca2+]i
Cell Loading
Fura-2 was used to detect changes in the cytoplasm calcium concentration. This 
indicator could be loaded into individual cells, with minimal alteration in cellular 
homeostasis (Tsien 1980), allowing for the determination of changes in [Ca2+]i 
occurring within the individual acinar cells. Fura-2 (Figure 2.9.1.) represents the latest 
generation of Ca2+ indicators (Grynkiewicz, Poenie et al. 1985). The cells were 
loaded at room temperature, which took approximately 30 minutes when the cells 
were in acute form or 15 minutes under primary culture conditions.
O-I C r| o- o-l
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Figure 2.9.1 : Figure illustrating the chemical structure of Fura-2.
The concentration of free calcium also alters the fluorescent properties of Fura-2 in 
that in its absence, the excitation maximum is approximately 380nm and when 
calcium is present the excitation maximum is 340nm. The variations in these two 
values are therefore functional in relation to [Ca2+]i as the light emitted by fura is 
relative to the concentration of calcium present when excited at either wavelength. To 
remove any effect induced by the dye the light emitted at 340nm and 380nm is 
ratioed as the concentration of the dye also affects intensity of light emitted. When 
Fura-2 is excited at either 340 or 380nm it emits maximally at 510nm.
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2.10 - Microfluorimetry
Chops light and 
selects specific 
340 and 380nm o
Monochronometer
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binocular microscope 
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Computer
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\
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computer where its 
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Figure 2.10.1: Schematic diagram of the microfluorimetry rig used to visualize and record acinar cell 
responses induced by agonists.
Measurement of [Ca2+], was determined in individual acinar cells or small clumps 
(with no more than 8 cells present) using a Cairn Spectrophotometer (Cairn 
Research, Cambridge). A Xenon arc lamp produces the excitation wavelengths and 
the output is controlled via a monochronometer, which cuts the light into the selected 
340/380nm wavelengths and thus selects for fura-2 wavelengths.
The alternating light is then passed along a quartz light guide, which guides it directly 
into the Nikon-diaphot inverted binocular microscope (TMD 100; Nikon, Kingston, 
UK). Upon entering the microscope the light is reflected using a dichroic mirror, which 
has a cut-off of approximately 400nm. The light is focussed upon the specimen within 
the experimental chamber upon the microscope stage via a CF Fluor oil quartz
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objective. The light then emitted by the specimen is reflected through a 510nm long 
pass emission filter and images captured using a CCD camera. The camera feeds 
the paired images, captured every 120 to 500 milliseconds dependent on acquisition 
rate, directly to the computer, which visualises and stores data. Figure 2.10.1 shows 
a simple diagrammatic representation of the Microfluorimetry rig.
It is also possible to alter the orientation of the emitted light using a plane mirror so 
that the emitted light can either be detected through the microscope eyepiece or to 
the CCD camera. Two dichoric mirrors allow for light selection, the first selects 
excitation from emitted wavelength and the second bounces the appropriate 
wavelength to the CCD camera. The camera detects emerging light at 510nm and 
allows visualisation of the cells during data collection. This type of calcium imaging 
was developed and employed to reveal changes in [Ca2+]j in various regions of the 
cell.
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2.11 - Perfusion Procedure
The cover-slips formed the base of a custom built perfusion chamber. The chamber 
itself was placed onto the stage of an inverted binocular microscope (Nikon, Japan). 
The cells were perfused continuously by a gravity fed system consisting of 8 parallel 
pipettes (0.5mm internal diameter). The system allowed for application of multiple 
test solutions and rapid changing of the bathing solution, approximately every 3 
seconds. The parallel pipettes were gathered at the terminal end and placed into a 
single perfusion tip which was in turn positioned 1mm from the cell under 
experimental investigation (figure 2.11.1).
C over-glass
Figure 2.11.1: Illustration of the primary perfusion system. Diagram courtesy of Dr. Luke Dawson.
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2.12 Statistics and Data Presentation
Data are presented as Mean ± Standard Error of the mean (with number of 
observations i.e. n=).
The experimental data for the Nitric Oxide sections are presented as percentages 
compared to original response i.e. at the first experimental response (post addition of 
NO maintenance solution or control solution dependent on experiment) the 
cumulative control result is 101.5 ± 3.39% of the original which is taken to be 100%. 
This allowed all data to be directly comparable as all cells were being compared to 
themselves initially then their final values compared with all other results.
Statistical test used = unpaired two tail T-test.
Significance stated at the 0.1, 1 and 5% levels where appropriate.
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Chapter Three
Results
Nitric Oxide
Mouse Submandibular Acinar Cells
U N I V E R S I T Y  O F
LIVERPOOL
Introduction
The starting point of these experiments was reproduction of previous work to ensure 
consistency of data. In the initial experiments NO induced Ca2+ mobilisation not 
inhibition and was thus causing hyperfunction and not hypofunction. These results 
support previous findings and confirm the expected effect of NO on Ca2+ as you 
would expect hyperfunction based on the ability of NO to stimulate the release of 
Ca2+ via its activity on the cGMP/cADPr pathway. The initial experiments and all work 
done previously were performed acutely and so only demonstrated the ability of NO 
to mobilise Ca2+ and not its ultimate effect. Subsequent experiments presented in this 
thesis were performed under more chronic conditions to show the effect of NO on 
acinar cells in the long term.
The experiments were performed using Mouse submadibular acinar cells. This cell 
type was chosen as it is readily available and from an acceptable model animal. All 
experiments were performed in accordance with the strict protocol described 
previously (Chapter 2 materials and methods section 2.8, figure 2.8.2), which was 
also prototyped using the mouse submandibular acinar cells. The response of mouse 
submandibular acinar cells to ACh follows a typical pattern as described previously 
(Chapter 2 materials and methods section 2.8, figure 2.8.1 trace A).
The experiments were conducted using four NO donors: S-nitroso-N- 
acetylpenicillamine (SNAP), Sodium nitroprusside (SNP), N-Ethyl-2-(1-ethyl-2- 
hydroxy-2-nitrosohydrazino)ethanamine (NOC-12), 3-[2-hydroxy-1 -(1 -methylethyl)-2- 
nitrosohydrazino]-1-propanamine (NOC-5) and two NO pathway inhibitors: 1H 
[1,2,4]oxadiazolo[4,3,alpha] quinoxaline-1-one (ODQ) and Ryanodine.
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Results
The first set of experiments were performed using S-nitroso-N-acetylpenicillamine 
(SNAP) only to ensure consistency of results with previous work. Figure 3.1.1 shows 
a representative trace demonstrating the effect of the NO donor SNAP on mouse 
submandibular acinar cells. The NO released by SNAP induced mobilisation of 
[Ca2+]i independently of ACh which is demonstrated by the gradual rise in level.
SNAP was selected based on the work carried out previously by Looms and 
colleagues (Looms, Tritsaris et al. 2001). In the first instance the protocol outlined by 
Looms was followed using a 200pM concentration of SNAP. However, it was 
subsequently identified that 100pM SNAP produced reproducible [Ca2+]i responses 
under the experimental conditions discussed here. This concentration of SNAP was 
the minimum dose which gave reproducible responses.
Table 3.1.1: Table of results for mouse submandibular acinar cells
Number of 
samples
Type of Response Degree of Response 
(Mean ± SE) 
as a Percentage
Time Taken to 
decrease to zero 
(where applicable)
n=12 Control 101.5 ± 3.39% N/A
n=15 SNAP 235.8 ± 35.39% 32
n=22 NOC-12 162.5 ± 10.4% 74
n=9 SNP 151.7 ±23.03% 40
n=5 NOC-5 200.2 ± 48.5% N/A
n=5 ODQ + SNAP 113.6 ± 3.83% 28
n=5 ODQ +NOC-12 103.3 ±2.23% 36
n=7 Ryanodine 115.2 ±5.11% N/A
n=8 Ryanodine + NOC-12 121.3 ± 10.84% N/A
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Change in [Ca2+]j in response to 200pM SNAP, illustrating 
how NO alone induced a [Ca2+]j signal response.
Figure 3.1.1
50 nM
4 min
SNAP (200 ^M ) stimulated increased [Ca2+]; measured in mouse 
submandibular acinar cells maintained in primary tissue culture fluid for 24 
hours.
Trace shows response to stimulation with NO donor SNAP only(see scale 
bar).
90
Acute Experiments
The second set of experiments were performed using all four NO donors acutely to 
show the effect of NO on ACh-evoked Ca2+ signal. Figure 3.1.2 parts A and B shows 
representative traces demonstrating the effect of the NO donor SNAP on the ACh- 
evoked increase in [Ca2+]j in mouse submandibular acinar cells. Trace A shows a 
series of control responses to ACh (50nM) over the protocol defined time points. 
Trace B shows the responses to ACh (50nM) in the presence of SNAP (200pM) over 
the same protocol defined time points. Comparison of the cell response to ACh 
(50nM) under control conditions (A) to that obtained following exposure to SNAP (B) 
at equivalent time points, shows that exposure of the mouse submandibular acinar 
cells to SNAP significantly (P<0.01) increased the [Ca2+]i plateau of response to ACh 
(50nM) from an average control response of 101.5 ± 3.39% (n=12) to 235.8 ± 
35.39% (n=15). The data in figure 3.1.2 demonstrate NO induced amplification of the 
ACh-evoked increase in [Ca2+]|.
Following the use of SNAP other alternative NO donors were identified and selected. 
This group of alternative NO donors included the “NOC’s” and N-Ethyl-2-(1-ethyl-2- 
hydroxy-2-nitrosohydrazino)ethanamine (NOC-12) was subsequently selected as a 
suitable alternative to SNAP because NOC-12 releases no biologically relevant 
degradation by-products. The by-products released by SNAP were considered to 
possibly have the ability, independently of NO, to induce a reduction in the [Ca2+]i 
response through cellular inhibition, so NOC-12 was considered as a more suitable 
NO donor in order to eliminate any possibility of result bias being introduced by the 
SNAP by-products. The suitability of each NO donor is discussed further within the 
introduction.
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Figure 3.1.2
Change in [Ca2^  in response to 50nM ACh, illustrating how 
100(iM SNAP induced amplification of the [Ca2+l  signal.
a cn n n  cn ACh 50 nM
50 nM
2 min
SNAP 200 |j.M
B □  □  ACh 50 nM □  □  □
ACh (50 nM) stimulated increased [Ca2*], measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 2 (trace A) and 48 hours 
(trace B) respectively.
Trace A shows response to repeated stimulation with 50nM ACh only (see 
scale b a r).
Trace B shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor SNAP acutely (see scale bar).
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Change in [Ca2^  in response to 50nM ACh, illustrating how 
200|uM NOC-12 induced amplification of the [Ca2^ signal.
Figure 3.1.2
c  □  □  □  ACh 50 nM □  □
50 nM
2 min
NOC-12 200 jxM
D □  □  □  □  ACh 50 nM
150 nM
2 min
ACh (50 nM) stimulated increased [Ca2^  measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows response to repeated stimulation with 50nM ACh only (see 
scale bar).
Trace D shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 acutely (see scale bar).
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Figure 3.1.2 parts C and D shows representative traces which demonstrate the effect 
of the NO donor NOC-12 on the ACh-evoked increase in [Ca2+]¡ in mouse 
submandibular acinar cells. Trace C shows a series of control [Ca2+]¡ responses to 
ACh (50nM) over the protocol defined time points. Trace D shows the [Ca2+]¡ 
responses to ACh (50nM) in the presence of NOC-12 (200pM) over similar protocol 
defined time points. Comparison of the [Ca2+]¡ response of cells to ACh under control 
conditions (C) to that obtained following exposure to NOC-12 (D) at equivalent time 
points, shows that exposure of the mouse submandibular acinar cells to NOC-12 
significantly (P<0.001) increased the plateau of response to ACh from an average 
control response of 101.5 ± 3.39 % (n=12) to 162.5 ± 10.4 % (n=22). So the 
amplification induced by either NO donor was statistically significant.
Following the use of SNAP and NOC-12 as donors of NO two other NO donors were 
selected to validate the results achieved. Sodium Nitroprusside (SNP) and 3-(2- 
Flydroxy-1 -(1 -methylethyl)-2-nitrohohydrazino)-1 -propanamine (NOC-5) were 
selected as alternative donors of NO. SNP allows direct comparison with SNAP as it 
is from the same group of NO donors, the s-nitrosthiols, and it too releases 
biologically relevant degradation by-products (as discussed Chapter 1 Introduction
1.2 Nitric oxide section). NOC-5 belongs to the NOC family so allows direct 
comparison with NOC-12, however, NOC-5 releases NO much more rapidly, 
approximately 3 times faster than NOC-12, at a rate more equivalent to SNAP. SNP 
and NOC-5 were used under the same experimental protocol and the results 
compared to those achieved using SNAP and NOC-12. A concentration of 75pM was 
selected for SNP as this was the lowest dose which would induce reproducible 
responses. NOC-5 was used at 200pM to keep it directly comparable to NOC-12.
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Figure 3.1.3 shows representative traces illustrating the acute affect of NO donor 
SNP (A) and NOC-5 (B) on the ACh-evoked increase in [Ca2+]i in mouse 
submandibular acinar cells. Trace A shows the [Ca2+]i responses to ACh (50nM) in 
the presence of SNP (75pM) over the protocol defined time points. Trace B shows 
the responses to ACh (50nM) in the presence of NOC-5 (200pM) over the protocol 
defined time points. Comparison of the [Ca2+]i responses of cells to ACh under control 
conditions (Figure 3.1.2 trace A) shown previously to that which was obtained 
following exposure to SNP and NOC-5 respectively at equivalent time points, shows 
that exposure of the mouse submandibular acinar cells to SNP or NOC-5 initially 
significantly (P<0.05) and (P<0.01) respectively increased the response to ACh from 
an average control response of 101.5 ± 3.39 % (n=12) to 151.7 ± 23.03 % (n=9) for 
SNP and from 101.5 ± 3.39% (n=12) to 200.2 ± 48.5% (n=5) for NOC-5. Both sets of 
results demonstrated NO induced amplification of the ACh-evoked increase in [Ca2+]|.
The data in figures 3.1.2 parts A to D and figure 3.1.3 demonstrate that the use of 
any of the four NO donors SNAP, NOC-12, SNP or NOC-5 induced amplification of 
the ACh-evoked increase in [Ca2+]i.
NO has been implicated in the pathogenesis of salivary gland hypofunction in SjS 
(Konttinen, Platts et al. 1997); (Looms, Tritsaris et al. 2001);(Looms, Tritsaris et al.
2002), in contrast my data indicate NO would induce hyper, not hypo-function. 
However, these experiments only determined the acute effect of NO on acinar cells. 
The levels of NO are known to be elevated in SjS patients, so the acinar cells of SjS 
patients are likely to be exposed chronically to NO. Therefore, longer duration 
experiments were performed to determine the chronic effect of NO.
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Change in [Ca^in response to 50nM ACh, illustrating how 
75pM SNP and 200|liM NOC-5 respectively induced 
amplification of the [Ca2+]t signal.
SNP 75 |xM
A D  □  ACh 50 nM Q  D
Figure 3.1.3
2 min
NOC-5 200 p.M_______________
B EH EH ACh 50 nM EH EH
2 min
ACh (50 nM) stimulated increased [Ca2!  measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor SNP acutely (see scale bar).
Trace B shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor NOC-5 acutely (see scale bar).
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Chronic Experiments
Figure 3.1.4 parts A and B shows representative traces demonstrating the chronic 
effect of the NO donor SNAP on the ACh-evoked increase in [Ca2+]j in mouse 
submandibular acinar cells. Trace A shows a prolonged series of control [Ca2+]i 
responses to ACh (50nM) over the protocol defined time period and shows how the 
cells maintained their ability to respond under control conditions over the expanded 
experimental protocol. Trace B shows the [Ca2+]i responses to ACh (50nM) in the 
presence of SNAP (100pM) over the same protocol defined time points. As described 
previously comparison of the acinar cell [Ca2+]j response to ACh under control 
conditions (A) to that obtained following exposure to SNAP (B), shows that exposure 
of the mouse submandibular acinar cells to NO alters the series of responses 
induced by ACh. At 32 minutes the ACh stimulated increase in [Ca2+]j response in the 
presence of SNAP was not significantly different from zero.
Figure 3.1.4 parts C and D shows representative traces demonstrating the chronic 
effect of NO donor NOC-12 on the ACh-evoked increase in [Ca2+]j in mouse 
submandibular acinar cells. Trace A shows a prolonged series of control [Ca2+]i 
responses to ACh (50nM) over the protocol defined time points, with cells 
maintaining the level of response. Trace B shows the [Ca2+]i responses to ACh 
(50nM) in the presence of NOC-12 (200pM) over the same protocol defined time 
points. Comparison of the [Ca2+]i response of cells to ACh under control conditions 
(C) to those obtained following exposure to NOC-12 (D) at equivalent time points 
shows the variation in response pattern over the experimental time period. At 74 
minutes the ACh stimulated increase in [Ca2+]i response in the presence of NOC-12 
was not significantly different from zero (figure 3.1.8).
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Figure 3.1.4
Change in [Ca2^  in response to 50nM ACh, illustrating how 
100|iM SNAP induced amplification and inhibition of the 
[Ca2+]i signal.
A D D  D D  D D D D D D  O D D  ACh 50 nM
UULLJUUUlXJuLfi
50 nM
2 min
| SNAP 100 nM__________________________________________________
B D D D D  D D D  D ACh 50 nM
5 min
ACh (50 nM) stimulated increased [Ca2!  measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows response to repeated stimulation with 50nM ACh only 
chronically (see scale bar).
Trace B shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor SNAP chronically (see scale bar).
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Change in [Ca2+]s in response to 50nM ACh, illustrating how 
200liM NOC-12 induced amplification and inhibition of the
Figure 3.1.4
[Ca2+]i signal.
c  DD O D D  0 D 0 0
10 min
D D 0 0 D O  ACh 50 nM
| NOC-12 200 itM
ACh 50 nM
d OO DO 0 0 D 0 D D D 0 0 DO □ 0 □ 0 D
ACh (50 nM) stimulated increased [Ca2+]; measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows response to repeated stimulation with 50nM ACh only 
chronically (see scale bar).
Trace D shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 chronically (see scale bar).
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Change in [Ca2+]j in response to 50nM ACh, illustrating how 
75pM SNP and 200pM NOC-5 respectively induced 
amplification and inhibition of [Ca2^  signal.
Figure 3.1.5
|SNP 75 hM
a d d  d d d d d d d  □  □
50 nM |______
5 min
NOC-5 200 (0.M
50 nM
5 min
ACh (50 nM) stimulated increased [Ca2+]| measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor SNP chronically (see scale bar).
Trace B shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor NOC-5 chronically (see scale bar).
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Figure 3.1.5 shows representative traces demonstrating the chronic affect of NO 
donors SNP and NOC-5 respectively on the ACh-evoked increase in [Ca2+]i in mouse 
submandibular acinar cells. Trace A shows the [Ca2+]j responses to ACh (50nM) in 
the presence of SNP (75pM) over the protocol defined time points. Trace B shows 
the [Ca2+]i responses to ACh (50nM) in the presence of NOC-5 (200pM) over the 
same protocol defined time points. Comparison of the [Ca2+]i responses of cells to 
ACh under control conditions shown previously to that which was obtained following 
exposure to SNP or NOC-5 respectively at equivalent time points, shows that 
exposure of the mouse submandibular acinar cells to SNP or NOC-5 initially induced 
amplification of the response but over time the response to ACh diminished. At 40 
minutes the ACh stimulated increase in [Ca2+]i response in the presence of SNP 
(cumulative data figure 3.1.9) was not significantly different from zero and NOC-5 
(cumulative data figure 3.1.10) was also able to inhibit the response to ACh. The data 
for NOC-5 does however show that the level of response never decreased to zero 
but this may be explained by the short half life of this particular NO donor. The data 
in figure 3.1.5 show that SNP and NOC-5 induced amplification and inhibition of the 
ACh-evoked increase in [Ca2+]i. and that over a prolonged period of time the cells 
stop responding to stimulus.
Comparison of data in figures 3.1.4 and 3.1.5 shows that following prolonged 
application of any of the four NO donors induced inhibition of the ACh-evoked 
increase in [Ca2+]i when compared to control. The data presented in figure 3.1.6 
shows the cumulative average responses achieved under control conditions and may 
be compared directly to those presented in figures 3.1.7 to 3.1.10 which represent 
the cumulative data for SNAP, NOC-12, SNP and NOC-5 respectively. When the 
average data in figures 3.1.7 to 3.1.10 is reviewed it suggests a chronic response 
pattern for all four NO donors. The average data for SNAP (figure 3.1.7) and SNP 
(figure 3.1.9) show that exposure of the mouse submandibular acinar cells to SNAP
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or SNP significantly (P<0.001) and (P<0.01) inhibited the response to ACh 
respectively compared to control (figure 3.1.6).These four alternative NO donors all 
induced amplification of the ACh-evoked increase in [Ca2+]i and also induced 
inhibition of the ACh-evoked increase in [Ca2+]i upon prolonged chronic exposure. 
The cumulative data presented as bar charts in figures 3.1.11 parts A and B allows 
direct comparison between the four NO donors patterns of [Ca2+]i response but also 
demonstrates their varying levels of activity.
Figure 3.1.12 shows a representative trace demonstrating the chronic affect of NO 
donors NOC-12 ACh-evoked increase in [Ca2+]i in mouse submandibular acinar cells 
followed by SERCA pump inhibitor Thapsigargin once response was not significantly 
different from zero. The data presented in figure 3.1.12 shows that the induced 
inhibition of response is not simply the result of a lack of Ca2+ within intracellular 
stores as the use of the thapsigargin post NO inhibition still induces a considerable 
mobilisation of Ca2+ which goes some way to prove that the cells still contain 
considerable Ca2+ stores. These post NO exposures to thapsigargin ensure that a 
lack of [Ca2+]i is not responsible for the inhibition of response observed following 
exposure of the acinar cells to NO. This observation was made in 6/7 similar 
experiments.
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Change in [Ca2^  in response to 50nM ACh did not diminish 
with repeated application over the experimental time period.
Figure 3.1.6
Time course showing cumulative data for 50nM ACh in mouse submandibular 
acinar cells. The data show the series of experimental time points where 
responses to 50nM ACh occurred. These data show the standard response of 
mouse submandibular acinar cells to 50nM ACh under control conditions.
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Change in [Ca2^  in response to 50nM ACh in the presence 
of 100 pM SNAP initially increases but then gradually 
decreases with repeated application over the experimental 
time period.
Figure 3.1.7
Time course showing cumulative data for 50nM ACh in the presence of 10OjaM 
SNAP in mouse submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
100pM SNAP occurred. Statistical significance compared to control and any 
error bars absent due to a lack of sample size.
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Change in [Ca2+]| in response to 50nM ACh in the presence
of 200 pM NOC-12 initially increases but then gradually 
decreases with repeated application over the experimental 
time period.
Figure 3.1.8
Time course showing cumulative data for 50nM ACh in the presence of 200|aM 
NOC-12 in mouse submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
200|j.M NOC-12 occurred. The final two time points have error bars absent due 
to a lack of sample size and any statistical significance is compared to control
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Change in [Ca2^  in response to 50nM ACh in the presence
of 75 pM SNP initially increases but then gradually 
decreases with repeated application over the experimental 
time period.
Figure 3.1.9
Time course showing cumulative data for 50nM ACh in the presence of 75^iM 
SNP in mouse submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
75pM SNP occurred. Statistical significance compared to control.
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Change in [Ca2+]| in response to 50nM ACh in the presence
of 200 pM NOC-5 initially increases but then gradually 
decreases with repeated application over the experimental 
time period.
Figure 3.1.10
Time (minutes)
Time course showing cumulative data for 50nM ACh in the presence of 200pM 
NOC-5 in mouse submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
200pM NOC-5 occurred. Final time point error bar absent due to a lack of 
sample size. Statistical significance compared to control.
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Change in [Ca2^  in response to 50nM ACh only and in the 
presence of 100pM SNAP, 200pM NOC-12, 100pM SNP 
and 200pM NOC-5 respectively over the experimental time 
period.
n =12 w CONTROL 
n =15 ■  SNAP 
n =22 □ NOC-12
** n = 9 H SNP
Figure 3.1.11 Trace A
300
250
200
150
100
50
0
n = 5 ■  NOC-5
* <0.05 
** <0.01 
*** <0.001
Time (minutes)
Bar chart showing cumulative data for 100pM SNAP ( end point 32 minutes), 
200pM NOC-12 (end point 78 minutes), 100pM SNP (end point 40 minutes) and 
200pM NOC-5 (end point 32 minutes) in mouse submandibular acinar cells. 
Specific time points selected to best illustrate the effect of all four NO donors on 
the ACh induced response in mouse submandibular acinar cells. The ACh only 
experiments had an end point of approximately 50 minutes and any statistical 
significance shown is experimental sample compared to control.
108
Pe
rc
en
ta
ge
 o
f I
ni
tia
l A
Ch
 R
es
po
ns
e
Change in [Ca2^  in response to 50nM ACh in the presence 
of 100jj,M SNAP, 200pM NOC-12, 100pM SNP and 
200pM NOC-5 respectively over the experimental time 
period.
Figure 3.1.11 Trace B
n =15 ■  SNAP 
n =22 □ NOC-12
Time (minutes)
Bar chart showing cumulative data for 100pM SNAP ( end point 32 minutes), 
200pM NOC-12 (end point 78 minutes), lOOpM SNP (end point 40 minutes) and 
200pM NOC-5 (end point 32 minutes) in mouse submandibular acinar cells.
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Change in [Ca^in response to 50nM ACh, illustrating how 
200pM NOC-12 induced amplification and inhibition of 
[Ca2+]j signal but how cells were still able to responded to 
Thapsigargin.
Figure 3.1.12
NOC-12 200^M
D D  D D  D D D  D D D 0 0 D 0  0 0 0  0  O A C h s o n M
100 nM
5 min
ACh (50 nM) stimulated increased [Ca2+]| measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 and 48hours 
respectively.
Trace shows responses with repeated stimulation with 50nM ACh before and 
after application of both NO donor NOC-12 chronically followed by exposure 
to SERCA pump inhibitor Thapsigargin post experimental run down (see 
scale bar).
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Inhib itors -  ODQ
Following the results achieved through use of all four NO donors (SNAP, NOC-12, 
SNP and NOC-5) the mode of action of NO had to be determined. As discussed 
previously, (Chapter 1 Introduction 1.2 Nitric oxide section) the most likely pathway 
involved in the activity of NO is the cADPr pathway so to investigate this hypothesis 
two inhibitors of this pathway were selected. The first inhibitor selected was ODQ as 
this blocks the initial, sGC, step of the pathway. SNAP and NOC-12 were selected to 
use with NO pathway inhibitors ODQ as they were both consistent in the initial 
experiments and SNAP was the original NO donor and both have relatively long half 
lives.
Figure 3.1.13 parts A and B shows representative traces demonstrating the affect of 
soluble Guanylate Cyclase (sGC) inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quihoxalon-1- 
one (ODQ) on the ACh-evoked increase in [Ca2+]i in mouse submandibular acinar 
cells of the NO donors SNAP and NOC-12 respectively. Trace A shows a series of 
[Ca2+]i responses to ACh (50nM) in the presence of SNAP (100pM) and also ODQ 
(10pM) over the protocol defined time points. Trace B shows the [Ca2+]i responses to 
ACh (50nM) in the presence of NOC-12 (200pM) and ODQ (10pM) over the same 
protocol defined time points. Comparison of the [Ca2+]i responses in figures A and B, 
shows that exposure of the mouse submandibular acinar cells to NO in the presence 
of ODQ removed the significant increase in response to ACh observed previously 
from an average SNAP response of 235.8 ± 35.39 % (n=15) to 113.6 ± 3.83 % (n=5) 
and an average NOC-12 response of 162.5 ± 10.4% (n=22) to 103.3 ± 2.23 % (n=5) 
respectively. In the presence of ODQ and SNAP or NOC-12 the Ca2+ signal did not 
increase significantly greater than control.
I l l
Figure 3.1.13
Change in [Ca2^  in response to 50nM ACh in the presence
of 100|uM SNAP and 200pM NOC-12 respectively in the
presence 10pM ODQ acutely.
|SNAP 100 |iM + ODQ 10 nM 
A □  □  ACh 50 nM
NOC-12 200 |iM + ODQ 10 _______________
B □ □ ACh 50 nM □  □  □
100 nM
2 min
ACh (50 nM) stimulated increased [Ca2!  measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 and 48hours 
respectively.
Trace A shows responses with repeated stimulation with 50nM ACh before 
and after application of both NO donor SNAP and NO inhibitor ODQ acutely 
(see scale bar).
Trace B shows responses with repeated stimulation with 50nM ACh before 
and after application of both NO donor NOC-12 and NO inhibitor ODQ 
acutely (see scale bar).
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However, more prolonged experiments were required to demonstrate what effect 
inhibitors of the cADPr pathway would have on the desensitisation of acinar cells to 
ACh induced previously by the NO donors, SNAP and NOC-12 respectively.
Figure 3.1.13 parts C and D shows representative traces demonstrating the effect of 
ODQ on the ACh-evoked increase in [Ca24}  in mouse submandibular acinar cells 
following chronic exposure in either SNAP and NOC-12. Trace C shows a prolonged 
series of [Ca2+]i responses to ACh (50nM) in the presence of both SNAP (100pM) 
and ODQ (10pM) over the protocol defined time points. Trace D shows the [Ca2+]i 
responses to ACh (50nM) in the presence of both NOC-12 (200pM) and ODQ 
(10pM) over the same protocol defined time points. Comparison of traces C and D 
shows that exposure of the mouse submandibular acinar cells to either NO donor in 
the presence of ODQ removed the significant increase in response to ACh observed 
previously. However, in-spite of the presence of ODQ the inhibition of the ACh 
induced [Ca2+]j response by NO still occurred with either SNAP or NOC-12. At 28 
minutes the ACh stimulated increase in [Ca2+]i response in the presence of SNAP 
and ODQ was not significantly different from zero. Whereas the time point at which 
the ACh stimulated increase in [Ca2+]j response in the presence of NOC-12 and ODQ 
was not significantly different from zero was 36 minutes. The data in figure 3.1.14 
parts C and D shows that over a prolonged period of time the cells still become less 
sensitive to ACh and finally stop responding to stimulus even in the presence of sGC 
inhibitor ODQ. Therefore the results suggest that the induced hypofunction may be 
independent of the NO pathway.
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Figure 3.1.13
Change in [Ca2^  in response to 50nM ACh in the presence
of 100pM SNAP and 200pM NOC-12 respectively in the
presence IOjiM ODQ chronically.
SNAP100 |xM + ODQ 10 i^M
c  □ □ □ □ □ □ D  D  ACh 50 nM
A 1*
i JL .
50 nM
5 min
NOC-12 200 |iM + ODQ 10^M
D D D □ □ □ □ □ □ □ □  ACh 50 nM
100 nM
5 min
ACh (50 nM) stimulated increased [Ca2+]; measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows responses with repeated stimulation with 50nM ACh before 
and after application of both NO donor SNAP and NO inhibitor ODQ 
chronically (see scale bar).
Trace D shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor NOC-12 and NO inhibitor ODQ 
chronically (see scale bar).
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The data in figures 3.1.14 and 3.1.15 show the cumulative average responses 
achieved using SNAP and NOC-12 in the presence of the NO pathway inhibitor ODQ 
respectively. Upon observation of these average data in figure 3.1.14 and 3.1.15 the 
chronic pattern of response induced by the presence of NO was clearly maintained 
even in the presence of ODQ. So ODQ does not inhibit the long term effect of NO 
and the induced reduction of the ACh-evoked [Ca2+]i response, so ODQ is only 
effective in the short term which suggests that the rundown induced by NO is 
independent of the cADPr pathway. The average data in figure 3.1.16 shows all 
average results represented as a bar chart to allow direct comparison between 
control and experimental conditions.
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Figure 3.1.14
Change in [Ca2+]| in response to 50nM ACh in the presence
61100pM SNAP ^nd 10pM ODQ showing the gradual
cfefctease in response over the experimental time period.
n = 5 SNAP+ODQ
Time (minutes)
Time pptirse showing cumulative data for 50nM ACh in the presence of 100(iM 
SN$P and 1OpM ODQ in mouse submandibular acinar cells. The etejta show the 
series of experimental time points where responses to 50nM ACh in thè 
presence of 10OjaM SNAP and 10pM ODQ occurred. Any statistical significance 
indicated is compared to control
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Change in [Ca2^  in response to 50nM ACh in the presence
of 200juM NOC-12 and 10pM ODQ showing the gradual 
decrease in response over the experimental time period.
Figure 3.1.15
n = 5 N O C -1 2  + O D Q
Time course showing cumulative data for 50nM ACh in the presence of 200pM 
NOC-12 and 10pM ODQ in mouse submandibular acinar cells. The data show 
the series of experimental time points where responses to 50nM ACh in the 
presence of 200pM NOC-12 and 10pM ODQ occurred. Any statistical 
significance indicated is compared to control.
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Change in [Ca2^  in response to 50nM ACh and 50nM ACh 
in the presence of 100 pM SNAP with 10 pM ODQ and 
200 pM NOC-12 with 10 pM ODQ respectively over the 
experimental time period.
n =12 □ CONTROL  
n = 5 ■  SNAP+ODQ
Figure 3.1.16
n = 5 E NOC-12 + ODQ
Time (minutes)
Bar chart showing cumulative data for 50nM ACh control (end point 50 minutes), 
100pM SNAP with 10pM ODQ (end point 28 minutes, no response stimulated at 
25 minutes) and 200pM NOC-12 with 10pM ODQ (end point 32 minutes) in 
mouse submandibular acinar cells. Any statistical significance indicated is 
compared to control.
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Inhibitors - Ryanodine
Following the results achieved using ODQ a second inhibitor of the cADPr pathway, 
Ryanodine, was used. Ryanodine acts on the RyR directly and so blocks the cADPr 
pathway at the final step whereas ODQ acts on sGC which is the initial step of the 
cADPr pathway as discussed earlier (Chapter 1 Introduction 1.2 Nitric Oxide section). 
NOC-12 was selected for use with Ryanodine to allow direct comparison with the 
ODQ data and NOC-12 produced much more consistent results and proved less 
problematic to use than SNAP.
Figure 3.1.17 parts A and B shows representative traces demonstrating the effect of 
the Ryanodine receptor inhibitor Ryanodine on NOC-12 on the ACh-evoked increase 
in [Ca2+]j in mouse submandibular acinar cells. Trace A shows a series of control 
[Ca2+]i responses to ACh (50nM) in the presence of Ryanodine (10pM) only over the 
protocol defined time points. Trace B shows the [Ca2+]i responses to ACh in the 
presence of both NOC-12 (200pM) and Ryanodine (10pM) over the same protocol 
defined time points. By comparing the [Ca2+], response of cells to ACh under 
Ryanodine only control conditions (A) to those obtained following combined exposure 
to both NOC-12 and Ryanodine (B) at equivalent time points, the data show that 
exposure of the mouse submandibular acinar cells to NOC-12 during exposure to 
Ryanodine significantly (P<0.05) removes the previous increased response to ACh 
from an average NOC-12 response of 162.5 ± 10.4 % (n=22) to 121.3 ± 10.84 % 
(n=8). Therefore the data in figure 3.1.17 demonstrate the inhibition of NO induced 
amplification of the ACh-evoked increase in [Ca2+]i by the Ryanodine receptor 
inhibitor Ryanodine.
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Change in [Ca2+]j in response to 50nM ACh in the presence 
of 10|uM Ryanodine and 200pM NOC-12 in the presence
Figure 3.1.17
100 nM
2 min
NOC-12 200 + Ryanodine 10
B □  □  ACh 50 nM [ | | |
2 min
ACh (50 nM) stimulated increased [Ca2!  measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows responses with repeated stimulation with 50nM ACh before 
and after application of NO pathway inhibitor Ryanodine only acutely (see 
scale bar).
Trace B shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor NOC-12 and NO pathway inhibitor 
Ryanodine acutely (see scale bar).
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Change in [Ca2^  in response to 50nM ACh in the presence 
of 10fiM Ryanodine and 200|aM NOC-12 with 10jiM
Figure 3.1.17
5 min
ACh (50 nM) stimulated increased [Ca2!  measured in mouse submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows responses with repeated stimulation with 50nM ACh before 
and after application of Ryanodine chronically (see scale bar).
Trace D shows responses with repeated stimulation with 50nM ACh before 
and after application of the NO donor NOC-12 and NO pathway inhibitor 
Ryanodine chronically (see scale bar).
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Figure 3.1.17 parts C and D shows representative traces demonstrating the chronic 
effect of Ryanodine on the effect of NOC-12 on the ACh-evoked increase in [Ca2+]i in 
mouse submandibular acinar cells. Trace C shows a series of control [Ca2+]i 
responses to ACh (50nM) in the presence of Ryanodine (10pM) only over the 
protocol defined time points. Trace D shows the [Ca2+]i responses to ACh (50nM) in 
the presence of both NOC-12 (200pM) and Ryanodine (10pM) over the same 
protocol defined time points.
The data in figures 3.1.18 and 3.1.19 show the cumulative average responses 
achieved, using Ryanodine alone and NOC-12 in the presence of Ryanodine. The 
cumulative data in figure 3.1.18 show that Ryanodine itself induces run-down by 
blocking the Ryanodine receptors directly. The data in figure 3.1.20 allows direct 
comparison between control, Ryanodine only and Ryanodine and NOC-12 together 
and demonstrates the very similar patterns of response with the only major variation 
being the maintained level of response under control conditions. As a result of these 
findings the usefulness of Ryanodine as an inhibitor of the effect of NO activity is 
limited as in the short term it functions to stop the amplification of response but use in 
chronic experiments is problematic. There is also no obvious additive effect between 
Ryanodine and NOC-12 as the use of NOC-12 in the presence of Ryanodine doesn’t 
induce further run-down than Ryanodine alone or vice-versa. Figure 3.1.21 is a 
simple bar chart which allows the degree of initial amplification to be observed and 
compared between control and experimental conditions.
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Change in [Ca2^  in response to 50nM ACh in the presence 
of 10 pM Ryanodine showing decrease with repeated 
application.
Figure 3.1.18
n = 7 RYANODINE
Time course showing cumulative data for 50nM ACh in the presence or absence 
of 10|j.M Ryanodine in mouse submandibular acinar cells. The data show the 
series of experimental time points where responses to 50nM ACh in the 
presence of 10pM Ryanodine occurred. Any statistical significance shown is 
compared to control.
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Change in [Ca2^  in response to 50nM ACh in the presence 
of both 10 pM Ryanodine and 200 pM NOC-12 showing 
gradual decrease in response.
Figure 3.1.19
n = 8 - ® -  NOC-12+RYANODINE
Time course showing cumulative data for 50nM ACh in the presence or absence 
of both 10pM Ryanodine and 200pM NOC-12 in mouse submandibular acinar 
cells. The data show the series of experimental time points where responses to 
50nM ACh in the presence of both 10pM Ryanodine and 200pM NOC-12 
occurred. Final three time points have no error bars present due to a lack of 
sample number.
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Change in [Ca2+l  in response to 50nM ACh and 50nM ACh 
in the presence of 200 pM NOC-12 with 10 pM Ryanodine 
and 10 pM Ryanodine respectively over the experimental 
time period.
n =12 m CONTROL
Figure 3.1.20
n = 8 ■  NOC-12 + Ryanodine 
n = 7 ■  Ryanodine
dUU 1 * <0.05
250 -
200
2 7 10 14 18 22 25 28 32 36 40 44 48 50 54
Time (minutes)
Bar chart showing cumulative data for 50nM ACh control (end point 50 minutes), 
100pM SNAP with 10pM ODQ (end point 28 minutes, no response stimulated at 
25 minutes) and 200pM NOC-12 with 10pM ODQ (end point 32 minutes) in 
mouse submandibular acinar cells. Any statistical significance shown is 
compared to control. There were statistically significant (<0.05) variations 
between NOC-12 only and Ryanodine and NOC-12 together at the 7,10 and 25 
minute time points and also statistically significant (<0.05) variations between 
Ryanodine only and NOC-12 only at the 7,10 and 48 minute time points.
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Figure 3.1.21:Data presented as a bar chart to allow direct comparison 
between all average results for all experimental conditions for the level of 
amplification induced at the third ACh stimulation compared to control
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Conclusion
The data in figure 3.1.4 parts A to D and figure 3.1.5 show how exposure of the 
mouse submandibular acinar cells to SNAP, NOC-12, SNP or NOC-5 respectively, 
changes the pattern of response and how NO initially induced amplification of the 
ACh-evoked increase in [Ca2+]j followed by NO induced inhibition of the ACh-evoked 
increase in [Ca2+]i over the experimental time period with NOC-12 exhibiting a more 
prolonged period of time but traces B and D in figure 3.1.4 and both traces in 3.1.5 
show cells becoming less sensitive to ACh and finally being unresponsive to ACh 
stimulus.
The cumulative normalised data in figures 3.1.7 to 3.1.11 demonstrate the chronic 
pattern of [Ca2+]i response induced following prolonged NO exposure. The data in 
figures 3.1.6 to 3.1.11 allow direct comparison between control responses and those 
responses achieved under experimental conditions with all experiments performed in 
accordance with the devised experimental protocol stated previously. The data 
overall shows that exposure of the mouse submandibular acinar cells to NOC-12 
inhibited the response to ACh but the rate of inhibition was not comparable to SNA P, 
SNP or NOC-5 as NOC-12 took far longer to induce inhibition of the response, NOC- 
12 demonstrated an alternative response pattern compared to SNAP, SNP and 
NOC-5 as the average values in figures 3.1.7 to 3.1.10 show. Variations in time 
course between the four is most likely a result of variations in the rate of NO release 
which varied between the four donors. Figure 3.1.12 demonstrates that the reduction 
in responsiveness to ACh following exposure to NO are not a result of decreased 
calcium stores as may be suggested as thapsigargin post NO inhibition still induces a 
considerable mobilisation of Ca2+ which goes some way to prove that the cells still 
contain considerable Ca2+ stores. These post NO exposures to thapsigargin ensure
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that a lack of [Ca2+]i is not responsible for the inhibition of response observed 
following exposure of the acinar cells to NO.
As described previously, (Chapter 1 Introduction 1.2 Nitric Oxide section) NO was 
selected for investigation as a possible cause of salivary hypofunction in SjS. These 
data would suggest that NO does have the ability to induce acinar hypo-function but 
only after prolonged time periods. However, the results were achieved over relatively 
short time periods when compared to the SjS patients likely NO exposure duration. 
Therefore, NO was able to induce healthy acinar cells to behave like SjS acinar cells. 
The chronic experiments were therefore compatible with the hypothesised role of NO 
in SjS. Another important result achieved over the duration of these experiments was 
that prolonged incubation of the acinar cells with the NO donors did not produce 
inhibition of response. Inhibition only occurred when cells were repeatedly stimulated 
with ACh, however, the responses to ACh which were achieved post NO donor 
incubation were smaller in magnitude compared to those which were not incubated. 
The response to 50nM ACh stimulation following prolonged pre-incubation (2-5 
hours) in the presence of NOC-12 was on average 49.7 ± 24.3% (n=9) of the 
averaged first response to ACh without pre-incubation.
In the presence of ODQ and SNAP or NOC-12 the Ca2+ signal did not increase 
significantly greater than control. Therefore these data support the concept that NO is 
causing an amplification in the [Ca2+]i response through the cADPr pathway as acute 
amplification induced by any either NO donor is prevented by addition of ODQ.
The average data in figures 3.1.14 to 3.1.16 shows that exposure of the mouse 
submandibular acinar cells to SNAP or NOC-12 still induces inhibition of response in 
the presence of ODQ which dose not vary significantly from the induced inhibition of 
response in the absence of ODQ for SNAP. However, although the degree of
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desensitisation of response to ACh does not change the rate of desensitisation does 
increase for NOC-12 in the presence of ODQ. This was previously noted by Takuma 
and colleagues who observed that the cytotoxic effect of NOC-12 was exacerbated 
by ODQ (Takuma, Phuagphong et al. 2002). We might speculate that ODQ amplifies 
the NOC-12 by increasing the rate of release of NO by NOC-12 but this effect of 
ODQ on NOC-12 was not investigated further.
The use of two cADPr pathway inhibitors allows validation and a clearer insight into 
where NO functions within the pathway as the two inhibitors function at opposite 
ends of the pathway as ODQ prevents the initial step and Ryanodine blocks the 
receptor directly so the use of both inhibitors greatly strengthens the NO/cADPr 
argument.
The data in figure 3.1.17 parts A and B shows that the use of NOC-12 in combination 
with Ryanodine prevented the induced amplification of the ACh-evoked increase in 
[Ca2+]j These data confirm that NO is mediating its effects through the cADPr 
pathway. Further experiments were required to demonstrate what effect inhibitors of 
the cADPr pathway would have on the de-sensitisation to ACh induced previously by 
the NO donor NOC-12.
The de-sensitisation observed in figure 3.1.17 trace C with Ryanodine only was 
expected as Ryanodine blocks the RyR in a sub-conductance state so would be 
expected to de-sensitise the RyR to ACh when used alone. The data in figure 3.1.20 
allows direct comparison between control, Ryanodine only and Ryanodine and NOC- 
12 together and demonstrates that the results produced from NOC-12 and 
Ryanodine were indistinguishable from the results produced using Ryanodine alone. 
The Use of Ryanodine produces results consistent with ODQ and confirms that the 
amplification induced by NO is mediated through the cADPr pathway. However, the
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chronic data produced from use of the ODQ and Ryanodine with the NO donors 
would suggest that NO induces desensitisation and inhibition of the ACh response 
independently of the cADPr pathway as neither inhibitor of this pathway blocked the 
NO induced inhibition. There was no significant difference observed between NOC- 
12 and Ryanodine and Ryanodine alone. Figure 3.1.21 allows direct comparison 
between the third response for all conditions compared to control.
So in summary all four donors were able to induce amplification and inhibition of the 
[Ca2+]i response. The degree of amplification and the rate of desensitisation induced 
by the NO donors varied between donors but was most likely relative to the individual 
donors rates of release of NO. The use of four donors removed the likelihood of the 
results achieved being an artefact of any one donor as all four donors gave similar 
patterns of response. The control data show that the mouse submandibular acinar 
cells ability to respond to stimulus did not diminish over the experimental time period. 
The NO exposed data demonstrate that the mouse submandibular acinar cells 
initially become hyper-responsive to 50nM ACh but then gradually become hypo- 
responsive over the experimental time period in the presence of any of the four NO 
donors.
The use of two inhibitors of the cADPr pathway demonstrated that the amplification 
induced was mediated through the cADPr pathway. However, the induced 
desensitisation persisted in the presence of both cADPr pathway inhibitors which 
indicates that the reduction in [Ca2+]i response to ACh is in-dependent of the cADPr 
pathway. The sum of these data suggest a role for NO in glandular hypofunction in 
SjS as the cells were desensitised to ACh following chronic exposure to NO.
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Chapter Four
Results
Nitric Oxide
Human Submandibular Acinar Cells
U N I V E R S I T Y 0 F
LIVERPOOL
Introduction
Following the work performed using mouse submandibular acinar cells subsequent 
experiments were performed on acinar cells from human submandibular tissue 
obtained, following ethical approval, from head and neck cancer operations. Tissue 
used was histologically normal and from non-irradiated patients. Experiments from 
such cells are much more valuable and would give a better insight when examining 
the pathological processes of the disease.
The two NO donors selected were NOC-12 and SNP. These two donors were 
selected as they were relatively easy to use and produced good results in the mouse 
submandibular acinar cells. Both NO pathway inhibitors were used but only in 
conjunction with NOC-12 as that gave the most reliable and consistent results. The 
human submandibular acinar cells appeared much more sensitive than the mouse 
submandibular acinar cells and as a result the control responses did demonstrate 
some degree of reduction over the experimental time period but the final results 
proved consistent with those achieved using the mouse submandibular acinar cells.
All experiments were performed in accordance with the strict protocol described 
previously (Chapter 2 materials and methods section 2.8, figure 2.8.2). The response 
of human submandibular acinar cells to ACh follows the same typical pattern as the 
mouse submandibular acinar cells as discussed previously (Chapter 2 materials and 
methods section 2.8, figure 2.8.1 trace A).
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Results - Acute Experiments
The initial experiments were performed acutely using NOC-12 and SNP to show the 
effect of NO on ACh-evoked Ca2+ signal in human submandibular acinar cells.
Table 4.1.1: Table of results for human submandibular acinar cells
Number of Type of Response Degree of Response Time Taken to
samples (Mean ± SE) decrease to zero
as a Percentage (where applicable)
n=9 Control 94.7 ± 3.43% N/A
n=3 SNP 1066.71260.34% 40
n=5 NOC-12 112.41 11.84% 62
n=3 NOC-12 + ODQ 108.51 1.06% 32
n=4 NOC-12 + Ryanodine 101 12.09% 44
n=3 Ryanodine 73.4 1 6.02% N/A
Figure 4.1.1 parts A and B shows representative traces demonstrating the effect of 
the NO donor SNP on the ACh-evoked increase in [Ca2+]j in human submandibular 
acinar cells. Trace A shows a series of control responses to ACh (50nM) over the 
protocol defined time points. Trace B shows the responses to ACh (50nM) in the 
presence of NO donor SNP (75pM) over the same protocol defined time points. 
Comparison of the response of cells to ACh (50nM) under control conditions (A) to 
that obtained following exposure to NO donor SNP (B) at equivalent time points, 
shows that exposure of the human submandibular acinar cells to an NO donor SNP 
significantly (P<0.001) increased the [Ca2+]i response to ACh (50nM) compared to 
control. When the data for all the experiments was gathered and expressed as
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Figure 4.1.1 parts C and D shows representative traces which demonstrate the effect 
of the NO donor NOC-12 on the ACh-evoked increase in [Ca2+]i in human 
submandibular acinar cells. Trace C shows a series of control [Ca2+]i responses to 
ACh (50nM) over the protocol defined time points. Trace D shows the [Ca2+]| 
responses to ACh (50nM) in the presence of the NO donor NOC-12 (200pM) over 
the same protocol defined time points. Comparison of the [Ca2+]j response of cells to 
ACh under control conditions (C) to that obtained following exposure to NO donor 
NOC-12 (D) at equivalent time points, shows that exposure of the human 
submandibular acinar cells to NO donor NOC-12 did not significantly increase the 
response to ACh compared to control. When the data for all the experiments was 
gathered and expressed as percentages the average control response was 94.7 ± 
3.43% (n=9) compared to 112.4 ± 11.84% (n=5) in the presence of NOC-12.
As stated previously (Chapter 1 Introduction 1.2 Nitric oxide) elevated levels of NO 
have been observed in SjS patients and NO has been suggested to have a role in 
the progression of the disease and the resulting salivary gland hypo-function. 
Unfortunately this preliminary data would suggest that NO induces hyper, not hypo- 
function as it enhanced the cells responses to ACh. However, these initial 
experiments only determined the acute effect of NO on acinar cells and in the 
salivary glands of SjS patients the acinar cells would be exposed to NO long-term so 
these experiments are less relevant to SjS patients. Extended duration experiments 
were required to determine the effect of NO long term.
percentages the average control response was 94.7 ± 3.43% (n=9) compared to
1066.7 ± 260.34% (n=3) in the presence of SNP.
134
Figure 4.1.1
Change in [Ca2+]| in response to 50nM ACh, illustrating how 
75pM SNP induced amplification of [Ca2^  signal.
a d d  □  □  ACh 50 nM
2 min
SNP 75 |iM _______________________________
B □  □  □  □  ACh 50 nM
100 nM
2 min
ACh (50nM) stimulated increased [Ca2*], measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 72 (control) and 48 
(SNP) hours respectively.
Trace A shows response to repeated stimulation with 50nM ACh only (see 
bar).
Trace B show s responses to repeated stim ulation w ith 50nM  Ach before and
a fte r application o f the NO donor SNP (see bar).
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Figure 4.1.1
Change in [Ca2!  in response to 50nM ACh, illustrating how 
200|iM NOC-12 induced amplification of [Ca2^  signal.
c □  □  □  □  ACh 50 nM
100 nM
2 min
NOC-12 200 |xM______________________________
D □  □  □  □  ACh 50 nM
2 min
ACh (50nM) stimulated increased [Ca2+l  measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 72 (control) and 24 
(NOC-12) hours respectively.
Trace C shows response to repeated stimulation with 50nM ACh only (see 
bar).
Trace D show s responses to repeated stim ulation w ith 50nM  Ach before and
afte r application o f the NO donor NOC-12 (see bar).
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Chronic Experiments
Following the initial results achieved a second set of experiments were conducted 
which exposed the human submandibular acinar cells more chronically to NO. These 
more chronic experiments were performed to determine the effect of NO exposure 
more long term and would be more relevant to the NO exposure in SjS patients. The 
results of this work could give a more accurate insight into the effect induced on the 
response of acinar cells to ACh following prolonged NO exposure.
Figure 4.1.2 parts A and B shows representative traces demonstrating the chronic 
effect of the NO donor SNP on the ACh-evoked increase in [Ca2+], in human 
submandibular acinar cells. Trace A shows a prolonged series of control [Ca2+]i 
responses to ACh (50nM) over the protocol defined time period. Trace A also shows 
that the cells under control conditions maintain their ability to respond over the 
expanded experimental protocol. Trace B shows the [Ca2+]i responses to ACh (50nM) 
in the presence of NO donor SNP (75pM) over the same protocol defined time 
points. As described previously comparison of the acinar cell [Ca2+]i response to ACh 
under control conditions (A) to that which was obtained following exposure to NO 
donor SNP (B), shows that exposure of the human submandibular acinar cells to an 
NO donor SNP initially increased the level of response to ACh. The control response 
in figure 4.1.2 trace A shows some degree of run-down over the duration of the 
experiment. However, the data in figure 4.1.2 part B show that over a prolonged 
period of time the cells become less sensitive to ACh and finally stop responding to 
stimulus. At 40 minutes the ACh stimulated increase in [Ca2+]i response in the 
presence of SNP was not significantly different from zero.
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Change in [Ca2^  in response to 50nM ACh, illustrating how 
75pM SNP induced amplification and inhibition of [Ca2^  
signal.
ACh 50 nM
a  DO 0 D 0 0 0 0 0 0 0 D 0 0
Figure 4.1.2
j J l J u ___h__x
100 nM
10 min
| SNP 75 p,M____________________________________________________
ACh 50 nM
B □ □ □ □ □ □ □ □ □  □ □
100 nM
5 min
ACh (50nM) stimulated increased [C a ^  measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows response to repeated stimulation with 50nM ACh only (see 
bar).
Trace B show s responses to repeated stim ulation w ith 50nM  Ach before and
afte r app lication o f the NO donor SNAP (see bar).
138
Figure 4.1.2
Change in [Ca2!  in response to 50nM ACh, illustrating how 
200jiM NOC-12 induced amplification and inhibition of [Ca2+]j 
signal.
c D D  D D  D D O D D  D D D AChsonM
100 nM
10 min
| NOC-12 200 nM________________________________________________
ACh 50 nM
d OO D 0 □ 0 □ 0 □ D 0 0 O D D
10 min
ACh (50nM) stimulated increased [Ca2+]; measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 48 (control) and 24 
(NOC-12) hours respectively.
Trace C shows response to repeated stimulation with 50nM ACh only (see 
bar).
T race D show s responses to  repeated stim ulation w ith 50nM  AC h before and
a fte r application o f the NO donor NO C-12 (see bar).
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Figure 4.1.2 parts C and D shows representative traces demonstrating the chronic 
effect of NO donor NOC-12 on the ACh-evoked increase in [Ca2+]¡ in human 
submandibular acinar cells. Trace C shows a prolonged series of control [Ca2+]¡ 
responses to ACh (50nM) over the protocol defined time points, with cells 
maintaining the level of response. Trace D shows the [Ca2+]¡ responses to ACh 
(50nM) in the presence of NO donor NOC-12 (200pM) over the same protocol 
defined time points. Comparison of the [Ca2+]¡ response of cells to ACh under control 
conditions (C) to those obtained following exposure to NO donor NOC-12 (D) at 
equivalent time points, shows that exposure of the human submandibular acinar cells 
to an NO donor NOC-12 slightly increased the level of response to ACh. However, 
the data in figure 4.1.2 part D also show that over a prolonged period of time the cells 
become less sensitive to ACh and finally stop responding to stimulus. At 62 minutes 
the ACh stimulated increase in [Ca2+]¡ response in the presence of NOC-12 was not 
significantly different from zero.
The data in figures 4.1.3 to 4.1.5 show the cumulative average responses achieved 
under control conditions, those achieved using NO donor SNP and those achieved 
using NO donor NOC-12 respectively. Upon review of the average data in figures
4.1.4 and 4.1.5 the chronic pattern of response of NO is clearly observable. The 
cumulative average data in figures 4.1.3 to 4.1.5 also allow direct comparison 
between control and experimental conditions. Figure 4.1.6 shows cumulative data 
presented as a bar chart to allow direct comparison between control and 
experimental conditions.
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Change in [Ca2+]i in response to 50nM ACh did not totally 
diminish with repeated application over the experimental 
time period.
Figure 4.1.3
Time course showing cumulative data for 50nM ACh in human submandibular 
acinar cells. The data show the series of experimental time points where 
responses to 50nM ACh occurred. These data show the standard response of 
human submandibular acinar cells to 50nM ACh under control conditions.
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Change in [Ca2^  in response to 50nM ACh in the presence 
of 75 pM SNP initially increases but then gradually decreases 
with repeated application over the experimental time period.
Figure 4.1.4
Time course showing cumulative data for 50nM ACh in the presence of 75pM 
SNP in human submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
75pM SNP occurred. The cumulative data was produced from a relatively small 
sample size due to the small amount of human tissue available but this 
significant increase in response was observed in each experiment.
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Change in [Ca2+]i in response to 50nM ACh in the presence 
of 200 |iM NOC-12 initially marginally increases but then 
gradually decreases with repeated application over the 
experimental time period.
Figure 4.1.5
Time course showing cumulative data for 50nM ACh in the presence of 200pM 
NOC-12 in human submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
200pM NOC-12 occurred.
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Figure 4.1.6
Change in [Ca2^  in response to 50nM ACh only and 50nM 
Ach in the presence of 75juM SNP and 200|iM NOC-12 
respectively over the experimental time period.
60 0  "1 ■  C O N TR O L
Bar chart showing cumulative data for 50nMACh control (end point 44 minutes), 
75pM SNP (endpoint 40 minutes) and 200pM NOC-12 (end point 66 minutes) in 
human submandibular acinar cells.
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Inhibitors - ODQ
Following the results achieved through use of the NO donors SNP and NOC-12, the 
mode of action of NO in human submandibular acinar cells had to be determined. As 
discussed previously, (Chapter 1 Introduction 1.2 nitric oxide section) NO is 
considered to act through the cADPr pathway so to investigate this hypothesis 
inhibitors of this pathway were once again used. NOC-12 was selected for use with 
the NO pathway inhibitors as it gave good results and proved much more consistent 
than SNP. ODQ was again selected as the first NO pathway inhibitor.
Figure 4.1.7 parts A and B shows representative traces demonstrating the affect of 
sGC inhibitor ODQ on the affect of NO donor NOC-12 on the ACh-evoked increase in 
[Ca2+]j in human submandibular acinar cells. Trace A shows a series of [Ca2+]j 
responses to ACh (50nM) in the presence of the NO donor NOC-12 (200pM) only 
over the protocol defined time points. Trace B shows the [Ca2+]i responses to ACh 
(50nM) in the presence of NO donor NOC-12 (200pM) and ODQ (10pM) over the 
same protocol defined time points. Comparison of the [Ca2+]i responses in figures A 
and B, shows that exposure of the human submandibular acinar cells to NO in the 
presence of ODQ slightly reduced the increase in response to ACh observed 
previously from an average NOC-12 response of 112.4 ± 11.84% (n=5) to 108.5 ± 
1.06% (n=3) for NOC-12 in the presence of ODQ. The data in figure 4.1.7 parts A 
and B demonstrate inhibition of the NO induced amplification of the ACh-evoked 
increase in [Ca2+]j by ODQ.
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Change in [Ca2+]i in response to 50nM ACh in the presence 
of 200pM NOC-12 and 200pM NOC-12 with 10pM ODQ 
respectively acutely.,______________________________
| NOC-12 200 |xM
a D D  □  □  ACh 50 nM
Figure 4.1.7
2 min
NOC-12 200 nM + ODQ 10 _______________________
B □  □  □  □  ACh 50 nM
2 min
ACh (50nM) stimulated increased [Ca2!  measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 24 (NOC-12) and 48 
(NOC-12/ODQ) hours respectively.
Trace A shows responses to repeated stimulation with 50nM ACh before and 
after application of NO donor NOC-12 (see bar).
Trace B shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 with NO pathway inhibitor ODQ 
(see bar).
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Change in [Ca2+]j in response to 50nM ACh in the presence 
of 200pM NOC-12 and 200pM NOC-12 in the presence 
10uM ODQ respectively chronically.__________________
| NOC-12 200 m.M
Figure 4.1.7
cDO □ 0 □ D 0 □ □ 0 □ 0 0 D □
100 nM
10 min
l NOC-12 200 nM + ODQ 10 i^M
d DO □ 0 0 □ □ 0 □ 0 ACh 50 nM
100 nM
10 min
ACh (50nM) stimulated increased [Ca2!  measured in human submandibular 
acinar cells maintained in primary tissue culture flpid for 24 hours.
Trace C shows responses to repeated stimulation with 50nM ACh before and 
after application of NO donor NOC-12 (see bar).
Trace D shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 and NO inhibitor ODQ (see bar).
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However, more prolonged experiments were required to demonstrate what effect 
inhibitors of the cADPr pathway would have on the de-sensitisation of acinar cells to 
ACh induced previously by the NO donor NOC-12.
Figure 4.1.7 parts C and D shows representative traces demonstrating the chronic 
effect of ODQ on the effect of NO donor NOC-12 on the ACh-evoked increase in 
[Ca2+]i in human submandibular acinar cells. Trace C shows a prolonged series of 
[Ca2+]i responses to ACh (50nM) in the presence NO donor NOC-12 (200pM) only 
over the protocol defined time points. Trace D shows the [Ca2+]i responses to ACh 
(50nM) in the presence of NO donor NOC-12 (200pM) and also ODQ (10pM) over 
the same protocol defined time points. Comparison of traces C and D shows that 
exposure of the human submandibular acinar cells to the NO donor NOC-12 in the 
presence of ODQ removed the significant increase in response but the de­
sensitisation of the acinar cells to ACh still occurred so ODQ does not prevent the 
rundown occurring. At 32 minutes the ACh stimulated increase in [Ca2+]j response in 
the presence of NOC-12 and ODQ was not significantly different from zero. As was 
observed in the mouse submandibular acinar cells the rate of inhibition induced by 
NOC-12 in the presence of ODQ appeared to be increased compared to NOC-12 
only as NOC-12 only took 62 minutes to induce total inhibition of the response to 
ACh.
The data in figures 4.1.8 and 4.1.9 show the cumulative average responses achieved 
using the NO donor NOC-12 in the presence of ODQ. The average data in figure 
4.1.9 is presented as a bar chart to allow direct comparison between control 
conditions and those involving the NO donor NOC-12 in the presence of ODQ.
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Figure 4.1.8
Change in [Ca2^  in response to 50nM ACh in the presence
of 200 pM NOC-12 and 10 pM ODQ gradually decreases
with repeated application over the experimental time period.
Time course showing cumulative data for 50nM ACh in the presence of 200pM 
NOC-12 and 10|j.M ODQ in human submandibular acinar cells. The data show 
the series of experimental time points where responses to 50nM ACh in the 
presence of200(a.M NOC-12 and 10pMODQ occurred.
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Figure 4.1.9
Change in [Ca2+]j in response to 50nM ACh and 50nM ACh
in the presence of 200 pM NOC-12 with 10 pM ODQ
respectively over the experimental time period.
n= 9 0  CONTROL 
n= 3 «  NOC-12 + ODQ
1 6 0
1 4 0
1 2 0  ~
2 7 10 14 18 22 25 28 32 36 40 44 48 50 54
Time (minutes)
Bar chart showing cumulative data for 50nM ACh control (end point 44 minutes) 
and 200pM NOC-12 with 10pM ODQ (end point 32 minutes) in human 
submandibular acinar cells.
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Inhibitor - Ryanodine
Following the results obtained with ODQ the second cADPr pathway inhibitor 
Ryanodine was again used. NOC-12 was again used as the NO donor to allow direct 
comparison with the ODQ data.
Figure 4.1.10 parts A and B show representative traces demonstrating the effect of 
the Ryanodine receptor inhibitor Ryanodine on the effect of NO donor NOC-12 on the 
ACh-evoked increase in [Ca2+]i in human submandibular acinar cells. Trace A shows 
a series of control [Ca2+]j responses to ACh (50nM) in the presence of Ryanodine 
(10pM) only over the protocol defined time points. Trace B shows the [Ca2+]i 
responses to ACh in the presence of both NO donor NOC-12 (200pM) and 
Ryanodine (10pM) over the same protocol defined time points. By comparing the 
[Ca2+]i response of cells to ACh under control Ryanodine only conditions (A) to those 
obtained following combined exposure to NO donor NOC-12 and Ryanodine (B) at 
equivalent time points, the data show that exposure of human submandibular acinar 
cells to NOC-12 in combination with Ryanodine demonstrate a significant (P<0.01) 
variation in response when compared to those with Ryanodine only.
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Change in [Ca2+]| in response to 50nM ACh in the presence 
of 10jnM Ryanodine and 200|iM NOC-12 in the presence of 
10pM Ryanodine respectively acutely.
| Ryanodine 10 |iM
a  □  □  □  □  ACh 50 nM
Figure 4.1.10
2 min
NOC-12 200 + Ryanodine 10
B □  □  □  □  ACh 50 nM
2 min
ACh (50 nM) stimulated increased [Ca2+]; measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows responses to repeated stimulation with 50nM ACh before and 
after application of NO pathway inhibitor Ryanodine (see bar).
Trace B shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 and NO pathway inhibitor 
Ryanodine (see bar).
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More prolonged experiments were again required to demonstrate what effect this 
inhibitor of the cADPr pathway would have on the de-sensitisation to ACh induced 
previously by the NO donor NOC-12.
Figure 4.1.10 parts C and D shows representative traces demonstrating the chronic 
effect of Ryanodine on the effect of NO donor NOC-12 on the ACh-evoked increase 
in [Ca2+]j in human submandibular acinar cells. Trace C shows a series of control 
[Ca2+]i responses to ACh (50nM) in the presence of Ryanodine (10pM) only over the 
protocol defined time points. Trace D shows the [Ca2+]i responses to ACh (50nM) in 
the presence of both NO donor NOC-12 (200|jM) and Ryanodine (10pM) over the 
same protocol defined time points. By comparing the [Ca2+]i response of cells to ACh 
under control Ryanodine conditions (C) to those obtained following combined 
exposure to NO donor NOC-12 and Ryanodine (D) at equivalent time points, shows 
that exposure to NOC-12 in the presence of Ryanodine over a prolonged time period 
does not prevent de-sensitisation of the acinar cells to ACh. At 44 minutes the ACh 
stimulated increase in [Ca2+]i response in the presence of NOC-12 and Ryanodine 
together was not significantly different from zero and the average data for NOC-12 
and Ryanodine together was significantly (P<0.05) different from control. However, at 
40 minutes the ACh stimulated increase in [Ca2+]j response in the presence of 
Ryanodine only was still significantly above zero. Ryanodine alone induces some 
degree of inhibition of the [Ca2+], responses to ACh (50nM) over the duration of the 
experiment but not as great as that induced by NOC-12 and Ryanodine together.
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Change in [Ca2^  in response to 50nM ACh in the presence 
of 10pM Ryanodine and 200 i^M NOC-12 in the presence of 
10uM Ryanodine respectively chronically._____________
f  Ryanodine 10^M
c D D  D D D D D D D  D D D D ACh 50 nM
Figure 4.1.10
J V J UUUUULJLJUJl
100 nM
10 min
| NOC-12 200 jxM + Ryanodine 10 i^M_____________________________
D □ D D D  D D O D D  DACh50nM
100 nM
5 min
ACh (50 nM) stimulated increased [Ca2!  measured in human submandibular 
acinar cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows responses to repeated stimulation with 50nM ACh before and 
after application of NO pathway inhibitor Ryanodine (see bar).
Trace D shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 and NO inhibitor Ryanodine (see 
bar).
154
Pe
rc
en
ta
ge
 o
f I
ni
tia
l A
Ch
 R
es
po
ns
e
Figure 4.1.11
Change in [Ca2+]j in response to 50nM ACh in the presence
of 10 pM Ryanodine decreases with repeated application
over the experimental time period.
Time course showing cumulative data for 50nM ACh in the presence of 10jj.M 
Ryanodine in human submandibular acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
10pM Ryanodine occurred.
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Change in [Ca2+]i in response to 50nM ACh in the presence 
of 10 pM Ryanodine and 200 pM NOC-12 over the 
experimental time period.
Figure 4.1.12
Time course showing cumulative data for 50nM ACh in the presence of 10pM 
Ryanodine and 200nM NOC-12 in human submandibular acinar cells. The data 
show the series of experimental time points where responses to 50nM ACh in 
the presence of 1 0jj,M Ryanodine and 200pM NOC-12 occurred.
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When the three data sets were compared between NOC-12 only, Ryanodine only 
and NOC-12 in the presence of Ryanodine there was some degree of variation 
between data sets. When the data for all the experiments was gathered and 
expressed as percentages the average NOC-12 response was 112.4 ±11.84% (n=5) 
compared to 101 ± 2.09% (n=4) for NOC-12 in the presence of Ryanodine whereas 
Ryanodine only had an average response of 73.4 ± 6.02% (n=3).
There was no statistically significant difference between NOC-12 only and NOC-12 in 
the presence of Ryanodine or Ryanodine only but there was a significant (P<0.01) 
difference when NOC-12 in the presence of Ryanodine was compared to Ryanodine 
only. There was also a statistically significant variation between NOC-12 and 
Ryanodine together and Ryanodine only (P<0.05) compared to control conditions. 
The data in figure 4.1.10 demonstrate the inhibition of the NO induced amplification 
of the ACh-evoked increase in [Ca2+]i by Ryanodine and also show initial inhibition 
induced by Ryanodine only.
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Figure 4.1.13
Change in [Ca2+]i in response to 50nM ACh only and 50nM 
ACh in the presence of 10pM Ryanodine only and 10pM 
Ryanodine and 200|uM NOC-12 together respectively over 
the experimental time period.
■  CONTROL
■  RYANODINE
■  NOC-12+RYANODINE
160 
140 
120 
100 
80 
60 
40 
20 
0
2 7 10 14 18 22 25 28 32 36 40 44
Time (minutes)
Bar chart showing cumulative data for 50nM ACh control (end point 44 minutes), 
10pM RYANODINE (end point 44 minutes) and 200jiM NOC-12 with 10pM 
RYANODINE (end point 44 minutes) in human submandibular acinar cells.
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The data in figures 4.1.11 and 4.1.12 show the cumulative average responses 
achieved, using Ryanodine alone and NO donor NOC-12 in the presence of 
Ryanodine respectively. When compared with figure 4.1.5 for NOC-12 alone the only 
observable variations between data sets were that NOC-12 decreases more rapidly 
when used in combination with Ryanodine compared to NOC-12 only. In all instances 
were NOC-12 is present the level decreases to zero which does not occur when 
Ryanodine alone is used. The average data in figures 4.1.11 and 4.1.12 also allow 
direct comparison of experimental data with those achieved under control conditions 
in figure 4.1.3. Figure 4.1.13 is the cumulative data presented as a bar chart to allow 
direct comparison between control and experimental conditions.
Conclusions
The data in figure 4.1.1 demonstrate that the use of either NO donor, SNP or NOC- 
12, induced amplification of the ACh-evoked increase in [Ca2+]¡, the results were not 
comparable as NOC-12 only induced a marginal increase in response. There was 
some degree of reduction with the control trace which explains why the percentage 
decreased to 94.7% as opposed to being maintained at 100%. One notable problem 
with trace B of figure 4.1.1 is the lack of responses to ACh only. This particular trace 
was only selected because there was a lack of SNP runs and this particular 
experiment gave the most suitable presentation of data. SNP proved difficult to use 
with the human submandibular cells due to their sensitivity.
Comparison of data in figure 4.1.2 shows that the use of either NO donor, SNP or 
NOC-12, initially induced amplification of the ACh-evoked increase in [Ca2+]¡ but the 
responses were not comparable as the increase induced by NOC-12 was only 
marginal compared to control. However, the data also show that both NO donors
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induced inhibition of the ACh-evoked increase in [Ca2+]j when compared to control. 
Trace B in figure 4.1.2 is not ideal as it only shows one stimulation with ACh prior to 
NO donor exposure but was the most suitable from the data available as the data set 
was very small due to the sensitivity of the Human submandibular acinar cells and 
problems with SNP usage.
The average cumulative data presented in figures 4.1.3 to 4.1.6 demonstrate that the 
desensitisation induced by ACh in the presence of both SNP and NOC-12 was more 
significant than that induced by ACh alone, so both NO donors were able to induce 
inhibition of the response to ACh in human submandibular acinar cells.
As described previously (Chapter 1 Introduction 1.2 nitric oxide section), NO was 
selected for investigation as a possible cause of salivary hypofunction in SjS. The 
chronic data could suggest that NO does have the ability to induce acinar hypo- 
function but only after prolonged time periods. Therefore NO induces healthy acinar 
cells to behave like SjS acinar cells. The chronic experiments are therefore 
compatible with the hypothesised role of NO in SjS.
The data in figure 4.1.7 parts A and B demonstrate inhibition of NO induced 
amplification of the ACh-evoked increase in [Ca2+]i by ODQ. Therefore these data 
support the hypothesis that NO is acting through the cADPr pathway. The acute 
amplification previously observed with NOC-12 is decreased by the addition of ODQ 
which may suggest that the acute amplification induced by NO is functioning through 
the cADPr pathway.
The data in figure 4.1.7 parts C and D show that over a prolonged period of time the 
cells still become less sensitive to ACh and finally stop responding to stimulus even 
in the presence ODQ. Therefore the results suggest that the hypofunction induced by
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NO is independent of the cADPr pathway. So in-spite of the presence of the sGC 
inhibitor ODQ use of the NO donor NOC-12 still resulted in inhibition of the acinar 
cells response to ACh.
As observed previously in the mouse submandibular acinar cells the cumulative 
average data presented in figures 4.1.8 and 4.1.9 show that using the NO donor 
NOC-12 in the presence of ODQ causes an enhancement of response. There 
appears to be some degree of additive effect between ODQ and NOC-12 as the use 
of NOC-12 in the presence of ODQ induces a more rapid de-sensitisation of the 
acinar cells to ACh but the level of inhibition is no greater. This amplification of the 
effect of NOC-12 by ODQ has been observed previously by Takuma and colleagues 
who noted that ODQ appeared to exacerbate the cytotoxic effect of NOC-12 as 
opposed to blocking it (Takuma, Phuagphong et al. 2002). We may speculate that 
this is due to ODQ accelerating the rate of release of NO from NOC-12 but further 
work is required to determine how ODQ amplifies the response of NOC-12.
The data in figure 4.1.10 parts A and B show that the use of NOC-12 with Ryanodine 
removed the induced amplification of the ACh-evoked increase in [Ca2+]i The use of 
Ryanodine with NOC-12 suggests that NO is acting through the cADPr pathway. The 
data in figure 4.1.10 parts C and D also show that over a prolonged period of time the 
cells still become less sensitive to ACh and finally stop responding to stimulus in the 
presence of both NO donor NOC-12 only and NOC-12 and Ryanodine together. The 
de-sensitisation observed in trace C with Ryanodine only would be expected as the 
mode of action of Ryanodine, which was determined previously, is direct blocking of 
the Ryanodine receptor so Ryanodine would gradually inhibit ACh stimulated 
responses.
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The cumulative data in figure 4.1.11 also shows that Ryanodine itself induces run­
down by blocking the Ryanodine receptors directly. As a result of these findings the 
usefulness of Ryanodine as a marker of NO pathway activity is limited as in the short 
term it functions to stop the induced amplification of the response to ACh but use in 
chronic experiments is problematic.
The cumulative data presented in figures 4.1.11 to 4.1.13 demonstrate the responses 
achieved using NOC-12 or Ryanodine alone and those using NOC-12 and 
Ryanodine together were hard to differentiate between as the average response 
patterns were very similar. There is no obvious additive effect between Ryanodine 
and NOC-12 with regard to the degree of desensitisation induced as NOC-12 only 
and NOC-12 and Ryanodine together both induce total inhibition of the response to 
ACh. However, the rate of desensitisation of the response to ACh in the presence of 
NOC-12 does seem to occur more rapidly when Ryanodine is also present which 
might add strength to the argument that the desensitisation induced by NO is 
independent of the cADPr pathway as both NOC-12 and Ryanodine alone induced a 
degree of desensitisation but the rate of desensitisation appears increased when 
both Ryanodine and NOC-12 are present as the combined experiment took less time 
to induce total inhibition of the response to ACh.
The inhibitory data from both ODQ and Ryanodine suggests that the hypofunction 
induced by NO most likely occurs independently of the cADPr pathway but more 
work is required to elucidate how NO induces inhibition of the response..
In summary the human submandibular acinar cells appeared more sensitive to ACh 
compared to the mouse submandibular acinar cells which may explain the observed 
decrease in response to ACh under control conditions. This increased sensitivity to 
ACh might also explain the modest increase in response to ACh in the presence of
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NOC-12 as the rate of release of NO is much slower from NOC-12 compared to other 
NO donors so it was unable to induce as great an effect in the human submandibular 
cells. There were also problems with the use of SNP which may be due to its more 
rapid rate of release of NO and may have influenced the outcome of the results due 
to the limited data set produced. The acute effects observed when either SNP or 
NOC-12 were used with human submandibular acinar cells did vary from the data 
achieved with mouse submandibular acinar cells, however, the chronic effects 
observed proved consistent and the final response pattern was the same regardless 
of NO donor as the chronic NO effect occurred with both NO donors.
The use of either inhibitor of the cADPr pathway removed the previously observed 
marginal amplification of the ACh-evoked increase in [Ca2+]j. However, the NO 
pathway inhibitors had no effect on the run down induced by NO which would 
suggest that inhibition is independent of the cADPr pathway. The use of two cADPr 
pathway inhibitors allows validation of where NO functions within the pathway as 
ODQ prevents the initial sGC step and Ryanodine blocks the RyR directly so the use 
of both inhibitors greatly strengthens the NO/cADPr argument. The results presented 
here suggest a possible role for NO in glandular hypofunction.
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Chapter Five
Results
Nitric Oxide
Mouse Lacrimal Acinar Cells
U N I V E R S I T Y O F
LIVERPOOL
Introduction
All experiments were performed in accordance with the strict protocol described 
previously (Chapter 2 materials and methods section 2.8, figure 2.8.2). The response 
of mouse lacrimal acinar cells to ACh follows the same typical pattern as the mouse 
submandibular acinar cells as discussed previously (Chapter 2 materials and 
methods section 2.8, figure 2.8.1 trace A).
Following the work performed using mouse and human submandibular acinar cells 
subsequent experiments were performed on mouse lacrimal acinar cells. These 
experiments would to determine if the effects observed in the submandibular acinar 
cells was specific to that cell type or if the responses also occurred in lacrimal cells.
The NO donor selected was NOC-12 to allow continuity of results between data sets. 
This donor was also selected as it was relatively easy to use and produced good 
results in the mouse submandibular acinar cells. Both NO pathway inhibitors ODQ 
and Ryanodine were again used in conjunction with NOC-12. The only variation was 
that Ryanodine only experiments were not conducted in a number great enough to 
provide valid interpretable results but the few that were performed did produce a 
similar pattern of response to that observed in mouse and human submandibular 
acinar cells.
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Results
Acute Experiments
The initial experiments were performed acutely using NOC-12 to show the effect of 
NO on ACh-evoked Ca2+ signal in mouse lacrimal acinar cells.
Table 5.1.1: Table of results for human submandibular acinar cells
Number of Type of Response Degree of Response Time Taken to
samples (Mean ± SE) decrease to zero
as a Percentage (where applicable)
n=7 Control 102.8 ±4.87% N/A
n=9 NOC-12 178.1 ±28.89% 36
n=7 NOC-12+ ODQ 102.1 ±3.76% 36
n=9 NOC-12 + Ryanodine 104.1 ±5.97% 48
Figure 5.1.1 parts A and B shows representative traces which demonstrate the effect 
of the NO donor NOC-12 on the ACh-evoked increase in [Ca2+]j in mouse lacrimal 
acinar cells. Trace A shows a series of control [Ca2+]i responses to ACh (50nM) over 
the protocol defined time points. Trace B shows the [Ca2+]| responses to ACh (50nM) 
in the presence of the NO donor NOC-12 (200pM) over similar protocol defined time 
points. Comparison of the [Ca2+]i response of cells to ACh under control conditions 
(A) to that obtained following exposure to NO donor NOC-12 (B) at equivalent time 
points, shows that exposure of the mouse lacrimal acinar cells to NOC-12 
significantly (P<0.05) increased the response to ACh from an average control 
response of 102.8 ± 4.87% (n=7) to 178.1 ± 28.89% (n=9) in the presence of NOC- 
12. The data in figure 5.1.1 parts A and B demonstrate NO induced amplification of 
the ACh-evoked increase in [Ca2+]|.
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Figure 5.1.1
Change in [Ca2!  in response to 50nM ACh, illustrating how 
200|iM NOC-12 induced amplification of the [Ca2+]j signal.
A D  □  □  | | ACh 50 nM
2 min
NOC-12 200 p.M__________________________
B □  □  ACh 50 nM □  □  □
2 min
ACh (50nM) stimulated increased [Ca2!  measured in mouse lacrimal acinar 
cells maintained in primary tissue culture fluid for 24 hours (control) and 2 hours 
(NOC-12) respectively.
Trace A shows response to repeated stimulation with 50nM ACh only (see 
bar).
Trace B shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 (see bar).
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Chronic Experiments
Figure 5.1.1 parts C and D shows representative traces demonstrating the chronic 
effect of NO donor NOC-12 on the ACh-evoked increase in [Ca2+]j in mouse lacrimal 
acinar cells. Trace C shows a prolonged series of control [Ca2+]i responses to ACh 
(50nM) over the protocol defined time points, with cells maintaining the level of 
response. Trace D shows the [Ca2+]i responses to ACh (50nM) in the presence of NO 
donor NOC-12 (200pM) over similar protocol defined time points. Comparison of the 
[Ca2+]i response of cells to ACh under control conditions (C) to those obtained 
following exposure to NO donor NOC-12 (D) at equivalent time points, shows that 
exposure of the mouse lacrimal acinar cells to an NO donor NOC-12 increased the 
level of response to ACh. However, the data in figure 5.1.1 also show that over a 
prolonged period of time the cells become less sensitive to ACh and gradually stop 
responding to stimulus. At the end of the experimental time period the ACh 
stimulated increase in [Ca2+]i in the presence of NOC-12 was significantly (P<0.001) 
different from control.
The data in figure 5.1.1 parts A and B demonstrate NO induced amplification of the 
ACh-evoked increase in [Ca2+]j and parts C and D demonstrate NO induced inhibition 
of the ACh-evoked increase in [Ca2+]i.
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Figure 5.1.1
Change in [Ca2+]j in response to 50nM ACh, illustrating how 
200pM NOC-12 induced amplification and inhibition of the 
[Ca2+]i signal.
C □ □ □ □ □  □ □ □ □ □ □ □ □
ACh 50 nM
5 min
|N0C-12 200 nM
D □  □  □ □ □ □ □  [ ]  ACh 50 nM
ft ft
1___ I
A A
V_____J l
50 nM
5 min
ACh (50nM) stimulated increased [Ca2!  measured in mouse lacrimal acinar 
cells maintained in primary tissue culture fluid for 24 hours and 2 hours 
respectively.
Trace C shows response to repeated stimulation with 50nM ACh only (see 
bar).
Trace D shows responses to repeated stimulation with 50nM ACh before and 
after application of the NO donor NOC-12 (see bar).
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The data in figures 5.1.2 and 5.1.3 show the cumulative average responses achieved 
under control conditions and those achieved using the NO donor NOC-12 and allow 
direct comparison between control and NO donor affected conditions. Upon review of 
the cumulative data in figure 5.1.3 the chronic pattern of response of NO is clearly 
observable. The data presented in figure 5.1.4 allows direct comparison between 
control and experimental conditions and shows the variation in response pattern.
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Change in [Ca2+]j in response to 50nM ACh did not diminish 
with repeated application over the experimental time period.
Figure 5.1.2
Time (minutes)
Time course showing cumulative data for 50nM ACh in mouse lacrimal acinar 
cells. The data show the series of experimental time points where responses to 
50nM ACh occurred. These data show the standard response of mouse lacrimal 
acinar cells to 50nM ACh under control conditions.
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Change in [Ca2+]j in response to 50nM ACh in the presence 
of 200 pM NOC-12 initially increases but then gradually 
decreases with repeated application over the experimental 
time period.
Figure 5.1.3
Time (minutes)
Time course showing cumulative data for 50nM ACh in the presence of 200fxM 
NOC-12 in mouse lacrimal acinar cells. The data show the series of 
experimental time points where responses to 50nM ACh in the presence of 
200pM NOC-12 occurred.
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Change in [Ca2+]j signal in response to 50nM ACh and 50nM 
ACh in the presence of 200 pM NOC-12 respectively over 
the experimental time period.
Figure 5.1.4
n= 7U  CONTROL  
n=9B  NOC-12 
250
200
2 7 10 14 18 22 25 28 32 36 40 44 48
Bar chart showing cumulative data for 50nM ACh control (end point 48 minutes), 
200jaM NOC-12 (end point 36 minutes) in mouse lacrimal acinar cells.
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Inhib itor - O DQ
Upon completion of the NOC-12 experiments and the observed inhibition induced 
under chronic conditions the mode of action of NO had to be determined in this 
alternative cell type. As discussed previously, (Chapter 1 Introduction 1.2 nitric oxide 
section) NO is considered to act through the cADPr pathway. To investigate this 
hypothesis the two inhibitors of this pathway, ODQ and Ryanodine, were again used. 
The use of both NO pathway inhibitors also allowed direct comparison with the 
results obtained from the other two cell types.
Figure 5.1.5 parts A and B shows representative traces demonstrating the affect of 
sGC inhibitor ODQ on the affect of the NO donor NOC-12 on the ACh-evoked 
increase in [Ca2+]i in mouse lacrimal acinar cells. Trace A shows a series of [Ca2+]i 
responses to ACh (50nM) only. Trace B shows the [Ca2+], responses to ACh (50nM) 
in the presence of NO donor NOC-12 (200pM) and ODQ (10pM) over the same 
protocol defined time points. Comparison of the [Ca2+], responses in figures A and B, 
shows that exposure of the mouse lacrimal acinar cells to NO in the presence of sGC 
inhibitor ODQ removed the significant increase in response to ACh observed 
previously from an average NOC-12 only response of 178.1 ± 28.89% (n=9) to 102.1 
± 3.76% (n=7) for NOC-12 in the presence of ODQ. The data in figure 5.1.5 parts A 
and B demonstrate significant (P<0.05) inhibition of NO induced amplification of the 
ACh-evoked increase in [Ca2+]j by the sGC inhibitor ODQ.
However, more prolonged experiments were required to demonstrate what effect 
inhibitors of the cADPr pathway would have on the de-sensitisation of acinar cells to 
ACh induced previously by the NO donor NOC-12.
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Change in [Ca2+]j in response to 50nM ACh and 50nM ACh 
in the presence of 200pM NOC-12 in the presence of 10jiM 
ODQ acutely.
Figure 5.1.5
A n n | | | | ACh 50 nM
A_n__ A.
100 nM
2 min
NOC-12 200 ^M + ODQ 10
B □  □  □  □  ACh 50 nM
100 nM
2 min
ACh (50 nM) stimulated increased [Ca2^  measured in mouse lacrimal acinar 
cells maintained in primary tissue culture fluid for 24 (control) and 48hours 
NOC-12/ODQ) respectively.
Trace A shows responses to repeated stimulation with 50nM ACh only (see 
bar).
Trace B show s responses to repeated stim ulation w ith 50nM AC h before and
a fte r application o f the NO donor NO C-12 and NO pathw ay inhib itor ODQ
(see bar).
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Figure 5.1.5
Change in [Ca2+]j in response to 50nM ACh and 50nM 
ACh in the presence of 200pM NOC-12 in the presence of 
10pM ODQ chronically
c □ D □ □ □ □ □ □ □ □ □ □ □
ACh 50 nM
5 min
[NOC-12 200 )j.M + ODQ 10^M
D □ □  D O  □ □  □ □ □  □  □  ACh 50 nM
100 nM
10 min
ACh (50 nM) stimulated increased [Ca2"! measured in mouse lacrimal acinar 
cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows responses to repeated stimulation with 50nM ACh only (see 
bar).
Trace D show s responses to  repeated stim ulation w ith 50nM  Ach before and
a fte r application o f the NO donor NO C-12 and NO inhib itor O D Q (see bar).
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Figure 5.1.5 parts C and D shows representative traces demonstrating the chronic 
effect of ODQ on the effect of the NO donor NOC-12 on the ACh-evoked increase in 
[Ca2+]¡ in mouse lacrimal acinar cells. Trace C shows a prolonged series of [Ca2+]¡ 
responses to ACh (50nM) only over the protocol defined time points. Trace D shows 
the [Ca2+]¡ responses to ACh (50nM) in the presence of NO donor NOC-12 (200pM) 
and also sGC inhibitor ODQ (10pM) over the same protocol defined time points. 
Comparison of traces C and D shows that exposure of the mouse lacrimal acinar 
cells to the NO donor NOC-12 in the presence of sGC inhibitor ODQ removed the 
significant increase observed with the NO donor NOC-12 only. However, the more 
prolonged experiment shows that the cells still become de-sensitised to ACh in the 
presence of ODQ. At 36 minutes the ACh stimulated increase in [Ca2+]¡ response in 
the presence of NOC-12 and ODQ was not significantly different from zero.
The data in figure 5.1.6 show the cumulative average responses achieved using the 
NO donor NOC-12 in the presence of the cADPr pathway inhibitor ODQ. Upon 
observation of the average data presented in figure 5.1.6 the chronic pattern of 
response is clearly observable. The average data in figure 5.1.7 shows all responses 
represented as a bar chart to allow direct comparison between ACh induced [Ca2+]¡ 
signal results obtained under control conditions, under NOC-12 only conditions and 
those obtained using NOC-12 in the presence of ODQ and demonstrates the clear 
chronic pattern of response in the absence or presence of ODQ. However, the 
presence of ODQ does not appear to enhance the effect of NOC-12 as was observed 
with the human and mouse submandibular acinar cells but this may simply be 
because the lacrimal acinar cells are more sensitive to NO in the first instance as 
they had the most rapid desensitisation rate to NOC-12.
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Change in [Ca2+]i in response to 50nM ACh in the presence 
of 200 pM NOC-12 and 10 pM ODQ gradually decreases 
with repeated application over the experimental time period.
Figure 5.1.6
250
200
150
100
50
0
0 10 20 30 40
Time (minutes)
Time course showing cumulative data for 50nM ACh in the presence of 200^iM 
NOC-12 and 10pM ODQ in mouse lacrimal acinar cells. The data show the 
series of experimental time points where responses to 50nM ACh in the 
presence of200pM NOC-12 and 10pM ODQ occurred.
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Change in [Ca2^  signal in response to 50nM ACh and 50nM 
ACh in the presence of 200 pM NOC-12 and 200 pM NOC-12 
with 10 pM ODQ respectively over the experimental time 
period.
Figure 5.1.7
n= 7U  CONTROL 
n = 9 B  NOC-12
Time (minutes)
Bar chart showing cumulative data for 50nM ACh control (end point 48 minutes), 
100pM NOC-12 (end point 36 minutes) and 200pM NOC-12 with 10pM ODQ 
(end point 36 minutes) in mouse lacrimal acinar cells.
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Inh ib itor - Ryanodine
As with the submandibular acinar cells following the work conducted with ODQ the 
second cADPr pathway inhibitor Ryanodine was again used to try and determine the 
mode of action of NO.
Figure 5.1.8 parts A and B shows representative traces demonstrating the effect of 
the Ryanodine receptor inhibitor Ryanodine on the effect of NO donor NOC-12 on the 
ACh-evoked increase in [Ca2+]i in mouse lacrimal acinar cells. Trace A shows a 
series of control [Ca2+]i responses to ACh (50nM) only over the protocol defined time 
points. Trace B shows the [Ca2+]i responses to ACh in the presence of both NO 
donor NOC-12 (200pM) and Ryanodine (10pM) over the same protocol defined time 
points. By comparing the [Ca2+]i response of cells to ACh under control conditions (A) 
to those obtained following combined exposure to NO donor NOC-12 and Ryanodine 
receptor Ryanodine (B) at equivalent time points, the data show that exposure of the 
mouse lacrimal acinar cells to an NO donor NOC-12 during exposure to Ryanodine 
inhibitor Ryanodine significantly (P<0.05) removes the previously observed increased 
in response to ACh from an average NOC-12 only response of 178.1 ± 28.89% (n=9) 
to 104.1 ± 5.97% (n=9) to NOC-12 in the presence of Ryanodine. The two traces are 
very similar and the cumulative data (figure 5.1.9) shows that the use of Ryanodine 
with NOC-12 reduces the level of response to one which is equal to the average 
control response of 102.8 ± 4.87% (n=7) and shows no significant variation between 
the average response of these two data sets.
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Figure 5.1.8
Change in [Ca2+]j in response to 50nM ACh and 50nM ACh
the presence of 200pM NOC-12 in the presence of 1OpM 
Ryanodine acutely.
A □  □  □  | | ACh 50 nM
2 min
NOC-12 200 + Ryanodine 10
B □  □  □  □  ACh 50 nM
A n h h
50 nM |________
2 min
ACh (50 nM) stimulated increased [Ca2^  measured in mouse lacrimal acinar 
cells maintained in primary tissue culture fluid for 24 hours.
Trace A shows responses to repeated stimulation with 50nM ACh only (see 
bar).
Trace B show s responses to repeated stim ulation w ith 50nM  A C h before and
a fte r application o f the NO donor NO C-12 and NO pathw ay inhib itor
R yanodine (see bar).
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Change in [Ca2^  in response to 50nM ACh in the presence 
of 200pM NOC-12 in the presence of 10pM ODQ and 10pM 
Ryanodine respectively over the experimental time period.
Figure 5.1.8
C □ □
| NOC-12 200 nM + ODQ lO^M
u~ q trn: a n n [ ]  Q  ACh 50 nM
100 nM
10 min
|NOC-12 200|xM + Ryanodine 10nM
D D D D D D D D D D D D D  D D ACh 50 nM
5 min
ACh (50 nM) stimulated increased [Ca2!  measured in mouse lacrimal acinar 
cells maintained in primary tissue culture fluid for 24 hours.
Trace C shows responses to repeated stimulation with 50nM ACh before and 
after application of NO donor NOC-12 and NO pathway inhibitor ODQ (see 
bar).
T race D show s responses to  repeated stim ulation w ith 50nM  AC h before and
a fte r application o f the NO donor NO C-12 and NO pathw ay inhibitor
R yanodine (see bar).
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Figure 5.1.8 parts C and D show representative traces demonstrating the chronic 
effect of NOC-12 in the presence of ODQ or Ryanodine respectively, on the ACh- 
evoked increase in [Ca2+]i in mouse lacrimal acinar cells. Trace C shows a series of 
[Ca2+]i responses to ACh (50nM) in the presence of both NOC-12 (200pM) and ODQ 
(10pM) over the protocol defined time points. Trace D shows the [Ca2+]i responses to 
ACh (50nM) in the presence of both NOC-12 (200pM) and Ryanodine (10pM) over 
the same protocol defined time points. By comparing the [Ca2+]i response of cells to 
ACh under combined exposure to ODQ and NOC-12 conditions (C) to those obtained 
following combined exposure to NOC-12 and Ryanodine (D) at equivalent time 
points, we can show that exposure of the mouse lacrimal acinar cells to NOC-12 
during exposure to either ODQ or Ryanodine removes the increase observed when 
NOC-12 only is used. However, the observed rundown in response and 
desensitisation of the cells to ACh still occurs in the presence of either ODQ or 
Ryanodine which could suggest that the hypofunction induced by NO occurs 
independent of the cADPr pathway.
At 48 minutes the ACh stimulated increase in [Ca2+]i response in the presence of 
NOC-12 and Ryanodine was not significantly different from zero. When the average 
values of the chronic experiments for NOC-12 in the presence of ODQ or Ryanodine 
are compared there is very little variation in the response pattern. They are both 
significantly (P<0.01) different compared to control but show no significant variation 
when compared to each other or when compared to NOC-12 only.
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Change in [Ca2+]j signal in response to 50nM ACh in the 
presence of 10 pM Ryanodine and 200 pM NOC-12 initially 
maintained but then rapidly decreases with repeated 
application over the experimental time period.
Figure 5.1.9
Time (minutes)
Time course showing cumulative data for 50nM ACh in the presence of 10pM 
Ryanodine and 200nM NOC-12 in mouse lacrimal acinar cells. The data show 
the series of experimental time points where responses to 50nM ACh in the 
presence of 1OpM Ryanodine and 200pM NOC-12 occurred.
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The data in figure 5.1.9 show the cumulative average responses achieved, using 
NOC-12 in the presence of Ryanodine. The cumulative data in figure 5.1.10 allows 
direct comparison between control conditions and those involving NOC-12 alone and 
NOC-12 in the presence of either Ryanodine or ODQ respectively. The key variations 
between the four data sets presented in figure 5.1.10 are the initial amplification 
observed when NOC-12 alone was used, the maintained level of response under 
control conditions. However, the pattern of reduction and gradual hypo-function of the 
cells was relatively equal under chronic conditions and there was little variation in the 
rundown between NOC-12 only and NOC-12 in the presence of either Ryanodine or 
ODQ.
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Change in [Ca2*} signal in response to 50nM ACh and 50nM 
ACh in the presence of 200 pM NOC-12 and 200 pM NOC-12 
with either 10 pM Ryanodine or 10pM ODQ respectively 
over the experimental time period.
Figure 5.1.10
n= 7B CONTROL
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n=9B NOC-12 
n=7B NOC-12 + ODQ
Bar chart showing cumulative data for 50nM ACh control (end point 48 minutes), 
200pM NOC-12 (end point 36 minutes) and 200pM NOC-12 with 10pM 
Ryanodine (end point 48 minutes) in mouse lacrimal acinar cells.
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C onclusions
The data in figure 5.1.1 parts A and B demonstrate that the use of the NO donor 
NOC-12 induced amplification of the ACh-evoked increase in [Ca2+]¡ so this 
preliminary data suggests NO would induce hyper-function of response. This data is 
in opposition to NO being implicated in the pathogenesis of salivary gland hypo- 
function in SjS as discussed previously (Chapter 1 Introduction 1.2 Nitric oxide 
section). However, these initial experiments only determine the acute effect of NO in 
lacrimal acinar cells. In the salivary glands of SjS patients the acinar cells would be 
exposed to NO much more long-term so these experiments are less relevant.
Comparison of data in figure 5.1.1 parts C and D show that although the use of the 
NO donor NOC-12 did initially induce amplification of the ACh-evoked increase in 
[Ca2+]¡ it did ultimately induce inhibition of the ACh-evoked increase in [Ca2+]¡ when 
compared to control. These chronic experiments would be more relevant to the NO 
exposure in SjS patients and would give a more accurate insight into the effect on 
acinar cell response to ACh following prolonged exposure to NO.
As described previously (Chapter 1 Introduction 1.2 nitric oxide section), NO was 
selected for investigation as a possible cause of salivary hypo-function in SjS. These 
data would suggest that NO does have the ability to induce acinar hypofunction but 
only after prolonged periods of time. Therefore NO has the capacity to induce healthy 
acinar cells to behave like SjS acinar cells. The chronic experiments are therefore 
compatible with the hypothesised role of NO in SjS.
The average data observed with NOC-12 in the presence of ODQ acutely was 
comparable to control ACh only conditions and showed no significant variation in
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results. The acute amplification is prevented by the addition of sGC inhibitor ODQ so 
the acute amplification activity of NO appears to be mediated through the cADPr 
pathway. The chronic data for NOC-12 and ODQ together is comparable to NOC-12 
only and total inhibition of the response occurs at approximately the same time point 
as NOC-12 only. The chronic data therefore suggests that inhibition of the response 
is occurring independently of the cADPr pathway.
So in-spite of the presence of ODQ the NOC-12 induced inhibition still occurred over 
the duration of the experimental time period. The data in figure 5.1.5 part D show that 
over a prolonged period of time the cells still become less sensitive to ACh and finally 
stop responding to stimulus even in the presence of sGC inhibitor ODQ. Therefore 
the results suggest that the induced hypo-function may occur independently of the 
proposed NO pathway.
The average data observed with NOC-12 in the presence of Ryanodine acutely was 
comparable to control ACh only conditions and showed no significant variation in 
results. The presence of Ryanodine removed the induced amplification of the ACh- 
evoked increase in [Ca2+]¡ which would suggest that the NO induced amplification is 
mediated through the cADPr pathway. However, the chronic data for NOC-12 and 
Ryanodine together show that Ryanodine did not prevent the NO induced inhibition 
of the ACh-evoked increase in [Ca2+]¡ which would suggest that the NO induced 
inhibition is not mediated through the Ryanodine receptor and NO may induce 
hypofunction independently of the cADPr pathway..
The use of two cADPr pathway inhibitors provide better insight as to if and where NO 
functions within the pathway as ODQ prevents the initial step and Ryanodine blocks 
the Ryanodine receptor directly so the use of both inhibitors could greatly strengthen 
the NO/cADPr argument. Both inhibitors of the cADPr pathway remove the previously
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observed amplification of the ACh-evoked increase in [Ca2+]j induced by NOC-12. 
The desensitisation patterns observed with either ODQ or Ryanodine with NOC-12 
respectively are highly similar to each other and both are similar to the inhibition 
induced by NOC-12 only. As with the mouse and human submandibular acinar cells 
the chronic results from both cADPr pathway inhibitors suggest that the hypofunction 
is independent of the cADPr pathway.
Figure 5.1.10 shows cumulative data which allows direct comparison between control 
conditions, NOC-12 only and NOC-12 in the presence of ODQ and Ryanodine 
respectively. The two main points of variation are the initial amplification observed 
when NOC-12 only was used and the response level maintained by ACh only. The 
rundown for all three sets of experimental data are relatively equal. Both inhibitors of 
the NO pathway were able to remove the NOC-12 induced amplification but neither 
had any effect on the rundown and the desensitisation of the acinar cells to ACh by 
NO.
In summary the lacrimal cells produced a set of response patterns similar to those 
observed previously with the human and mouse submandibular acinar cells. The 
NOC-12 induced amplification when acutely applied and desensitisation when 
chronically applied. Both inhibitors of the cADPr pathway inhibited the initial 
amplification but had no effect on the desensitisation induced by NO which once 
again suggested that the amplification was mediated through the cADPr pathway but 
that the desensitisation was most likely independent of the cADPr pathway. The 
results again suggest that NO has the ability to mediate acinar cell hypofunction and 
demonstrate that lacrimal cells respond in the same manner as submandibular cells.
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Chapter Six
Results
Adenosine Tri-phosphate 
As a Stress signal inducer
U N I V E R S I T Y  0 F
LIVERPOOL
Introduction
Following the experiments conducted with nitric oxide other factors which may be up- 
regulated under stress conditions were identified. Adenosine tri-phosphate (ATP) has 
been suggested to function as a stress signal and we wanted to determine how it 
might mediate a stress response. We observed responses to ATP in human and 
mouse submandibular acinar cells and also mouse lacrimal acinar cells.
We hypothesised that ATP would stimulate a pattern of response alternative to ACh 
which would be clearly visualised using Microfluorimetry techniques. However, we 
were unable to visualise any variation in response pattern which may suggest that 
either the variations induced by stimulations from either ACh or ATP occur much 
more subtly or that our rate of sampling was not great enough to identify any 
variations which may occur. Although we were unable to visualise variations in 
response pattern between ACh and ATP we did observe a degree of addition of 
response when ACh and ATP were used together and this varied from simply 
increasing the concentration of ACh which may suggest that ATP mobilises Ca2+ 
from stores which are unreceptive to ACh. This data was consistent with previous 
work conducted but we did not investigate this further.
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3 separate traces showing the change in [Ca2+l  signal in response to 50nM ACh and 
100pM ATP stimulation respectively.
Trace A shows [Ca2+]i response to two separate single stimulations by 50nM ACh 
and 100pM ATP respectively (see scale bar) measured in mouse submandibular 
acinar cells maintained in primary culture for 2 hours.
Trace B shows [Ca2+]i response to 100pM ATP stimulation during constant 50nM 
ACh stimulation (see scale bar) measured in mouse submandibular acinar cells 
maintained in primary culture for 2 hours.
Trace C shows [Ca2+]i response to 50nM ACh stimulation during constant 100pM 
ATP stimulation (see scale bar) measured in mouse submandibular acinar cells 
maintained in primary culture for 2 hours.
Figure 6.1.1
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Figure 6.1.1 Part D: shows the average dose responses to 100pM, 250pM and 
500pM ATP plus the average response to 500nM ACh in mouse submandibular 
acinar cells.
ACH AND ATP RESPONSES IN MOUSE SUBMANDIBULAR CELLS
Figure 6.1.1 Part E: shows the average dose responses to 100pM, 250pM and 
500pM ATP plus the average response to 500nM ACh in human submandibular 
acinar cells.
ATP AND ACH RESPONSES IN HUMAN 
SUBMANDIBULAR CELLS
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Change in [Ca2+]i in response to 50nM ACh.
Part A shows the [Ca2+]i signal in response to 50nM ACh stimulation as seen in the 
initial response in figure 6.1.1 trace A but expanded out to allow more clear 
observation of response pattern (see scale bar).
Part B shows a series of TIF images showing the actual acinar cell increased [Ca2+]i 
response to 50nM ACh stimulation in real time, with each numbered TIF image 
equating exactly to the numbered vertical shaded lines on the trace shown in figure
6.1.2 part A.
Figure 6.1.2
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Change in [Ca24}  signal in response to 100pM ATP.
Part A shows the [Ca2+]j signal in response to 100pM ATP stimulation as seen in the 
second response in figure 6.1.1 trace A expanded out to allow more clear 
observation of response pattern (see scale bar).
Part B shows a series of TIF images showing the actual acinar cell increased [Ca2+], 
response to 100pM ATP stimulation in real time, with each numbered TIF image 
equating exactly to the numbered vertical shaded lines on the trace shown in figure
6.1.3 part A.
Figure 6.1.3
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ATP was selected for investigation based on its activity as a marker of stress as 
receptors with which it interacts are known to be up-regulated under conditions of 
stress. The traces in figure 6.1.1 demonstrate how mouse submandibular acinar 
cells increase [Ca2+]j in response to stimulation with 50nM ACh and 100pM ATP 
respectively. The mouse submandibular acinar cells were able to mobilise Ca2+ in 
response to either agonist but the responses varied between agonists. This may be 
due to the suggested variation in function between ACh and ATP as ACh is released 
to stimulate fluid secretion whereas ATP is released under conditions of stress so the 
response stimulated by each agonist might vary based on their individual function.
The initial response in figure 6.1.1 part A shows a typical ACh response, similar to 
the one described previously in Chapter 3 Results Nitric oxide mouse submandibular 
acinar cells figure 3.1.1: trace A. The most obvious variation between the responses 
in figure 3.1.1 trace A is the large initial response ‘spike’ observed with 100pM ATP 
which does not occur with 50nM ACh. This is unlikely to be due to the variations in 
concentration as the presence, absence, or size of the ‘spike’ is largely independent 
of the agonist concentration. The second important variation is the oscillatory nature 
of the response. As shown in figure 6.1.1. part A first response which demonstrates a 
clear oscillatory pattern when cells were stimulated with ACh. This type of response 
pattern was commonly but not universally observed with ACh but was not observed 
on any occasion with ATP as shown by figure 6.1.1 part A second response. This 
might simply be due to the variation in function between ACh and ATP but was not 
investigated further.
Both responses initiate immediately upon exposure to stimulus which is 
characterized by a rapid rise in [Ca2+]i, observed as an upward "spike" in the trace 
from resting [Ca2+]j level. Both responses have an initial spike but the ATP response 
has a much larger initial spike. Both responses then stabilize to a sustained plateau
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in the [Ca2+]¡, at a level below that of the "spike". The magnitude of the plateau phase 
of the response increased in proportion with agonist concentration. The initial ACh 
response has an oscillatory plateau whereas the second ATP response has a level 
plateau. The ATP response does not hold as level as the ACh response which may 
be relative to the variation in stimulation type as appears to very gradually decrease 
following the initial spike while the cell is still exposed to stimulus which is not 
observable in the ACh response. In both responses once the stimulus was removed 
there was a return to the resting [Ca2+]¡ level.
We conducted ATP stimulation experiments in both mouse and human 
submandibular acinar cells and also mouse lacrimal acinar cells and all were able to 
mobilize Ca2+ in response to ATP stimulation. Mouse lacrimal acinar cells did appear 
to give a larger response to ATP compared to mouse and human submandibular 
acinar cells but this might simply be due to an increased sensitivity to ATP in lacrimal 
acinar cells. However, the lacrimal acinar cells experimental number (n=5) was 
relatively small, experiments were conducted using only one concentration of ATP 
(100pM) and ATP responses only occurred subsequent to ACh responses so the 
data was of only limited value but did demonstrate clearly the ability of mouse 
lacrimal acinar cells to respond to ATP. The human submandibular acinar cell data 
set demonstrated a clear dose response which was not as clearly observable in the 
data set from the mouse submandibular acinar cells, but, both sets of data showed a 
deviation in the dose response pattern at 250pM ATP (figures 6.1.1 part D is the 
mouse dose data and figure 6.1.1 part E is the human ATP dose data).
These data suggest that ATP stimulates activation of the same processes as ACh as 
the cells produced a similar response following stimulation with ATP as they did 
following stimulation with ACh. So ATP would most likely be functioning through the 
P2Y receptors which are known to be associated with G-protein activation
200
(Abbracchio and Burnstock 1994) and are known to be present in the salivary glands 
(Turner, Landon et al. 1999) as discussed earlier (Chapter 1 Introduction 1.3 ATP 
section).
The data presented in figure 6.1.1 traces B and C demonstrates an additive effect 
between ACh and ATP as the combination of the two appears to be increased when 
compared to either individually. This type of response pattern was observed a 
number of times in both human (n=20) and mouse (n=60) submandibular acinar 
cells.
Figure 6.1.1 part B shows an initial increase in [Ca2+]i in response to 50nM ACh 
stimulation followed by a further increase in [Ca2+]i when the mouse submandibular 
acinar cells were subsequently stimulated with 100pM ATP also. Once ATP 
stimulation was removed the [Ca2+]i response level reduced to a [Ca2+]j response 
level marginally higher than the previous ACh [Ca2+]i response level. The [Ca2+]i 
response to ACh was maintained until ACh stimulation was removed. The cells 
maintained an oscillatory response pattern throughout the duration of the stimulus 
exposure but the response became more oscillatory when the cells were exposed to 
both ACh and ATP. Once ACh stimulation was removed the [Ca2+]i response level 
reduced further but did not return to the original base line.
Figure 6.1.1 part C shows an initial increase in [Ca2+]i in response to 100pM ATP 
stimulation followed by a further increase in [Ca2+]i when the mouse submandibular 
acinar cells were subsequently stimulated with 50nM ACh also. Once ACh 
stimulation was removed the [Ca2+]i response level reduced to a [Ca2+]i response 
level marginally lower than the previous ATP [Ca2+]j response level. The [Ca2+]| 
response to ATP appeared to constantly reduce back to base line throughout the 
duration of ATP only exposure but reduced further once ATP stimulation was
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removed but did not return to the original base line. The oscillatory response pattern 
varies throughout the experimental time frame. When the cells were initially 
stimulated with ATP only they have no observable oscillatory response pattern but 
once stimulated with ATP and ACh together the cells have a clearly observable 
oscillatory response pattern. However, when the ACh stimulation was removed the 
response again becomes a sustained plateau with no observable oscillatory 
response pattern.
When parts B and C from figure 6.1.1 are compared the order of the addition of ACh 
and ATP does not appear to affect the outcome as both traces show similar patterns 
of response. The addition of ACh in figure 6.1.1 part C appears to induce some 
degree of oscillation to the response pattern which does not persist once ACh in 
removed and ATP appears to induce a sustained plateau with no observable 
oscillations. However, the addition of ATP to figure 6.1.1 part B does appear to make 
the oscillatory response more intense which might be a direct result of increased 
Ca2+ mobilisation and the oscillations reduce once ATP is removed. The degree of 
oscillation might be connected to the response induced by the agonist but was not 
investigated further.
Following the observations made on response traces like figure 6.1.1 parts B and C a 
series of experiments were conducted to demonstrate the additive effect between 
ACh and ATP. A series of response stimulations were selected which produced an 
interesting set of data and clearly demonstrated an additive effect between ACh 
(50nM) and ATP (100pM). This series of experiments were conducted in mouse 
submandibular acinar cells (n=45) and consisted of the cells being exposed to ACh 
only, ACh and ATP together and ATP only. The average results for these 
experiments were: ACh only 32.71 ± 4.17%; ACh and ATP together 44.44 ± 4.77%; 
ATP only 8.97 ± 2.30%. This data series show significant (P<0.001) differences
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The occurrence of an additive effect between ACh and ATP may indicate the 
mobilization of Ca2+ through an alternative pathway such as other types of purinergic 
receptors (P2X) or from alternative Ca2+ stores as discussed earlier (Chapter 1 
Introduction 1.3 ATP section). The original work conducted by Gallacher in 1982 
demonstrated the presence of purinergic receptors in parotid acinar cells from mice 
but it was also observed during these original experiments that the response patterns 
of ACh and ATP were indistinguishable (Gallacher 1982).
Following the determination that ACh and ATP demonstrate some degree of additive 
effect we speculated that ACh and ATP may stimulate different patterns of response. 
Experiments were then conducted to elucidate if ATP and ACh initiated their 
responses at separate points within the acinar cell. These experiments were 
conducted following the suggestion that ACh and ATP would initiate at different 
points based on the suggestion that ATP acts as a stress signal and P2Y2 receptors 
are known to be up-regulated in the SjS animal model NOD.B10 mice (Schrader, 
Camden et al. 2005). We speculated that stimulation by ATP could produce a 
different pattern of response in the acinar cell compared to ACh, which would 
distinguish between fluid secretion stimulation and stress. It was considered that the 
point of initiation would be the key as a variation in initiation point might induce a 
variation in response pattern and ACh and ATP would induce responses at different 
points in the cell.
between ATP only and stimulation with ACh and ATP together and also the ACh only
stimulation. The data are presented as mean ± standard error as a percentage and
the value relates to the increase above base line.
The data presented in figures 6.1.2 and 6.1.3 show a series of cell images in real
time and allow the pattern of response to be studied and compared between ACh
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and ATP. The signal appears to originate at approximately the same place following 
stimulation by ACh and ATP as seen in image number 4 in figure 6.1.2 and image 
number 5 in figure 6.1.3. The data show that the initiation point of ATP does not vary 
from the initiation point of ACh and there appears to be no variation in the response 
pattern. So the two sets of TIF images presented in figures 6.1.2 and 6.1.3 part B 
show that the response initiates at approximately the same region of the cell 
following stimulation with ACh and ATP and proceeds in the same manner around 
the cell regardless of stimulus. The section of experimental trace presented in part A 
of figures 6.1.2 and 6.1.3 demonstrate the presence (ACh) or absence (ATP) of an 
oscillatory response pattern, most likely due to variations in Ca2+ mobilisation. Based 
on this series of experiments ATP does not appear to stimulate a response in the 
opposite direction to ACh as was speculated so the data could not substantiate our 
speculation that ATP initiates a response pattern alternative to that induced by ACh.
We were unable to visualise a variation in response pattern between ACh and ATP 
from the series of experiments conducted as both appeared to follow the same 
pattern of response which initiated at the apical pole and moved to the basolateral 
pole. ACh produces a well known spatial/temporal pattern of Ca2+ signal which 
moves clearly from the apical to the basolateral pole (Harmer, Smith et al. 2005) and 
we speculated that ATP may induce a signal at the basolateral pole which might 
move to the apical pole and so move in a totally opposite direction compared to ACh. 
Both responses appear to follow the same approximate pattern of response and 
move to approximately the same areas of the cell which would suggest that there is 
no variation in the response between ACh and ATP. So ACh and ATP demonstrated 
very similar patterns of response overall.
So in summary this data would suggest that ATP does induce a variation in response 
compared to ACh with respect to Ca2+ stores mobilized based on the observed
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additive effect of response between ACh and ATP. We cannot explain how cells may 
use ATP as part of a stress signal or how cells may differentiate between ACh and 
ATP when the responses appear indistinguishable. We speculated that ACh and ATP 
would produce different Ca2+ signals but we observed no variation in movement of 
the responses induced by ACh and ATP as ATP appeared to initiate at the same 
point as ACh and apparently follows the same pattern of response with the exception 
of the lack of oscillation induced by ATP. Further experiments would be required to 
elucidate the effect of elevated ATP levels in acinar cells.
205
Chapter Seven
Results
Cell -  Cell Coupling and the 
Effects of Nitric Oxide
U N I V E R S I T Y  O F
LIVERPOOL
Introduction
The aim of these experiments was to determine if acinar cells communicate at an 
intercellular level and how this may occur. We hypothesised that some degree of cell 
to cell communication must occur within salivary glands and would be vital for 
salivary secretion. A key feature in Sjögrens syndrome is infiltration of lymphocytes at 
specific loci within the salivary and lacrimal glands. Based on this fact we 
hypothesised that the main reason for this may be due to specific cells within the 
salivary and lacrimal glands attracting the lymphocytes and suggested that such cells 
may function as so called ‘pacemaker’ cells. The existence of such cells would go 
some way to explain why a whole gland may be inhibited by the presence of a limited 
number of lymphocytes.
We determined that the level of synergy between cells may be demonstrated by the 
degree of synchrony observed between specific cells. The level observed is the cells 
Ca2+ response to ACh with or without the presence of NO. Cells were selected under 
specific conditions, where cell to cell communication may or may not occur, and the 
degree of synchrony analysed. The level of synchrony was determined by how in 
phase or out of phase the cells were i.e. how similar their patterns of response were. 
We also tried to identify if any cell within specific groups of cells appeared to regulate 
the responses of other cells i.e. controlling their response pattern and determining 
when they would respond.
The experiments with NO were selected to determine what effect NO may have at 
the multiple cell level based on its effect at the single cell level.
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Part A: Change in [Ca2+]i signal in response to a series of 50nM ACh stimulations in 
the absence and presence of 200pM NOC-12 in mouse submandibular acinar cells 
maintained in primary culture for 2 hours and presented as a specific section of an 
experimental trace (see scale bar).
Part B: The section of experimental trace taken from part A and broken down into the 
two specific selected cells responses at each time point with each stimulation point of 
interest given as an individual figure at each time point and then shown in relation to 
one another (see scale bar).
Cell one is designated by red and cell two is designated by green.
The cells presented here are in different acini and are therefore not connected so 
there is little chance of cell to cell communication occurring.
Figure 7.1.1
Change in [Ca2+]j signal in response to 50nM ACh in the absence and presence of
200pM NOC-12 demonstrating no degree of synchronisation.
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ACh 50 nM 1=1
Part A: Change in [Ca2+], signal in response to a single 50nM ACh stimulation in 
mouse submandibular acinar cells maintained in primary culture for 2 hours, taken 
from the 2nd application point from figure 7.1.1 and presented as a specific section of 
the experimental trace and marked in figure 7.1.1 part B by the single shaded strip 
(see scale bar).
Part B: A sequence of TIF images illustrating the cells responding in real time. The 
sequence of TIF images equate exactly to each numbered vertical shaded area 
presented on the trace in part A.
Cell one designated as red, cell two designated as green.
The cells presented here are in different acini and are therefore not connected so 
there is little chance of cell to cell communication occurring.
Figure 7.1.2
Change in [Ca2+]i signal in response to 50nM ACh demonstrating no degree of
synchronisation.
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Part A: Change in [Ca2+]i signal in response to repeated 50nM ACh stimulation in 
mouse submandibular acinar cells maintained in primary culture for 24 hours and 
presented as a whole experimental trace (see scale bar).
Part B: The whole experimental trace from part A broken down into each specific 
response time point and with each stimulation point presented as an individual figure 
for each of the three selected cells and then shown in relation to one another (see 
scale bar).
Cell one designated as red, cell two designated as green and cell three designated 
as blue.
The cells presented here are within the same acini.
Figure 7.1.3
Change in [Ca2+]i signal in response to 50nM ACh demonstrating lack of
synchronisation.
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Part A: Change in [Ca2+]i signal in response to a single 50nM ACh stimulation in 
mouse submandibular acinar cells maintained in primary culture for 24 hours 
produced at the 5th application point given as a specific section of the experimental 
trace illustrated in figure 7.1.3 part A and marked by the first horizontal shaded strip 
in figure 7.1.3 part B (see scale bar).
Part B: A sequence of TIF images illustrating the cells responding in real time. The 
sequence of TIF images equate exactly to each vertical shaded line given on the 
trace in part A.
Cell one designated as red, cell two designated as green and cell three designated 
as blue.
The cells presented here are within the same acini.
Figure 7.1.4
Change in [Ca2+]i signal in response to 50nM ACh demonstrating lack of
synchronisation at 5th stimulation point.
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Part A: Change in [Ca2+]i signal in response to a single 50nM ACh stimulation in 
mouse submandibular acinar cells maintained in primary culture for 24 hours 
produced at the 13th application point given as a specific section of the experimental 
trace illustrated in figure 7.1.3 part A and marked by the second horizontal shaded 
line in figure 7.1.3 part B (see scale bar).
Part B: A sequence of TIF images illustrating the cells responding in real time. The 
sequence of TIF images equate exactly to each vertical numbered shaded line given 
on the trace in part A.
Cell one designated as red, cell two designated as green and cell three designated 
as blue.
The cells presented here are in the same acini.
Figure 7.1.5
Change in [Ca2+]j signal in response to 50nM ACh demonstrating lack of
synchronisation at 13th stimulation point.
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A ACh 50 nM 13th Application
Part A: Change in [Ca2+]j signal in response to 50nM ACh stimulation in human 
submandibular acinar cells maintained in primary culture for 48 hours, given as a 
specific section of trace (see scale bar).
Part B: A sequence of TIF images illustrating the cells responding in real time. The 
sequence of TIF images equate exactly to the vertical grey lines presented on the 
trace in part A.
Cell one designated as red, cell two designated as green.
Cells are within the same acini and in direct contact with one another.
Figure 7.1.6
Change in [Ca2+]i signal in response to 50nM ACh demonstrating cell -  cell
communication.
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Change in [Ca2+]i signal in response to 50nM ACh in the absence and presence of 
200pM NOC-12 demonstrating synchronisation.
Part A: Change in [Ca2+]i signal in response to repeated 50nM ACh stimulation in the 
presence of 200pM NOC-12 in mouse submandibular acinar cells maintained in 
primary culture for 2 hours and presented as a whole experimental trace (see scale 
bar).
Part B: The whole experimental trace from part A broken down into each specific 
response time point for each of the three selected cells and with each stimulation 
point presented as an individual figure at each time point and then shown in relation 
to one another (see scale bar).
Cell one designated as red, cell two designated as green and cell three designated 
as blue.
The cells presented here are in the same acini.
Figure 7.1.7
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Part A: Change in [Ca2+]j signal in response to a single 50nM ACh stimulation in 
mouse submandibular acinar cells maintained in primary culture for 2 hours produced 
at the 1st application point given as a section of the experimental trace taken from a 
specific stimulation point from figure 7.1.7 part A and marked by the first horizontal 
shaded strip in figure 7.1.7 part B (see scale bar).
Part B: A sequence of TIF images illustrating the cells responding in real time. The 
sequence of TIF images equate exactly to the numbered vertical shaded lines 
presented on the trace in part A.
Cell one designated as red, cell two designated as green and cell three designated 
as blue.
The cells presented here are in the same acini.
Figure 7.1.8
Change in [Ca2+]i signal in response to 50nM ACh demonstrating synchronisation at
the 1st stimulation point.
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Figure 7.1.9
Change in [Ca2+]i signal in response to 50nM ACh in the presence of 200pM NOC-12 
demonstrating synchronisation at the 7th stimulation point.
Part A: Change in [Ca2+]i signal in response to a single 50nM ACh stimulation in the 
presence of 200pM NOC-12 in mouse submandibular acinar cells maintained in 
primary culture for 2 hours produced at the 7th application point given as a section of 
the experimental trace and taken from a specific stimulation point from figure 7.1.7 
part A and marked by the second horizontal shaded strip in figure 7.1.7 part B (see 
scale bar).
Part B: A sequence of TIF images illustrating the cells responding in real time. The 
sequence of TIF images equate exactly to the numbered vertical shaded lines 
presented on the trace in part A.
Cell one designated as red, cell two designated as green and cell three designated 
as blue.
The cells presented here are in the same acini.
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A ACh 50 nM in the presence of NOC-12 200pM 7th Application
225
Following the results achieved using nitric oxide on submandibular and lacrimal 
acinar cells the degree of cell to cell communication was investigated. Acinar cells 
were selected dependent on the degree of oscillation and the number of cells 
present. As mentioned in earlier sections (Chapter 3 results nitric oxide and mouse 
submandibular acinar cells) the cells selected responded typically to ACh and gave 
good oscillations in [Ca2+]i response signal. The preliminary measure of how well 
coupled cells are is the extent to which the Ca2+ oscillations are synchronised. This 
pattern of response offered an opportunity to study the progression of the Ca2+ waves 
across individual cells and the communication of Ca2+ signals from one cell to 
another. Cells which demonstrated no degree of contact were initially observed 
during stimulation to determine the degree of cell to cell communication and what 
effect this may have on the pattern of response. The data in figure 7.1.1 part A show 
the series of experimental time points where responses to 50nM ACh occurred in the 
presence or absence of 200pM NOC-12. Figure 7.1.1 part A shows a section of 
experimental trace demonstrating a series of nice oscillatory responses to stimulation 
in the presence and absence of 200pM NOC-12.
The data in figure 7.1.1 part B show the individual stimulation points which occurred 
in figure 7.1.1 part A numbered 1 to 4 with cell one designated by red and cell two 
designated by green and the experimental trace from part A broken down into the 
two individual responses at each specific response time point. These two individual 
illustrations at each time point in figure 7.1.1 part B show the two separate cells 
[Ca2+]i signal responses to stimulation with ACh 50nM in the absence and presence 
of 200pM NOC-12 in mouse submandibular acinar cells.
The first cell designated by the red trace in figure 7.1.1 part B which is presented as 
the first column of responses appears to maintain a good oscillatory response pattern 
which varies very little at each stimulation point. The second cell designated by the
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green trace and presented as the second column of responses has a much more 
random oscillatory pattern compared to cell one. Both have obvious oscillations and 
cell one has a good initial response spike whereas cell two does not appear to have 
a response initiation spike. The data show how the oscillatory responses of the two 
acinar cells changed over this specific experimental time period. Cell one has a nice 
regular oscillatory pattern whereas cell two has a much more random response 
pattern. The two traces in figure 7.1.1 part B do not demonstrate any degree of 
synchronisation when compared to one another.
The data presented in figure 7.1.2 show a specific time point selected from figure
7.1.1. This specific stimulation point is marked by the single horizontal shaded region 
on figure 7.1.1 part B and is the 2nd stimulation of the mouse submandibular acinar 
cells by 50nM ACh and occurs in the absence of 200pM NOC-12. Figure 7.1.2 part A 
is the two individual illustrations from the 2nd ACh stimulation placed together as a 
section of experimental trace to allow analysis of synchronisation between the two 
cells. Figure 7.1.2 part B is a series of TIFS numbered 1 to 36 which equate to the 
series of vertical shadings presented in figure 7.1.2 part A and show the real time 
responses of the two selected mouse submandibular acinar cells and allow the 
pattern of response to be observed.
The data in figure 7.1.2 would suggest that there is no degree of synchronisation 
between these cells at this experimental time point as the cells have no obvious 
response pattern with relation to one another and have independent oscillatory 
patterns. This could suggest that the cells require direct cell to cell contact to induce 
a unified oscillatory pattern. This particular experiment shows the two clearly 
disconnected cells responding with totally random patterns with relation to one 
another. The data appears to confirm that acinar cells require cell to cell contact to 
allow synchronisation of the oscillatory pattern and that synchronisation is not a result
227
of the cells natural rhythm. The acinar cells would have no direct reason to oscillate 
together. So any observed synchronous oscillations would be the result of cells 
communicating cell to cell so acinar cells would not naturally oscillate at roughly the 
same frequency. The data in figures 7.1.1 and 7.1.2 demonstrate the lack of 
oscillatory rhythm between two disconnected cells so no direct contact between cells 
means no synchronisation of oscillatory rhythm.
The data in cell to cell figure 7.1.3 part A shows a whole experimental trace with 
repeated 50nM ACh stimulation in mouse submandibular acinar cells. The 
stimulations occurred at specific time points numbered 1 to 15. The data in figure
7.1.3 part B shows the whole experimental trace from part A broken down into each 
specific response time point and each point is subsequently broken down into three 
individual illustrations of response. These three individual illustrations at each time 
point in figure 7.1.3 part B show the three separate cells change in [Ca2+]j signal in 
response to stimulation with ACh 50nM in mouse submandibular acinar cells. The 
data show how the oscillatory responses of the three acinar cells changed over the 
experimental time course.
The first cell designated by the red traces and shown as the first of the three 
illustration sets initially has no obvious oscillations and the two other cells are 
designated by green for the second cell and blue for the third cell and green and blue 
only appear to have initial spikes of response and no overly obvious oscillations. The 
patterns of oscillations gradually increase for all three selected cells at each further 
experimental time point. The cell two is also the first to initiate a response and is 
observed to increase its level of oscillations more rapidly and the oscillations are 
much more obvious in this particular cell. The levels of oscillations also seem to 
decrease over time towards the end of the experimental time frame for cell three and
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is reduced in cell two but cell one seems to maintain its oscillatory level relatively 
well.
The data presented in cell to cell figures 7.1.4 and 7.1.5 show specific time points 
selected from figure 7.1.3. These specific stimulation points are marked by two 
horizontal shaded bands on figure 7.1.3 part B and are the 5th and 13th stimulation of 
the mouse submandibular acinar cells by 50nM ACh. Figure 7.1.4 part A is the three 
individual illustrations from the 5th ACh stimulation placed together as a section of 
experimental trace to allow analysis of synchronisation between the three cells. 
Figure 7.1.4 part B is a series of TIFS numbered 1 to 23 which equate exactly to the 
series of vertical bands present on figure 7.1.4 part A and show the real time 
responses of the mouse submandibular acinar cells. The data in figure 7.1.4 would 
suggest that there is no degree of synchronisation between these cells at this 
experimental time point as the cells have no obvious response pattern with relation to 
one another and have apparently independent oscillatory patterns.
The data in figure 7.1.5 part A is the three individual illustrations from the 13th ACh 
stimulation placed together as a section of experimental trace to allow analysis of 
synchronisation between the three cells. Figure 7.1.5 part B is a series of TIFS 
numbered 1 to 23 which equate exactly to the series of vertical bands present on 
figure 7.1.5 part A and show the real time responses of the mouse submandibular 
acinar cells. The data in figure 7.1.5 would suggest that there is no degree of 
synchronisation between these cells at this experimental time point as the cells have 
no obvious response pattern with relation to one another and have independent 
oscillatory patterns. The cells do not appear to be coupled and no cross talk between 
cells is apparent.
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The data in figures 7.1.4 and 7.1.5 suggest that the designated cells do not 
demonstrate any degree of synchronisation initially and do not become more 
synchronous over the duration of the experiment. The only apparent variation in 
response over time is the change in time delay between the individual cells initiation 
of responses which appears to reduce. Cell one and cell three have much more 
similar patterns of response when all three cells are directly compared. Cell two has 
a much more obvious oscillatory pattern and always responds first to ACh 50nM 
stimulation. The cells do not appear to demonstrate any degree of cell to cell 
communication and these data also suggest that acinar cells do not have a natural 
oscillatory rhythm at which they respond as the cells were not synchronous so 
synchronicity appears to be dependent on cell to cell communication.
However, the data in figure 7.1.6 part A demonstrates clear cell to cell coupling as 
one cell controls the initiation of the [Ca2+]i response in the other cell in a small clump 
of human submandibular acinar cells. The responses demonstrate a clear oscillatory 
response pattern which is maintained throughout the duration of the [Ca2+]j response 
to 50nM ACh. The first cell designated by red always initiates a [Ca2+]i response 
which is followed by a [Ca2+]i response in the other cell designated by green. The red 
cell has an oscillatory frequency that is exactly twice that of the frequency of the 
other cell but keeps the other cell in the same phase. This data suggests that the first 
cell is acting as a pacemaker cell as discussed earlier (Chapter 1 Introduction 1.4 
cell-cell coupling section). The series of TIF images presented in figure 7.1.6 part B 
show the clear pattern of response in the acinar cells in real time and allow the 
transmission of the response [Ca2+]i signal to be followed from cell to cell and it is 
clear from these sequence of images numbered 5 to 8 that the Ca2+ signal in the red 
designated cell is driving that in the green designated cell. The cells in figure 7.1.6 
demonstrate spontaneous cell to cell communication and give the appearance of cell 
to cell communication. The data in figure 7.1.6 demonstrates a very clear example of
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cell to cell Ca2+ signalling. These data suggest that there may be a role for 
pacemaker cells in submandibular cells and subsequently a role in glandular 
hypofunction in SjS.
Based on these responses we then wanted to know what effect NO had on cell to cell 
coupling and whether NO altered Ca2+ signalling between acinar cells. The data in 
figure 7.1.7 part A shows a whole experimental trace with repeated 50nM ACh 
stimulation in the presence of 200pM NOC-12 in mouse submandibular acinar cells. 
The stimulations occurred at specific time points numbered 1 to 13. The data in figure
7.1.7 part B shows the whole experimental trace from part A broken down into each 
specific response time point and each point is subsequently broken down into three 
individual illustrations of response. These three individual illustrations at each time 
point in figure 7.1.7 part B represent the three separate selected cells change in 
[Ca2+]i signal in response to stimulation with ACh 50nM in the absence and presence 
of 200pM NOC-12 in mouse submandibular acinar cells. The data show how the 
oscillatory responses of the three acinar cells changed over the experimental time 
course.
All three selected cells (designated by red for cell one, green for cell two and blue for 
cell three) regions initially have good obvious oscillations and cell one appears to 
maintain its pattern of response relatively well over the experimental duration. Cell 
two and cell three do become slightly less oscillatory over the duration of the 
experiment. Cell three designated by the blue traces also seems to develop a large 
response spike upon initiation of the [Ca2+]i response signal over the duration of the 
experiment but conversely the size of the response spike upon initiation of the [Ca2+]i 
signal in the cell two designated by the green traces decreases. Cells one and two 
maintain their response initiation pattern throughout the duration of the experiment 
but the time lag between the initiation of response between these two cells and cell
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three increases over the experimental time period. Cell one designated by the red 
traces maintains its oscillatory pattern throughout the duration of the experiment and 
the cells designated two and three also maintain their oscillatory patterns relatively 
well.
The data presented in figures 7.1.8 and 7.1.9 show specific time points selected from 
figure 7.1.7. These specific stimulation points are marked by two horizontal shaded 
regions on figure 7.1.7 part B and are the 1st and 7th stimulation of the mouse 
submandibular acinar cells by 50nM ACh in the presence of 200pM NOC-12. Figure
7.1.8 part A is the three individual illustrations from the 1st ACh stimulation placed 
together as a section of experimental trace to allow analysis of synchronisation 
between the three cells. Figure 7.1.8 part B is a series of TIFS numbered 1 to 36 
which equate exactly to the series of vertical numbered lines present on figure 7.1.8 
part A and show the real time responses of the mouse submandibular acinar cells. 
The data in figure 7.1.8 would suggest that there is a degree of synchronisation 
between these cells at this experimental time point as the cells have an obvious 
response pattern with relation to one another and appear to have a relatively 
synchronous oscillatory pattern. There appears to be a degree of order with relation 
to response which the cells follow throughout the duration of this particular 
stimulation with 50nM ACh in the presence of 200pM NOC-12.
Figure 7.1.9 part A is the three individual illustrations from the 7th ACh stimulation 
placed together as a section of experimental trace to allow analysis of 
synchronisation between the three cells. Figure 7.1.9 part B is a series of TIFS 
numbered 1 to 36 which equate exactly to the series of vertical lines present on 
figure 7.1.9 part A and show the real time responses of the mouse submandibular 
acinar cells. The data in figure 7.1.9 would suggest that the degree of 
synchronisation observed in figure 7.1.8 has been enhanced. The cells appear to be
232
more synchronous at this time point and still follow a specific response order so the 
cells do appear to be coupled in this instance. The data presented in figures 7.1.7 to
7.1.9 would suggest that cross talk between the cells is occurring as the cells seem 
to be further synchronised in figure 7.1.9 compared to figure 7.1.8 so the cells are 
more synchronous at the 7th time point than at the 1st time point but show 
synchronicity throughout the duration of the experiment.
The data in figures 7.1.8 and 7.1.9 suggest that the designated cells are synchronous 
and become more synchronous over the duration of the experimental time period. 
The cells appear to follow a specific response pattern with relation to one another 
and maintain this pattern throughout the duration of the experiment. The data in 
figures 7.1.8 and 7.1.9 demonstrate that the cells are relatively synchronous 
throughout the duration of the experiment. The first response to ACh shown in figure 
7.1.8 occurs in the absence of 200pM NOC-12 and the cells are still obviously 
synchronous so the synchronicity is not a result of the NOC-12. However, the cells 
do seem to become more synchronous over the duration of the experimental time 
period as is clear in figure 7.1.9 so NOC-12 may enhance synchronicity but does not 
appear to induce it based on these data.
So in summary when acinar cells oscillate there is a tendency for the oscillatory 
signals to adopt very similar periodicity and phase. This tendency increases with the 
application of repeated stimulation with ACh but in contrast cells that are not touching 
show no evidence of synchronisation and have varying periodicity and phase. The 
data presented here show that the Ca2+ signal may serve to integrate the secretory 
responses of individual acinar cells into a functional unit. Furthermore, prolonged 
exposure to NO did not affect the aspect of cell to cell signalling which is very 
important as NO did induce desensitisation at the single cell level. When the cells are 
not in direct contact there is not opportunity for cell to cell communication and as a
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result there is no cell to cell communication. These data suggest that when cells are 
in direct contact they do appear to talk and NO seems to increase the degree of 
synchronisation over the experimental time period. However, in these experiments it 
is hard to determine whether any one cell is acting to direct the function of those near 
based on the use of primary perfusion which bathes all cells equally. But the data 
presented in figure 7.1.6 does suggest cell to cell communication and shows clear 
periodicity and the ability of one cell to drive the response in other neighbouring cells. 
So the existence of cell to cell communication in acinar cells would provide an 
opportunity to understand how limiting factors may induce hypofunction of the whole 
gland in SjS.
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Chapter Eight
Discussion, Conclusion 
& Future Work
U N I V E R S I T Y  O f
LIVERPOOL
8.1 Introduction
Sjogren's syndrome (SjS) is one of the three most common autoimmune disorders 
(Pillemer, Matteson et al. 2001), which has been demonstrated to have a population 
prevalence similar to that of rheumatoid arthritis (Hazes and Silman 1990). 
Individuals with SjS have been noted to have features which predispose them to 
development of the disease. Evidence shows that sufferers have specific genetic 
similarities in relation to HLA-linkages and in particular there is a prevalence of HLA- 
DR2, DR3, DR5 and HLA-B8 (Scully 1986; Fox, Tornwall et al. 1999; Jonsson, Haga 
et al. 2000). It is also likely that there is a hormone related factor which may 
contribute to the disease in SjS based on the strong sexual dimorphism with female 
prevalence at a ratio of 9:1 compared to males (Scully 1986). Depending on genetic 
predisposition any immune response which affects homeostasis of the glandular 
environment may give rise to glandular dysregulation and result in the development 
of autoimmunity.
It was originally assumed that the lack of saliva produced by SjS patients was the 
direct result of glandular atrophy as a consequence of immune mediated destruction 
of the acinar cells (Scully 1986). However, it was more recently observed that most 
SjS patients have large quantities of residual acinar tissue which appears 
histologically normal but simply does not function (Fox and Maruyama 1997; Fox, 
Tornwall et al. 1999; Humphreys-Beher, Brayer et al. 1999). Following the realisation 
that many SjS patients have residual tissue, Dawson and colleagues conducted 
experiments on human labial acinar cells taken from SjS patients and demonstrated 
that the cells have the ability to respond to stimulation in vitro (Dawson, Field et al.
2001). However, the cells do exhibit decreased sensitivity to ACh which was shown 
as a right shift in concentration dependence. Such findings suggest that the lack of
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fluid secretion observed in SjS is not a direct result of glandular atrophy but more 
likely a result of glandular hypofunction. Advancements in the understanding of SjS 
and the identification of the underlying mechanisms involved give greater scope for 
the development of future treatments and future hope for SjS patients.
One factor which is clear is that when salivary glands respond to an insult they 
always induce inflammation regardless of the source of the initial challenge. 
Inflammation of the salivary glands is associated with increases in capillary 
permeability which would most likely be mediated by NO. NO is a known potent 
vasodilator and was originally identified based on its relaxation of endothelial tissue.
Desensitisation of the acinar cells and the stress conditions induced are the primary 
focus of the research presented in this thesis and may go some way to explain the 
glandular hypofunction observed in SjS.
The determination that NO is elevated in SjS may have important implications as the 
data strongly suggest that NO may have the ability to modulate the magnitude of the 
[Ca2+]i subsequent to salivary acinar cell stimulation by agonist. In Sjogren’s 
syndrome sources of NO include not only that produced by invading immune cells 
but also NO may be produced by the salivary and lacrimal acinar cells themselves as 
NOS activity and cGMP production were significantly increased following activation of 
muscarinic receptors by antimuscarinic antibodies or carbachol (Bacman, Berra et al. 
1998; Perez Leiros, Sterin-Borda et al. 1999; Bacman, Berra et al. 2001) in a Ca2+- 
dependent manner. Any increased permeability induced by NO would allow 
inflammatory bodies such as lymphocytes and macrophages to enter the glandular 
interstitium and these are also known to release NO so could in theory increase the 
problem induced by NO as they allow more NO to become available which in turn 
would allow more lymphocytes to enter the salivary glands.
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8.2 A Possible role for nitric oxide in acinar hypofunction
The primary focus of this investigation was the identification of the physiological roles 
of NO in the fluid secretion pathway.
The sum of the data presented here could indicate that NO may have a physiological 
role under normal conditions and may function acutely to induce an increased rate of 
secretion by sensitising the acinar cells to ACh. It is impossible to determine the 
actual physiological levels of NO as it is rapidly broken down so we do not know the 
actual levels present in vivo as they would be difficult to determine so we cannot say 
how accurately the levels we used in vivo compare to those found in vitro. My 
findings also highlighted a possible role for NO in the development of acinar 
hypofunction through desensitisation of the acinar cells to ACh following chronic 
exposure to NO. The NO induced desensitisation could suggest a role for NO in SjS.
This interest in NO is based on the knowledge that increased levels of NO have been 
demonstrated in both the saliva (Konttinen, Platts et al. 1997) and the expired air 
from patients with SjS (Ludviksdottir, Janson et al. 1999). It has also been reported 
that the levels of NOS are elevated in the labial glands of patients with SjS 
(Konttinen, Platts et al. 1997) and evidence suggests that SjS IgG may have the 
capacity to increase levels of NOS and cGMP in both salivary and lacrimal acinar 
cells (Bacman, Berra et al. 1998; Perez Leiros, Sterin-Borda et al. 1999; Bacman, 
Berra et al. 2001).
NO donors have previously been used to stimulate salivary acinar cells to mobilise 
Ca2+ (Looms, Tritsaris et al. 2001), which was suggested to most likely occur through 
activation of the RyR. Previous work conducted in other cell types (Galione, 
McDougall et al. 1993; Galione, White et al. 1993) determined that the formation of
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cADPr was linked to the formation of cGMP, which in turn is produced in response to 
cell stimulation with NO (Denninger and Marietta 1999) and this was confirmed by 
the 2001 study by Looms and colleagues (Looms, Tritsaris et al. 2001). We initially 
found that higher concentrations of NO donor were able to induce spontaneous Ca2+ 
release, in the absence of agonist stimulation (Figure 3.1.1). In this study it was 
demonstrated that exposure of mouse submandibular acinar cells to NO initially 
increased the acinar cells sensitivity to ACh. This initial amplification of the response 
induced by NO may be explained by the normal secretory pathway involving cADPr 
(Galione, McDougall et al. 1993; Galione and White 1994); (Guse 1999); (Galione 
and Churchill 2000; Galione and Churchill 2002). We understand how hypersecretion 
may be induced by NO and the amplification induced by acute application of NO 
observed in my data makes sense in relation to current knowledge. This type of 
phenomenon has previously been reported in mouse submandibular acinar cells that 
were exposed to cADPr prior to stimulation with ACh (Harmer, Gallacher et al. 2001). 
In acinar cells the release of Ca2+ through the RyR is not considered to be the point 
of initiation of the Ca2+ signal but these results are consistent with data which 
demonstrated that high concentrations of cADPr, which is now known to be the 
endogenous RyR agonist, induced mobilisation of Ca2+ (Galione and White 1994); 
(Harmer, Smith et al. 2001).
The most likely role of cADPr and RyR is modulation of the ACh-evoked Ca2+ signal 
but it must also be noted that mobilisation of Ca2+following cADPr stimulation of RyR 
is not necessarily coupled to activation of an extracellular receptor. My experimental 
protocol was designed to be as close as possible to physiological conditions in order 
to determine whether NO had the capacity to function in a regulatory role with regard 
to RyR, however the concentrations selected were levels which we believed would 
be most appropriate to levels found in SjS patients but as stated previously it is
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impossible to determine this accurately due to the very nature of NO. My data show 
that, in both human and mouse submandibular cells and also mouse lacrimal cells, 
exposure to NO donor enhanced the subsequent response to agonist stimulation. 
This is most likely the direct result of NO release rather than an artefact of a 
particular NO donor because similar enhancement was observed using three 
chemically unrelated NO donors, SNAP, SNP and NOC-12 and also a second type of 
NOC, NOC-5. The increased levels of cADPr induced by NO would be expected to 
induce increased acinar cell sensitivity to ACh and may also account for findings in 
MRL/ipr mice whose cells exhibited hypersensitivity to ACh in vitro (Zoukhri, Hodges 
etal. 1998).
The amplification of the ACh response was suggested to be induced through the 
cADPr pathway and the use of two inhibitors of this pathway, ODQ and Ryanodine, 
demonstrated that this was most likely the case. Both inhibitors removed the 
previously observed NO induced amplification. These two inhibitors were selected as 
ODQ blocks the activation of sGC and so acts at the initiation of the pathway and 
Ryanodine blocks the RyR directly and so acts at the termination of the pathway. 
These two inhibitors prove that the NO induced amplification of the ACh response in 
acinar cells is acting in a cGMP-dependent manner. However, in SjS we observe 
hypofunction not hyperfunction and so proposed that the hypofunction which may be 
induced by NO must occur over a more prolonged time period so more chronic 
experiments were conducted.
When the acinar cells were exposed to NO chronically the major observation was the 
induced inhibition of response to ACh over time. This was again proved to be 
independent of the NO donor type used as all NO donors exhibited a similar pattern 
of response. The type of cell used also had no effect on outcome as all three cell 
types exhibited a similar pattern of response to NO donor. The sum of these findings
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may suggest a possible universal mechanism which is conserved between cell types 
and also between species.
The cause of the inhibition was suggested to be most likely the direct result of Ca2+ 
store depletion which would be logical as if the stores are depleted there is no Ca2+ to 
mobilise which would result in a lack of response to ACh. However, this was proved 
not to be the case as the use of Thapsigargin, an inhibitor of the SERCA pump 
(Smith and Gallacher 1994); (Smith and Reed 1996), induced an observable Ca2+ 
response (Figure 3.1.12) and so demonstrated that stores were still able to function 
and inhibition is not the result of a lack of Ca2+. This then suggested that the inhibition 
could be related to the cGMP pathway but the use of ODQ disproved this as the 
reduction in response to ACh still occurred in the presence of ODQ so the inhibition 
is independent of the cGMP pathway.
The next suggested cause was desensitisation of the RyR directly, but inhibition of 
the ACh response still occurred when Ryanodine was used following prolonged 
exposure to NO. These data were more problematic than ODQ as the use of 
Ryanodine in the absence of NO donor induced a significant inhibition of the ACh 
response in all three cell types, this is understandable as Ryanodine acts to block the 
RyR directly. There appeared to be no observable additive effect between ryanodine 
and NO donor together in the mouse submandibular and lacrimal acinar cells. 
However, there was some degree of additive effect observed in the human 
submandibular acinar cells as the level decreased more rapidly when NOC-12 and 
Ryanodine were used together than when NOC-12 was used alone and when only 
Ryanodine was used an increased level of inhibition was also observed in this cell 
type. This suggests that the human submandibular cells are more sensitive to 
Ryanodine than the mouse cells but the human cells were generally more sensitive. 
The sum of these findings suggests that the inhibition induced by NO was
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independent of the cGMP pathway but as figure 3.1.12 proved it was not a result of 
Ca2+ store depletion which led to the suggestion that the inhibition may be the result 
of nitrosylation.
Until relatively recently it was thought that the only outcome of nitrosylation was 
apoptosis as apoptosis occurred when proteins were nitrosylated (Sarih, 
Souvannavong et al. 1993) and other evidence showed that local high concentrations 
of NO may induce nitrosylation of aa residues which could cause cellular dysfunction 
and possibly promote cell death (Denninger and Marietta 1999). However, it has 
since been determined that apoptosis is not the only consequence of nitrosylation as 
it has been shown that the nitrosylation of cysteine residues could regulate the 
function of a broad spectrum of proteins (Stamler, Lamas et al. 2001); (Dickinson and 
Forman 2002); (Brune 2005). Most recently there is evidence demonstrating the 
presence of signature residues or motifs within proteins that have the potential to act 
as targets for nitrosylation. Such motifs have been identified and extensively studied 
in RyR (Dulhunty, Gage et al. 2001); (Sun, Xu et al. 2003). However, these motifs are 
also found in the IP3R (Khan, Wagner et al. 2006), which is unsurprising based on 
their homology. We have no evidence to indicate that RyR are being down-regulated 
through nitrosylation and other components of the stimulus-secretion pathway may 
be the target of nitrosylation not RyR. There is also evidence to suggest that the 
targets of nitrosylation include muscarinic receptors and upon nitrosylation, the 
distribution of receptors at the cells surface may be affected (Maggio, Barbier et al. 
1995); (Wang, Moniri et al. 2006), which is another possible explanation for the 
desensitisation of the acinar cells to ACh. However, inhibition induced by nitrosylation 
of some component of the stimulus secretion pathway, perhaps RyR may provide the 
basis for a mechanism to explain the observed right shift in dose dependence in the 
labial glands of SjS patients (Dawson, Field et al. 2001) and also explain the 
desensitisation induced by NO observed in the experiments presented here.
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So in summary, although the best understood mechanism by which NO exerts its 
affects on cellular function is cGMP-dependent through the activation of sGC 
(Denninger and Marietta 1999), there are many ways in which NO is thought to 
mediate its biological effects both directly and indirectly such as nitrosylation 
(reviewed (Blaise, Gauvin et al. 2005)). The evidence presented from the chronic 
experiments is consistent with a role for NO in glandular hypofunction by a cGMP 
independent mechanism. This is possibly through s-nitrosylation of a key component 
of the stimulus-secretion pathway which is as yet unidentified. All four NO donors 
(SNAP, SNP, NOC-12 and NOC-5) produced similar patterns of response with the 
only variation being the degree of the response to ACh which was most likely related 
to the rate of NO release of the individual NO donors but was not investigated further. 
Acinar cells were also incubated with NO donors to determine the effect of NO 
following longer term chronic exposure, however, this appeared to have no obvious 
effect as hypofunction did not occur in the absence of repeated ACh stimulation but it 
was noted that when cells were stimulated with ACh the observed change in [Ca2+]i 
was much lower than the previous control responses which were not pre-incubated 
and as stated previously were reduced by approximately 50% compared to control.
So these data could certainly go some way towards explaining the observed right 
shift in the ACh concentration dependence in human labial glands from SjS patients 
(Dawson, Field et al. 2001) based on the knowledge that NO is known to be elevated 
in SjS (Konttinen, Platts et al. 1997); (Ludviksdottir, Janson et al. 1999); (Wanchu, 
Khullar et al. 2000); (Pertovaara, Antonen et al. 2007). It may be the chronic NO 
exposure of the salivary acinar cells of SjS patients in vivo which causes the reduced 
sensitivity of the acinar cells to ACh. We were able to re-produce this outcome in 
vitro by chronically exposing healthy acinar cells, from both human and mouse 
sources, to NO which led to the production of SjS like cells from previously healthy 
acinar cells. We have demonstrated that nitric oxide from four different nitric oxide
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donors is capable of significantly reducing or totally abolishing the acinar [Ca2+]i 
response to ACh and so has the capacity to induce glandular hypofunction. NO 
therefore fits into the proposed alternative non-apoptotic SjS model (Dawson, Fox et 
al. 2006).
8.3 A  Possible role for adenosine tri-phosphate in acinar hypofunction
The key theme of this thesis is desensitisation and the occurrence of stressful 
conditions in acinar cells. ACh is not the only Ca2+ mobilising agonist to which acinar 
tissue may be exposed in vitro. The other Ca2+ mobilising agonist which has been 
implicated under stressful conditions is ATP and ATP is suggested to act as a 
possible stress mediator. We wanted to see if time course and progression of a Ca2+ 
signal in response to ATP differed significantly from ACh. ACh has a specific and 
well characterised response pattern which initiates at the apical pole and spreads 
from there to the basolateral pole. We speculated that an ATP mediated signal may 
originate at a different point in the cell. Such variations in initiation point would allow a 
clear distinction between Ca2+ mediated fluid secretion and a Ca2+ mediated stress 
signal. My data (figure 6.1.1 part A) demonstrated the ability of mouse and human 
submandibular acinar cells and mouse lacrimal acinar cells to respond to ATP.
The ability to mobilise Ca2+ in response to stimulation by ATP has previously been 
demonstrated in both rat submandibular (McMillian, Soltoff et al. 1987; McMillian, 
Soltoff et al. 1988); (Dehaye, Moran et al. 1999) and mouse parotid gland (Gallacher 
1982) and data have suggested that the ability to secrete in response to ATP may be 
mediated by P2X and P2Y. More recent data demonstrated the ability of isolated 
human labial glands to respond to ATP (Pedersen, Dissing et al. 2000). My data 
(figure 6.1.1 parts B and C) also demonstrated a degree of additive effect between
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ACh and ATP. Based on the responses observed we may speculate that the 
response to both agonists is likely to occur through the same pathway and using the 
same G-protein coupled receptors. The ATP activity is likely to be through the P2Y 
which are known to be associated with G-protein activation. When the two agonists 
were used in conjunction there was an obvious additive effect, this was observed as 
an increased response as the level increased by approximately the same level as the 
ATP response when ATP was used in conjunction with ACh. If ATP and ACh 
mobilised Ca2+ from the same intracellular stores then this additive effect would not 
be observed.
At first sight it appears that the additive nature of the Ca2+ signal would suggest that 
at least some of the Ca2+ is mobilised by an alternative subset of Ca2+ stores by ATP. 
ACh may have a certain specific Ca2+ pool and ATP possibly has an alternative Ca2+ 
pool (Berridge, Lipp et al. 2000); (Petersen, Tepikin et al. 2001); (Berridge 2006); 
(Petersen and Tepikin 2008). This variation in pool may be the key to the variation in 
response that ACh and ATP induce as the mobilisation of Ca2+ from different stores 
may produce a different Ca2+ signal and this stimulates the variation in response of 
the acinar cells. My data also demonstrated the lack of an oscillatory response 
pattern following stimulation with ATP but an oscillatory response pattern was 
frequently observed when cells were stimulated with ACh which may also suggest 
that a possible variation in response pattern between these two agonists may be the 
factor which results in a variation in outcome and how Ca2+ may regulate two totally 
different signal types.
Following the initial observation that the response patterns induced by ACh and ATP 
where apparently the same response pattern across the cell was tracked to produce 
an experimental time course for each agonist (figures 6.1.2 and 6.1.3). The results 
suggested no variation in response between ACh and ATP as the images show that
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the response initiates at approximately the same point following stimulation with 
either agonist. This may possibly be due to limitations in the sampling system that 
was used as the resolution may not be adequate to visualise such variations in 
initiation point. The sum of these results suggested that there may not be differences 
in the initiation point of the signal between ACh and ATP but there could be 
variations in the Ca2+ pool that is mobilised following agonist stimulation but the data 
also suggests that the Ca2+ signal in response to ATP may be carried in the same 
manner as an ACh induced signal. This would mean that the same mechanisms are 
involved and the signal would also initiate at the apical pole and like a response to 
ACh would move from the apical pole to the basolateral (Thorn, Lawrie et al. 1993); 
(Harmer, Smith et al. 2005). This would explain the lack of variation in initiation point 
and may explain why signals induced by ACh and ATP appear to be the same.
8.4 A  Possib le role fo r cell - cell coupling in acinar hypofunction
The results so far have focussed on the factors which may induce acinar cell 
hypofunction at the single cell level. The functional unit of the salivary gland is more 
likely to be the acinus not the individual acini. The results presented in this section 
aim to shift the focus from the individual cell to the response of the cell as part of a 
group. The nature of the epilemmal arrangement of the nerves and the limited 
innervation within the salivary glands (Garrett and Kidd 1993) would be explained by 
cell to cell coupling as all cells within the salivary gland are unlikely to be exposed to 
the same stimulus. Cell to cell communication could function to propagate the signal 
to those cells which are less directly exposed to stimulus. So the organisation of the 
gland must allow signals to perpetuate throughout the gland with only a relatively 
limited nerve/acinar cell interface. If there is no actual variation between the
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individual acinar cells within an acinus then there will automatically be variations in 
the level of stimulation that each cell receives based on glandular innervation as 
some cells will always receive higher doses of stimulant simply due to their position 
with relation to the nerves. Communication between acinar cells would allow for 
unification of the response signal following stimulation. It would be pointless for cells 
to just signal randomly or for only one cell to be stimulated so there must be some 
degree of communication present in salivary acinar cells.
The experiments that we conducted in vitro were unable to mimic the exact effects 
experienced by the cells in vivo. The primary perfusion system stimulated all cells 
simultaneously which made the process of determining cell to cell coupling more 
difficult. The [Ca2+]i was inclined to rise simultaneously in all acinar cells within the 
small clumps investigated. However, there were occasions when agonist stimulation 
gave rise to a series of oscillations in [Ca2+]i and not prolonged plateau. When such 
responses occurred it presented the opportunity to observe the pattern of response 
and the progression of signal between cells. It became evident that in cells where 
communication was absent the oscillatory pattern was similar but there was no 
suggestion that the basic frequency was the same. Figures 7.1.1 and 7.1.2 were 
produced from cells situated in separate acini and so could not possibly be in direct 
contact and shared oscillatory pattern was observed which is what we anticipated as 
this lack of contact removes the cells ability to communicate directly with one 
another. These cells have no apparent natural frequency at which they respond and 
the lack of contact suggests that the lack of synchrony is due to a lack of cell to cell 
communication.
These data show that acinar cells do not appear to have the same fundamental 
frequency and there was no evidence to suggest that acinar cells have a natural 
basic frequency at which to oscillate. Cells respond at a similar frequency but are
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never synchronous as only tiny variations in the frequency will deter the cells from 
hitting and assuming the same phase if cells do not communicate cell to cell as 
shown in figures 7.1.3 to 7.1.5, which are situated within the same acini but do not 
appear to be communicating.
There is no direct reason why cells should be synchronous if they are not 
communicating because if they are not communicating they should never be 
synchronous. These data suggests two things: (i) cells do appear to communicate 
under normal circumstances; (ii) acinar cells must be in direct contact with one 
another for communication to occur.
The data in figure 7.1.9 shows that 1 cell appears to be in charge of the oscillation 
frequency. This would suggest the presence of pacemaker cells like those found in 
cardiac tissue (Bers 1991); (Katz 1992) which fire first in response to stimulation, as 
the pacemaker cells are those with the highest natural frequency and this frequency 
drives the response. So in acinar cells the cell which drives the frequency would be 
assumed to be the one with the highest natural frequency which would then produce 
a co-ordinated output like that observed in cardiac tissue. This type of response is 
observable in figure 7.1.6 which shows cells responding synchronously but cell one 
appears to drive the response and has an oscillatory pattern which is twice the 
frequency of the other cell. So this driving cell has a base frequency which is twice 
that of the other cell and as a result proceeds to induce the other cell to respond in 
the same phase and although the other cell is not as active it is still able to respond 
in exactly the same phase as the driving cell.
The results suggest that acinar cells do talk to each other and this may be a way of 
synchronising the cells of an acinus in a co-ordinated way to nerve stimulation. NO 
was observed to desensitise the cells at a single cellular level and if it also has the
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ability to inhibit cell to cell coupling then it may give rise to desensitisation at the level 
of the acinus. However, the data suggested that NO does not have an effect on cell 
to cell coupling and does not induce reduced synchronisation as shown in figures 
7.1.7 to 7.1.9 which show cells which are synchronised and responding together in 
phase and period in both the absence and presence of NO. Over the experimental 
time course of these experiments we did not observe any reduction in the level of cell 
to cell synchronisation of signalling. The data indicate that NO might actually 
enhance the level of synchronisation as the response in figure 7.1.9 is more 
synchronous than that observed in 7.1.8. So in summary we had expected to see 
reduced synchronisation in response to the presence of NO based on the 
desensitisation induced by NO at the single cell level which would make the gland 
less functional, but NO does not appear to affect synchronisation and does not 
appear to induce inhibition of response at the acinus level so the role of NO in cell to 
cell coupling is unclear.
So in summary the results presented in this study suggest that acinar cells do 
communicate in an intercellular manner and there is likely to be cellular coupling 
within the salivary glands. Intercellular signalling has been observed previously in 
acinar cells from rat parotid tissue using ATP and CCh (Segawa, Takemura et al.
2002). Their data demonstrated a variation in synchronicity of signalling between 
acini and duct cells and also more importantly that acinar cells within an acinus 
respond synchronously and behave as a functional unit (Segawa, Takemura et al. 
2002). My data would suggest that this may also occur in mouse submandibular 
acinar cells. The presence or absence of synchronisation is most likely due to 
variations between cells as observed in the variation between results from apparently 
similar groups of cells (figures 7.1.3 to 7.1.5 and 7.1.7 to 7.1.9). Cells must be in 
direct contact with one another to communicate as shown by figure 7.1.1 and 7.1.2 
as these cells exhibited no signs of synchronicity.
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These data also suggest that NO acts to increase the sensitivity of the cells to ACh 
and so make the cells more able to respond in a synchronous manner, so NO may 
act to prime the cells to ACh and enhance cellular coupling under normal conditions. 
However, in SjS the levels of NO are elevated which may lead to an excessive level 
of activation and unlike under normal conditions the level of enhancement induced by 
NO may be detrimental to cellular coupling which may reduce the level of 
synchronicity and therefore enhance the glandular hypo-function. In order for the 
whole acinus to function as a single unit there must be cell to cell communication as 
although individual cells function in response to stimulation the whole acinus will 
respond as a functional unit without cell to cell communication. These data also 
suggest that some cells do appear to have slightly increased frequencies of response 
and cells do appear to communicate which would be all that is required to make the 
acinus function as a unit.
So the theory of cell coupling in salivary glands could provide a suitable explanation 
as to why the individual cells within the salivary glands function as a whole unit and if 
these so called ‘pacemaker’ cells do exist it could go some way to explain why the 
infiltrating lymphocytes occur at such specific areas of the gland and have the ability 
to disable a whole gland through inhibition of a few cells. In summary the theory of 
cell to cell coupling with relation to SjS is extremely intriguing as it would provide a 
viable link between glandular hypofunction and the observable key features in SjS.
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8.5 A  m echanism  to account fo r acinar hypofunction in Sjogren's  
syndrom e
When you consider the vast number of interactions that are necessary for fluid 
secretion and the complexity of the process as a whole numerous factors could be 
responsible or involved in the SGH exhibited in SjS patients. The results from this 
study suggest that one of the most likely factors is de-sensitisation of the acinar cells 
to ACh and it would be expected that over time the lack of sensitivity to ACh and lack 
of function of the salivary glands would lead to glandular atrophy which would 
account for the classical model of destruction being the cause of SGH in SjS. The 
data from this study also show that cell coupling is likely to play an enormous part in 
SGH and would offer a viable explanation for the specificity of the lymphocytic 
infiltration points and how a relatively small number of lymphocytes may elicit 
inhibition in a whole gland. The progression of the disease is still unclear and even 
the initiating event is open to debate as the events which lead to the development of 
many autoimmune diseases such as SjS are still poorly understood.
We hypothesise based on the evidence presented in this study that the focal 
infiltration may be directed by the cellular organisation of the gland and the infiltrating 
cells may be attracted to the suggested ‘pace-maker’ cells. The elevated levels of 
NO may act to enhance this situation further by both allowing increased capillary 
permeability and by also de-sensitising individual acinar cells, which in combination 
could explain hypo-function of the whole gland.
It is highly likely that many factors are involved in the desensitisation of the acinar 
tissue in SjS which eventually leads to SGH. NO is produced following activation of 
NOS and the concentration of NO surrounding the acinar cells would be further 
increased by secretion of NO from the surrounding nerves but the greatest amount
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would be produced by the invading lymphocytes and macrophages, as NO is known 
to be produced at high concentrations by specialised immune cells such as 
macrophages and lymphocytes (Forstermann, Gath et al. 1995); (Lomniczi, Suburo 
et al. 1998). As the local concentration of NO increases there would be increased 
activation of sGC which would result in a subsequent increase in the intracellular 
concentration of cGMP. My data demonstrates that NO either directly or through 
activation of the RyR via cADPr alters acinar sensitivity to ACh. Following long term 
exposure to NO the cell changes state from hyper-excited to hypo-excited as it 
becomes less sensitive to ACh and as my data also suggested a process that may 
be mediated by a loss of muscarinic receptors based on inhibitory data. My study 
demonstrated that chronic exposure to NO did affect the ability of an acinar cell to 
respond to agonist. The acinar cells used in these experiments were isolated primary 
cells. My data also demonstrated that although NO did not induce cell coupling and 
synchronisation of the oscillatory pattern of the response it did appear to enhance the 
oscillatory pattern and made the cells more synchronised and so may also act as an 
intercellular messenger.
These ideas for the development of acinar hypofunction in SjS are still speculative, 
but we do appear to be getting closer to understanding the development of the 
disease and ultimately the cause of SGH in SjS following the initial attempts made to 
explain the novel finding of acinar desensitisation in SjS. The evidence suggesting 
the presence of synchronisation in acinar cells and the idea of cell coupling would go 
some way to explain and connect the many separate areas of research in SjS.
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C onclusion
Following chronic exposure to NO the acinar cells become desensitised in response 
to ACh. This desensitisation is seen in both submandibular and lacrimal and both 
human and mouse cells. My belief is that this desensitisation would be an important 
general mechanism that could possibly amplify the effects of other antisecretory 
agents such as the M3R antibodies found in some SjS individuals and so may 
account for the glandular hypofunction which is observed in SjS. So NO is suggested 
as a unifying feature and is likely to have a primary role in the development of 
glandular hypofunction in SjS as the results presented here demonstrate how chronic 
exposure to NO induced healthy acinar cells to become SjS like and much less 
sensitive to ACh. The presence of cell to cell communication may also provide a 
plausible explanation as to why in the case of SjS patients a small number of 
invading lymphocytes may inhibit a whole gland.
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Future w ork
In order to further explore the cause of acinar desensitisation to agonist in SjS, the 
point of NO activity must be determined as it appears to work independently of the 
cGMP pathway to induce hypo-function. The use of Biotinylation may prove useful to 
identify points of nitrosylation (Jaffrey, Erdjument-Bromage et al. 2001; Jaffrey and 
Snyder 2001) in acinar cells. The process identifies points of nitrosylation using the 
biotin switch method and visualises using immunoblotting techniques which may 
prove useful for mapping the effect of NO in acinar cells.
Further work conducted using more specific application of ATP may demonstrate 
variations in signal initiation points. A Patch clamp pipette could be used to 
administer ATP more directly to specific regions of a cell or the sampling rate may be 
increased to allow improved visualisation of the response initiation points.
Further work on cell to cell coupling including the use of patch clamp pipette on 
specific individual cells within a small cell clump to identify signal propagation 
between cells and how external factors may affect cell to cell coupling such as the 
use of IP3 which has previously been suggested as a possible intercellular signalling 
molecule (Rottingen and Iversen 2000).
The aim of this work is to provide hope for patients with SjS and also to allow the 
future development of treatments at least for those still in the early stages of the 
disease and hopefully to offer some alleviation of symptoms in most.
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